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Abstract 
Prdm14 is a member of the conserved family of Prdm proteins, which are 
emerging as crucial regulators of multiple early developmental processes and 
diseases. Members of the Prdm family are characterized by the presence of a 
single PR domain and a variable number of DNA-binding zinc fingers. Most 
members of the Prdm proteins directly influence transcription through intrinsic 
histone methyltransferase activity or recruitment of cofactors. In this thesis, a 
functional analysis of Prdm14 was undertaken to elucidate its role during early 
vertebrate development using the X. laevis model system.  
Prdm14 is expressed during gastrulation in the prospective 
neuroectoderm. At late neural plate stages, the expression is restricted to the 
territories of primary neurogenesis. In tailbud stage embryos, expression of 
prdm14 is detected in postmitotic neurons of the central nervous system and a 
subset of the cranial ganglia. Prdm14 is regulated positively by the proneural 
bHLH gene neurog2 and negatively by the Notch signaling pathway, which is 
strongly suggestive for a role during primary neurogenesis. Overexpression of 
prdm14 in X. laevis embryos promotes the proliferation of neural progenitor 
cells, which results in the expansion of the neural plate and in a transient 
inhibition of neuronal differentiation. In tailbud stage embryos, prdm14 
overexpression induces the formation of ectopic neurons in the non-neural 
ectoderm that express markers indicative of a sensory glutamatergic neuronal 
cell fate. In pluripotent animal cap cells, prdm14 overexpression is sufficient to 
induce a glutamatergic neuronal cell fate supporting the studies in embryos. 
The downstream transcriptional network induced by prdm14 was studied 
through RNA-sequencing analysis of prdm14-injected animal caps at the 
equivalent of neural plate and tailbud stage. Predominant among the prdm14-
upregulated genes were ligands and signaling components of the Wnt pathway 
and Wnt-regulated genes. Consistent with the RNA-sequencing analysis, 
prdm14 overexpression in the embryo activated a canonical Wnt-signaling 
reporter. In addition, many of the upregulated genes have previously been 
shown to be involved in neural crest and sensory neuron specification, including 
the key neural plate border specifiers pax3 and zic1. The activation of these 
genes may in part be attributed to the ability of prdm14 to activate canonical 
Abstract                                                                                                                        VII 
Wnt-signaling. Taken together, the results of this thesis provide evidence for 
multiple roles of Prdm14 during the development of the nervous system. During 
gastrulation Prdm14 promotes maintenance of the neural ectoderm and the 
specification of the neural plate border, which will give rise to neural crest and 
Rohon-Beard sensory neurons. Also suggested by the expression and 
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1.1 Xenopus neurogenesis 
The African clawed frog Xenopus is an attractive model organism to 
elucidate the molecular mechanics of early vertebrate development. The two 
species mainly used are the allotetraploid Xenopus laevis (X. laevis), and the 
closely related Xenopus tropicalis (X. tropicalis), which has a diploid and 
sequenced genome (Amaya, 2005; Geach and Zimmerman, 2011; Grainger, 
2012). One of the key advantages of the Xenopus model system is the external 
development of the embryos, which makes them readily accessible for chemical 
treatments and microinjections of DNA, mRNA or antisense morpholino 
oligonucleotides. More recently, the use of gene editing tools like TALENs or 
CRISPR/Cas have been successfully applied in the Xenopus model system (Lei 
et al., 2012; Nakayama et al., 2013; Guo et al., 2014; Liu et al., 2014). A 
relatively simple and yet powerful experimental method is the animal cap assay, 
in which prospective ectodermal cells of the animal pole are isolated from a 
blastula stage embryo. These cells are an attractive source for in vitro studies of 
differentiation since they are pluripotent and able to differentiate into many cell 
types upon overexpression of different mRNAs (Ariizumi et al., 2009; Borchers 
and Pieler, 2010). 
Xenopus is an important and compelling model organism in studies of 
early vertebrate neurogenesis, not only due to afore mentioned advantages, but 
also as the primary neurons are born during the first 24 hours of development 
(Hartenstein, 1989; Roberts, 2000). These neurons are termed primary neurons 
and arise in the posterior neural plate in three bilateral longitudinal domains 
(Chitnis et al., 1995). With the exception of the trigeminal placodes, neuronal 
differentiation in the anterior neural plate is delayed until late neurula stages 
(Papalopulu and Kintner, 1996). The primary nervous system is required for 
touch responses and movements of the early tadpole (Roberts, 2000). 
Secondary neurogenesis occurs prior to metamorphosis and generates the 
mature nervous system required for the adult frog (Wullimann et al., 2005). 
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1.2 Neural induction 
One of the earliest events in the development of the vertebrate nervous 
system is the specification of the dorsal ectoderm into a neural lineage, which 
occurs through the process of neural induction (Pera et al., 2014). The induced 
neuroectoderm forms the neural plate and is comprised of mitotically active 
neural precursor cells separated from the non-neural ectoderm by the neural 
plate border (Aruga and Mikoshiba, 2011) (Fig. 1.1). The neural plate is a 
bilayered epithelium with a superficial and a deeper sensorial layer 
(Hartenstein, 1989; Chalmers et al., 2002). The primary neurons are born in the 
sensorial layer, while the cells in the superficial layer continue to proliferate and 
will later give rise to secondary neurons (Hartenstein, 1989; Chalmers et al., 
2002; Wullimann et al., 2005). The neural plate will give rise to the brain, spinal 
cord and retina and derivatives of the neural plate border include the neural 
crest, neurogenic placodes, Rohon-Beard sensory neurons and the hatching 
gland (Kuroda et al., 2004; Rossi et al., 2009; Bae et al., 2014).  
 
Fig. 1.1 Overview of the establishment of the central nervous system in X. laevis. After 
neural induction the dorsal ectoderm forms the neural plate. The non-neural ectoderm and the 
neural plate are separated by the neural plate border. After neurulation, the neurons 
differentiate into distinct subtypes, while the neural plate border contributes to the most dorsal 
aspect of the neural tube from where neural crest cells, Rohon-Beard sensory neurons and 




Many of the key experiments that essentially contributed to our 
understanding of vertebrate neural induction have been carried out in X. laevis, 
using transplantation and animal cap assay experiments (Linker and Stern, 
2004). One crucial finding was the observation that intact animal cap explants, 
which normally give rise to atypical epidermis, differentiate into neural tissue 
upon dissociation (Wilson and Hemmati-Brivanlou, 1995) (Fig. 1.2). This 
suggested that a soluble inhibitor of the neural fate is present in the animal cap, 
but is diluted out upon dissociation (Grunz and Tacke, 1989; Sato and Sargent, 
1989). This idea was further supported by the neuralization of animal caps upon 
overexpression of a dominant-negative activin receptor, and the inhibition of a 
neural fate when dissociated animal cap cells were cultured in the presence of 
BMP4 (Hemmati-Brivanlou and Melton, 1992; Hemmati-Brivanlou and Melton, 
1994; Wilson and Hemmati-Brivanlou, 1995). The sum of these findings led to 
the postulation of the “default model” of neural induction. In this model, the 
default state of the ectoderm is thought to be neural and requires the inhibition 
of epidermal promoting BMP signaling (Hemmati-Brivanlou and Melton, 1997; 
Stern, 2005; Pera et al., 2014).  
 
 
Fig. 1.2 Experimental evidence supporting the default model of neural induction in X. 
laevis. Intact ectodermal explants (animal caps), excised from the animal pole of a blastula 
stage embryo (stage 8-9) will give rise to atypical epidermis. If this tissue ectopically expresses 
a dominant-negative activin receptor (dn ActR) or is dissociated, these cells acquire an anterior 
neural fate. Addition of BMP to dissociated cells will restore epidermal fate (Muñoz-Sanjuán and 
Brivanlou, 2002; modified). 
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The inhibition of BMP signaling can occur on different levels, including 
extracellular inhibition by factors secreted from different signaling centers 
(Kuroda et al., 2004; Ozair et al., 2013) (Fig. 1.3). At blastula stages, Chordin 
(Piccolo et al., 1996; Sasai et al., 1994) and Noggin (Smith and Harland, 1992; 
Lamb et al., 1993) are secreted from the blastula Chordin- and Noggin-
expressing (BCNE) center, which is located in dorsal animal cells (Kuroda et al., 
2004). During gastrulation, Chordin, Noggin, Follistatin (Hemmati-Brivanlou et 
al., 1994) and Cerberus (Bouwmeester et al., 1996; Piccolo et al., 1999) are 
expressed in the Spemann organizer, which involutes and secretes these BMP 
antagonists into the overlying prospective neuroectoderm (Aruga and 
Mikoshiba, 2011).  
Despite the multiple lines of evidence supporting the “default model” of 
neural induction, numerous studies have convincingly challenged this model. In 
chick embryos, a requirement for FGF signaling prior to BMP antagonism has 
been demonstrated (Streit et al., 2000). Furthermore, the dissociation of X. 
laevis animal caps triggers the activation of the FGF pathway, while if FGF-
signaling is blocked, neuralization of the dissociated animal caps is prevented 
(Kuroda et al., 2005). Taken together, it is now accepted that inhibition of BMP 
signaling alone is not sufficient for neural induction but that FGF signaling is 
also required (Kengaku and Okamoto, 1995; Lamb and Harland, 1995; Streit et 
al., 2000; Pera et al., 2003; Linker and Stern, 2004, Delaune et al., 2005) (Fig. 
1.3). In addition, an involvement of Ca²+-influx in the process of neural induction 




Fig. 1.3 Overview of the molecular mechanisms resulting in neural induction in  
X. laevis. BMP ligand binding triggers autophosphorylation and dimerization of the receptors, 
which in turn leads to the phosphorylation of SMAD1. SMAD1 and -4 form a complex and 
translocate to the nucleus where they activate the expression of epidermal genes such as 
gata2, msx1 and vent1/2. This activation can be inhibited extracellularly by secreted BMP 
inhibitors (Chordin, Noggin, Cerberus and Follistatin). Active FGF signaling together with 
inhibition of BMP cause neuralization of the epidermis by expression of pan-neural genes such 
as sox3, sox15 and zic1/3. 
 
1.3 Stabilization of the neural fate 
Neural induction results in the expression of several transcription factors 
within the neuroectoderm (Sasai, 1998; Moody and Je, 2002) including 
members of the Sry-related high-mobility group box (sox) family, which are 
expressed in the neural progenitor cells (Lefebvre et al., 2007). Sox2 and sox3 
are early pan-neural genes belonging to the SoxB1 subfamily, which maintain 
the neural progenitor state (Penzel et al., 1997; Uchikawa et al., 1999; Graham 
et al., 2003; Pevny and Placzek, 2005). Sox15 (also known as soxd) is also 
broadly expressed throughout the neural plate and is induced in response to 
BMP inhibition. Overexpression of sox15 expands the neural plate and 
promotes a delayed neuronal differentiation (Mizuseki et al., 1998b). Other 
transcription factors that maintain proliferating neural progenitors are the coiled-
coiled protein Geminin (Kroll et al., 1998; Seo and Kroll, 2006; Papanayotou et 
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al., 2008) and the forkhead/winged helix transcription factor FoxD5 (Solter et al., 
1999; Sullivan et al., 2001).  
Members of the zic family of zinc finger transcription factor genes are 
expressed throughout the neural plate border and are required in early 
neurogenesis and neural crest formation (Houtmeyers et al., 2013). 
Overexpression of zic1, 2 and 3 in X. laevis results in the expansion of the 
neural plate and promotes neural crest formation. In addition, zic1 and zic3 both 
promote neurogenesis upon overexpression (Nakata et al., 1997; Mizuseki et 
al., 1998a, Rogers et al., 2009). In contrast, zic2, which is also expressed 
between the territories of primary neurogenesis, inhibits neuronal differentiation 
(Brewster et al., 1998).  
 
1.4 Neuronal differentiation 
In X. laevis the primary neurons are born in three longitudinal bilateral 
domains in the sensorial layer of the posterior neural plate and the anteriorly 
located trigeminal placodes (Papalopulu and Kintner, 1996) (Fig. 1.4A). In these 
territories of primary neurogenesis, the first genes expressed are proneural 
basic helix-loop-helix (bHLH) transcription factor gene of the neurogenin family 
(Imayoshi and Kageyama, 2014). Members of this family are transcriptional 
activators that heterodimerize with more broadly expressed E proteins and bind 
within the regulatory domains of their target genes at E box motifs (CANNTG) 
(Bertrand et al., 2002). These proneural genes trigger general neurogenesis 
and promote the differentiation of specific neuronal and/or glial cells, which 
suggest a common set of target genes for generic neurogenesis but an 
individual set of target genes for distinct neuronal subtypes (Powell and Jarman, 
2008). 
The neurogenins are orthologs of the Drosophila neuronal determination 
factor atonal (Ma et al., 1996; Nieber et al., 2009) and exhibit a proneural 
activity by inducing downstream proneural transcription factors and regulating 
cell-cycle exit (Ma et al., 1996; Bertrand, 2002; Souopgui et al., 2002; de la 
Calle-Mustienes et al., 2002). The neurogenins are already expressed during 
early gastrulation, prefiguring the domains of primary neurons in the deep layer 
of the prospective neuroectoderm. The expression of neurog1 and neurog2 is 
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present in all three longitudinal stripes of primary neurogenesis with neurog2 
being expressed much broader (Ma et al., 1996; Nieber et al., 2009). Neurog3 
has a much more restricted expression domain that encompasses the medial 
domain (Nieber et al., 2009).  
Neurog2 is the best characterized proneural gene in X. laevis and its 
expression is induced by the pre-pattern genes zic1, zic3 and the pan-neural 
gene sox15, whereas zic2 represses the expression and function of neurog1 
and neurog2 (Mizuseki et al., 1998a; Mizuseki et al., 1998b, Rogers et al., 
2009). Neurog2 induces the expression of several neuronal differentiation factor 
genes such as for the transcription factors neurod1 (Ma et al., 1996), neurod4 
(Perron et al., 1999), ebf2 (Dubois et al., 1998), ebf3 (Pozzoli et al. 2001), myt1 
(Bellefroid et al., 1996), mtgr1 (Koyano-Nakagawa and Kintner, 2005), hes6 
(Koyano-Nakagawa et al., 2000), the RNA binding protein seb4r (Boy et al., 
2004), as well as the Notch ligands dll1 and dll4 (Chitnis et al., 1995; Bray, 
2006). Neurog2 additionally induces the expression of the cell cycle inhibitor 
genes gadd45-γ and pak3, which enables a proliferating cell to exit the cell 
cycle and start to differentiate (Souopgui et al., 2002; de la Calle-Mustienes et 
al., 2002). Surprisingly, the cdk inhibitor gene cdknx is required for neuronal 
differentiation by promoting the stabilization of Neurog2 (Vernon and Philpott, 
2003; Nguyen et al., 2006). 
 
1.5 Neurulation and neuronal subtype specification 
During neurulation, the neural plate folds and gives rise to the neural 
tube. The posterior neural tube forms the spinal chord, in which distinct 
neuronal subtypes are specified depending on their dorso-ventral position 
(Hartenstein, 1989; Roberts, 2000) (Fig. 1.4). In the closed neural tube, the 
neural precursor cells are located in the inner ventricular zone (Fig. 1.4B). As 
neural cells exit the cell cycle, they start to migrate outwards through the 
subventricular zone into the marginal zone where they differentiate into mature 
neurons (Taverna and Huttner, 2010; Spear and Erickson, 2012; Miyata et al., 
2014). The dorso-ventral patterning of the neurons is the consequence of two 
opposing morphogen gradients, BMP generated in the dorsal roof plate and 
sonic hedgehog (SHH) secreted from the ventral floor plate (Le Dreau and 
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Marti, 2012). This dorso-ventral morphogen gradient leads to the specification 
of distinct progenitor domains within the ventricular zone of the neural tube, 
which are defined by the expression of specific bHLH and homeodomain 
transcription factors (Jessell et al., 2000; Alaynick et al., 2011). The 
differentiating cells start to express a unique combinatorial code of transcription 
factors specific for its subtype and begin to migrate outwards through the 
subventricular zone into the marginal zone where the cells terminally 
differentiate into distinct populations of neurons (Ge et al., 2006; Powell and 
Jarman, 2008; Alaynick et al., 2011).  
 
 
Fig. 1.4 Neuronal subtype specification in X. laevis. (A) In the open neural plate primary 
neurons are born in the sensorial layer of the neural plate bilaterally in three longitudinal stripes 
and in the trigeminal placodes. After neurulation, the primary neurons differentiate into specific 
neuronal subtypes depending on their position within the neural plate and subsequently on their 
dorso-ventral position within the closed neural tube. Dashed blue line indicates level of section. 
Nc, notochord (B) Neurons in the lateral stripes will give rise to Rohon-Beard sensory neurons, 
while neurons in the intermediate stripe differentiate into interneurons. Neurons that are located 
in the medial stripe will become motorneurons. In the closed neural tube, the neural progenitor 
cells are located in the ventricular zone where Notch signaling is high. Beginning with 
differentiation, the cells migrate through the subventricular zone into the marginal zone where 
they terminally differentiate and mature.  
 
The first neurons are born at mid-gastrula stages and are the laterally 
located Rohon-Beard mechanosensory neurons (Lamborghini et al., 1980; 
Rossi et al., 2009) (Fig. 1.4A). These neurons are responsible for touch 
responses of Xenopus and zebrafish embryos and arise from the neural plate 
border, which is exposed to intermediate levels of BMP signaling and 
contributes to the most dorsal aspect of the neural tube (Rossi et al., 2008; 
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Rossi et al., 2009, Groves and LaBonne, 2014). With a slight delay, the 
ventrally located neurons differentiate into motorneurons and Kolmer-Agdhur 
cells. The latter are cells of unknown function but are speculated to be primitive 
sensory cells (Hartenstein, 1993; Djenoune et al., 2014). The last neurons to 
differentiate are the interneurons, which can be subdivided into seven different 
subtypes (Hartenstein, 1993; Roberts et al., 2012). 
1.6 Lateral inhibition 
The neural plate is comprised of a homogenous population of equipotent 
proliferating cells (Beatus and Lendahl, 1998). Through the activity of proneural 
factors such as Neurog2 and Ascl1, lateral inhibition is triggered. This leads to 
the inhibition of neuronal differentiation in neighbouring cells, resulting in a “salt-
and-pepper” like pattern of postmitotic neurons (Chitnis et al., 1995; Lewis, 
1996; Vasconcelos and Castro, 2014) (Fig. 1.5A). The process of lateral 
inhibition is mediated by Notch signaling between two neighboring cells. In the 
signal sending cell that is destined to differentiate into a neuron, the proneural 
transcription factors induce the expression of transmembrane Notch ligands 
such as dll1 and 4 as well as jag1 in X. laevis (Kiyota and Kinoshita, 2002; Bray, 
2006). The Notch ligands then bind to the Notch1-receptor on a neighboring 
signal receiving cell (Chitnis et al., 1995; Bray, 2006), thereby inducing a series 
of proteolytic processes within the signal receiving cell that leads to the 
cleavage of the intracellular domain of the Notch receptor (NICD) (Schroeter et 
al., 1998; Selkoe and Kopan, 2003). NICD translocates into the nucleus, where 
it displaces a co-repressor of Rbp-j and acts as a co-activator inducing the 
expression of genes of the hairy and enhancer of split related (hes) family 
(Wettstein et al., 1997). These direct Notch target genes are bHLH transcription 
factor repressor proteins, which inhibit the expression and activity of proneural 
genes such as neurog2 in the signal receiving cell (Dawson et al., 1995; 
Wettstein et al., 1997; Li and Baker, 2001; Schneider et al., 2001; Cau et al., 
2002; Louvi and Artavanis-Tsakonas, 2006). Hence, the signal sending cell 
differentiates into a neuron, whereas the neighboring signal receiving cell is 
prevented from differentiating into a neuron and remains in a proliferating 
undifferentiated state to maintain a neural progenitor pool (Dawson et al., 1995; 
Wang and Barres, 2000). Besides its role in lateral inhibition in the neural plate, 
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the Notch signaling pathway is also required for the maintenance of a progenitor 
pool of proliferating neurons in the ventricular zone of the neural tube (Lindsell 
et al., 1996; Imayoshi and Kageyama, 2011). 
 The selection process that determines which cell from a pool of 
equipotent progenitors will differentiate into a neuron is not fully understood 
(Goodfellow et al., 2014). It has been shown that Neurog2 activates the zinc 
finger transcription factor gene myt1, which enables a cell to escape lateral 
inhibition (Bellefroid et al., 1996). Furthermore, the oscillating expression of 
proneural genes in neural progenitor cells, contributes to the determination of 
which cells differentiate into neurons (Hatakeyama and Kageyama, 2006; 
Nelson and Reh, 2008; Kageyama et al., 2008, Goodfellow et al., 2014). In 
mouse, the oscillating expression of neurog2 and dll1 is inverse to the Notch-
mediated induction of hes1, which is an inhibitor of the proneural factors 
(Shimojo et al., 2008) (Fig. 1.5B). Because of this oscillation, neurog2 
expression in a cell does not necessarily result in the differentiation of the cell 
into a neuron, but requires a certain threshold of neurog2 to be reached and 
maintained (Kageyama et al., 2008, Goodfellow et al., 2014). The expression of 
hes1 is regulated by autorepression as well as mRNA and protein instability 
(Hirata et al., 2002; Momiji and Monk, 2009). The hes1 mRNA is subject to 
degradation by miR-9, which itself is repressed by Hes1 (Bonev et al., 2012). By 
this double-negative feedback loop, the expression of hes1 oscillates (Bonev et 
al., 2012). As the mature miR-9 is only slowly degraded, it accumulates in the 
cell, which leads to increased degradation of hes1 mRNA. Thus, the proneural 
factors are released from repression and the cell differentiates into a neuron 






Fig. 1.5 Delta-Notch pathway mediated-lateral inhibition. (A) In the cell that is destined to 
differentiate into a neuron, Neurog2 activates the expression of dll1, which translocates to the 
membrane and interacts with the membrane bound Notch receptor on the signal receiving 
neighboring cell. In the signal receiving cell, the intracellular domain of Notch (NICD) is released 
by proteolytic cleavages and translocates to the nucleus. Together with the transcription factor 
Rbp-j, NICD activates the expression of transcription factors of the Hes-family, which inhibit the 
expression and function of proneural factors and therefore inhibit neurogenesis. (B) The 
expression of hes1 and neurog2 show an inverse oscillation. If hes1 expression is extinguished, 
neurog2 expression is sustained, which leads to the differentiation of neural progenitor cells into 
neurons in a “salt-and-pepper” like pattern (Vasconcelos and Castro, 2014; modified). 
 
1.7 Neural crest 
The neural crest is a multipotent population of cells that arises from the 
neural plate border and is unique to vertebrates (Gammil and Bronner-Fraser, 
2003) (Fig. 1.6).  It is characterized by its high migratory potential and the ability 
to give rise to multiple derivatives that derive from three different neural crest 
subpopulations, the cranial-, trunk- and vagal neural crest, which are located 
along the anterior-posterior axis (Simões-Costa and Bronner, 2015). The cranial 
neural crest cells contribute to the facial skeleton and neurons of the cranial 
sensory ganglia (Couly et al., 1998), whereas the vagal neural crest cells form 
the outflow tract of the heart and enteric ganglia of the gut (Le Douarin and 
Teillet, 1973; Creazzo et al., 1998). In the peripheral nervous system, the dorsal 
root and sympathetic ganglia are formed by the trunk neural crest (Le Douarin 
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and Smith, 1988). The melanocytes arise from neural crest cells of all three 
subpopulations (Le Dourain et al., 2004). Upon neural tube closure, the trunk 
neural crest cells contribute to the most dorsal aspect of the neural tube before 
they start the process of migration and differentiation (Le Dourain et al., 2004).  
The formation of the neural crest occurs during gastrulation and is a 
multi-step process, which can be divided into neural plate border induction 
followed by neural crest specification, migration and differentiation (Pegoraro 
and Monsoro-Burq, 2012; Simões-Costa and Bronner, 2015) (Fig. 1.6A). The 
induction of the neural plate borders requires intermediate levels of BMP as well 
as Wnt, FGF and Notch signaling (Endo et al., 2002; Monsoro-Burq et al., 2003; 
Yardley and Garcia-Castro, 2012; Groves and La Bonne, 2014). The 
combinatory effects of these signaling pathways result in the expression of 
several genes within the neural plate border, which form a synexpression group 
that cross-regulates each other’s expression (Nikitina et al., 2008; Bhat et al., 
2013). Among these neural plate border specifiers are tfap2, msx1, zic1, gbx2, 
pax3/7, dlx5/6, hairy2, c-myc, gata2/3 and foxi1/2 (Bellmeyer et al., 2003; 
Meulemans and Bronner-Fraser, 2004; Monsoro-Burq et al., 2005; Nichane et 
al., 2008; Khudyakov and Bronner-Fraser, 2009; de Croze et al., 2011). Pax3 
together with zic1 is sufficient, to promote the expression of the neural crest 
specifiers in animal cap cells (Milet et al., 2013). In contrast, pax3 alone 
promotes the formation of the hatching gland, while zic1 alone induces a pre-
placodal ectodermal fate (Hong and Saint-Jeannet, 2007; Bae et al., 2014). The 
activity of the neural plate border specifiers results in the specification and 
migration of neural crest cells by inducing the expression of foxd3, snai2 and 
sox8/9/10 (Dottori et al., 2001; Luo et al., 2003; Cheung et al., 2005; Monsoro-




Fig. 1.6 Neural crest development in X. laevis. (A) Through the combinatory activity of Wnt, 
Notch, BMP and FGF signaling, the neural plate border inducing genes are activated. These 
genes mutually promote themselves and activate the neural crest specifying genes, that leads 
to the migration and differentiation of the neural crest cells (Pegoraro and Monsoro-Burq, 2012; 
modified). (B) Schematic illustration of a neurula stage embryo (dorsal view, anterior to top). 
Highlighted are the positions of the neural plate, and the neural plate border with its derivatives 
(pre-placodal ectoderm, hatching gland, neural crest, Rohon-Beard sensory neurons) (Hong 
and Saint-Jeannet, 2007; modified).  
 
1.8 The Prdm protein family 
Early vertebrate neurogenesis relies on multiple transcription factors and 
signaling pathways to ensure the proper establishment of the developing 
nervous system with its distinct neuronal and glial subtypes. In recent years, the 
Prdm proteins have emerged as critical players in neuronal subtype 
specification and neural crest formation (Hohenauer and Moore, 2012). Prdms 
belong to a highly conserved protein family whose members are involved in 
several cellular functions including the maintenance of stemness in embryonic 
stem cells and early developmental processes (Hohenauer and Moore, 2012). 
Deregulation of Prdms has also been implicated in several human diseases 
including cancer (Fog et al., 2012).  
 
1.8.1 Structural properties of Prdm proteins 
Prdms are chromatin modifying proteins characterized by the presence of 
an N-terminally located PR-domain (Fog et al., 2012) (Fig. 1.7). The PR-domain 
is similar to the SET (Suppressor of variegation 3-9, Enhancer of zeste and 
trithorax) domain, found in several histone lysine methyltransferases (Huang, 
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2002). Correspondingly, several Prdm members have been shown to harbor 
intrinsic HMTase-activity (Fog et al., 2012; Hohenauer and Moore, 2012). The 
methylation occurs on different lysine residues, which can result in 
transcriptionally silenced (Prdm2, 3, 6, 8, 16) as well as active (Prdm9) 
chromatin states (Table1.1) (Kim et al., 2003; Wu et al., 2008; Eom et al., 2009; 
Hayashi et al., 2005; Bellefroid, unpublished; Hanotel et al., 2014; Pinheiro et 
al., 2012). However, a systematic analysis of the putative HMTase activity of 
other Prdms has not been carried out to date. Interestingly, the conserved motif, 
which is essential for the histone methylation on lysine by most SET proteins 
(H/RxxNHxC), is absent in the PR-domain (Rea et al.; 2000). While not all 
PRDMs show intrinsic HMTase-activity, several have been shown to recruit 
histone-modifying co-factors such as histone methyltransferases, deacetylases 
and acetyltransferases (Kouzarides, 2007; Fog et al., 2012; Hohenauer and 
Moore, 2012).  
 
  
Table 1.1 Prdms with known intrinsic HMTase activity. Histone modifications depicted in red 
promote heterochromatin formation, while histone modifications shown in green represent a 
transcriptionally active euchromatin state. 
 
With the exception of Prdm11, all members feature a variable number of 
C2H2 zinc fingers in their C-terminus(Fog et al., 2012; Hohenauer and Moore, 
2012) (Fig. 1.7). Through the zinc fingers, Prdms can bind to DNA and 
consensus binding sites that have been characterized for Prdm1, 3, 5, 9, 14 and 
16 (Delwel et al., 1993; Funabiki et al., 1994; Kuo and Calame, 2004; Duan et 
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al., 2007; Seale et al., 2007; Baudat et al., 2010; Chia et al., 2010; Ma et al., 
2011; Bard-Chapeau et al., 2012). 
 
 
Fig. 1.7 Overview of the protein structure of members of the Prdm family. Shown is the 
longest isoform of each Prdm protein. The red box depicts the PR-domain and the blue bars 
represent zinc fingers. The structure is based on the mouse sequence. 
 
 
1.8.2 The role of Prdms in early vertebrate neurogenesis and 
neural crest formation 
Several members of the prdm family are expressed in the developing 
nervous system of vertebrates (Kinameri, et al., 2008; Sun et al., 2008; Liu et 
al., 2012, Eguchi, et al., 2015). Functional analyses of individual prdms have 
been carried out in various model systems and several have been shown to be 
involved in the specification of distinct neuronal subtypes and the specification 
of the neural crest (Hernandez-Lagunas et al., 2011; Ding et al., 2013; Hanotel 
et al., 2014).  
 
1.8.2.1 Prdms in neural crest formation 
In zebrafish as well as in X. laevis, prdm1 is expressed at the neural 
plate border and essential for the migration of the trunk neural crest cells and 
the formation of Rohon-Beard sensory neurons (Hernandez-Lagunas et al., 
2005; Rossi et al., 2008; Rossi et al., 2009; Olesnicky et al., 2010; Hernandez-
Lagunas et al., 2011; Powell et al., 2013). In zebrafish it has been shown that 
Introduction 16 
prdm1a is coexpressed with the neural crest specifiers foxd3 and tfap2a, which 
are directly regulated by Prdm1a (Powell et al., 2013). Furthermore, Prdm1 
regulates the expression of sox10 and islet1, which are required for the 
specification of the neural crest and the formation of Rohon-Beard sensory 
neurons (Olesnicky et al., 2010; Hernandez-Lagunas et al., 2011). The 
expression of prdm1 in the neural plate border of the chick embryo was recently 
reported, suggesting a conservation of function (Zwane and Nikitina 2015). 
 
1.8.2.2 Regulation of neuronal subtype specification by Prdms 
Prdm12 has been shown to play a role in neuronal subtype specification 
in X. laevis and zebrafish. In the developing spinal cord, prdm12 promotes the 
formation of V1-interneurons at the expense of V0-neurons (Bellefroid, 
unpublished; Zannino et al., 2013). In addition, X. laevis prdm12 is also required 
for the specification of sensory neurons as it regulates the expression of 
transcriptions required for sensory neuron formation such as sncg, islet1 and 
tlx3 (Nagy et al., 2015). 
In mouse and X. laevis, prdm13 is a target of the Ptf1a-Rbp-J complex 
and responsible for the promotion of a GABAergic over a glutamatergic fate of 
neurons (Chang et al., 2013; Hanotel et al., 2014). Prdm13 promotes a 
GABAergic neural fate through the inhibition of the glutamatergic selector gene 
tlx3 (Chang et al., 2013; Hanotel et al., 2014). 
 
1.8.2.3 Prdms in axon outgrowth 
In the mouse spinal cord, prdm8 is first expressed in the progenitor 
populations of ventral interneurons and motor neurons (Komai et al., 2009). 
Together with the transcription factor Bhlhb5 (also known as Bhlhe22), Prdm8 
forms a repressor complex to repress cdh11, whose downregulation is required 
for proper axon outgrowth of corticospinal motor neurons (Ross et al., 2012).  
Prdm14 is required for proper motorneuron axon outgrowth in zebrafish. 
Loss of Prdm14 through mutation or injection of a splicing morpholino leads to 
shortened axons in caudal primary (CaP) motor neurons, which in turn results in 
defective embryonic movement. It has been shown that Prdm14 binds to the 
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promoter region of the transcription factor gene islet2 and thus activates its 
expression, which is necessary for proper CaP axon outgrowth (Liu et al., 
2012). 
1.8.3 Prdm14 is an epigenetic regulator and stemness factor 
While in zebrafish a function for prdm14 has been described for 
motorneuron axon outgrowth, prdm14 in mice and humans is described in the 
context of primordial germ cell specification and stemness maintenance (Fog et 
al., 2012; Liu et al., 2012; Nakaki and Saitou, 2014). Prdm14 harbors a single 
PR-domain and six zinc finger domains that are highly conserved in vertebrates, 
while the N-terminus of the protein is more divergent (Nakaki and Saitou, 2014). 
Through its zinc finger domains, Prdm14 can bind and regulate its target genes 
(Ma et al., 2011). Through ChIP-seq analysis in mouse and human ESC 
(hESC/mESC) the consensus binding sequence has been identified as 5’-
GGTCTCTAA-3’ (Yamaji et al., 2013). Unlike other Prdms, no intrinsic HMTase 
activity has been demonstrated for Prdm14. However, in mammalian cell 
cultures it has been shown that Prdm14 regulates pluripotency and epigenetic 
reprogramming (Nakaki and Saitou, 2014). In mESCs Prdm14 interacts with the 
H3K27me3-ase PCR2, which leads to the repression of fgfr1 and fgfr2 and 
thereby to an inhibition of differentiation (Grabole et al., 2013; Yamaji et al., 
2013). Furthermore, the Prdm14/PCR2 complex represses expression of the de 
novo methyltransferases dnmt3a, dnmt3b and dnmt3l, which leads to low levels 
of methylation in mESC (Grabole et al., 2013). Through complexation with Ten-
Eleven Translocation (TET) proteins, Prdm14 promotes the demethylation of 
germline specific promoters by oxidation of 5-methylcytosine (5mC) to 5-
hydroxymethylcytosine (5hmC) (Hacket et al., 2013; Okashita et al., 2014).  
Besides its repressing properties, Prdm14 is able to activate the 
expression of genes that are required to maintain pluripotency such as sox2 or 
klf5 and in a complex with PRMT4, Prdm14 activates its target genes in mESC 
through H3 arginine 26 dimethylation (Ma et al., 2011; Burton et al., 2013; Chan 
et al., 2013; Yamaji et al., 2013; Nakaki and Saitou, 2014). Thus, regulation of 
Prdm14 target genes is context dependent and Prdm14 can act as an activator 
as well as a repressor (Ma et al., 2011; Nakaki and Saitou, 2014). 
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It is suggested that Prdm14 is involved in the core pluripotency circuitry 
in hESC were it binds to the proximal enhancer of oct4 and activates its 
expression (Chia et al., 2010). Similar to mESCs, Prdm14 occupies several 
target genes together with Oct4, Sox2 and Nanog (Chia et al., 2010). However, 
prdm14 itself is also occupied by these three factors (Boyer et al., 2005; Chia et 
al., 2010). 
Prdm14 is also required together with Prdm1 for the formation of 
primordial germ cells in mice (PGCs) by regulating three critical steps: 
repression of the somatic mesodermal program, reacquisition of potential 
pluripotency by sox2 activation and epigenetic reprogramming through genome-




In recent years, the Prdm proteins have emerged as critical 
transcriptional regulators involved in stemness maintenance, differentiation and 
epigenetic modification (Fog et al., 2011; Hohenauer and Moore, 2012). In 
addition, several members of the prdm family play crucial roles in the 
development of the neural crest and central nervous system (Hernandez-
Lagunas et al., 2005; Rossi et al., 2008; Rossi et al., 2009; Olesnicky et al., 
2010; Hernandez-Lagunas et al., 2011; Powell et al., 2013, Liu et al., 2012; 
Zannino et al., 2013; Hanotel et al., 2014; Nagy et al., 2015). In a screen for 
target genes repressed by the Notch pathway effector protein Hes5.1, prdm14 
was identified in X. laevis (Klisch, 2006). Owing to the key role members of this 
family have during early development, a functional analysis of prdm14 using the 
X. laevis model system was undertaken. Specifically, the developmental 
processes regulated by prdm14 are to be investigated as well as the 
downstream gene regulatory network. 
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2. Material and Methods 
2.1 Material 
2.1.1 Model organism 
During this study the South African clawed frog Xenopus laevis was used 
as a model system using animals obtained from Nasco (Ft. Atkinson, USA). The 
animals were kept according to the directive 2010/63/EU on the protection of 
animals used for scientific purposes. The developmental stages were 
determined according to Nieuwkoop and Faber (1967). 
2.1.2 Bacteria 
The chemical competent Escherichia coli-Strain XL1-Blue was used for 
transformations.  
XL1-Blue: recA1, endA1, gyrA96, thi-1, hsdR17, supE44, relA1, lac[F’proAB, 
laclqZΔM15, Tn10(Tetr)] (Stratagene) 
2.1.3 Antibiotics and Media 
For culture medium 32 g Luria Bertani (LB) was dissolved in 1 liter dH2O 
and autoclaved for 20 min at 121°C. After cooling down to 50°C the selective 
antibiotic was added. The agar plates were poured under a sterile bench and 
stored at 4°C in the dark. As selective antibiotic Ampicillin was used (stock: 100 
mg/ml in dH2O, working: 100 μg/ml, stored in the dark at -20°C). 
2.1.4 Oligonucleotides 
Oligonucleotides were purchased from Sigma-Aldrich and dissolved in 
HPLC-H2O to a concentration of 100 µM or 500 µM. The following sequences of 
the oligonucleotides are written in 5’ to 3’ direction. 
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2.1.4.1 RT-PCR Oligonucleotides (Primer)  
Gene 
Sequence TA 
°C Forward reverse 
neurog2 GCGCGTTAAAGCTAACAACC GTTCAGGTGGAGCTCAGAGG 60 
tubb2b ACACGGCATTGATCCTACAG AGCTCCTTCGGTGTAATGAC 57 
tlx3 GCCAACAAGTACAAGTGCACAG CAGGAGCCAGACTCACATTGAC 57 
prdm14
a ex1-2 
CAGGACAAGTCACCAGGGAG CAACTGCAACGAGTCCCTG 60 
prdm14
b ex1-2 
CTATGGTAGCGACTCAAGGACCG CAACTGCAACGAGTCCCTG 60 
odc GCCATTGTGAAGACTCTCTCCATTC TTCGGGTGATTCCTTGCCAC 56 
Table 2.1 Summary of RT-PCR oligonucleotides and their annealing temperatures 
2.1.4.2 Sequencing oligonucleotides 
Primer Sequence TA °C 
           SP6 TTAGGTGACACTATAGAATAC 56 
           T7 TAATACGACTCACTATAGGGCGA 56 
           T7 (pCS2+) TCTACGTAATACGACTCACTATAG 56 
           T3 AATTAACCCTCACTAAAGGG 56 
           GR7 ATCCTGCATATAACAACTTC 56 
Table 2.2 Summary of sequencing oligonucleotides and their annealing temperatures 
2.1.4.3 Morpholino oligonucleotides 
The morpholino oligonucleotides (MO) used in this study were purchased 
from Gene Tools (Philomath, USA). The MOs were dissolved in RNase free 
H2O to a concentration of 20 ng/nl and stored at 4°C. Before injection the MO 
were heated for 5 min at 65°C. The following sequences of the MO are depicted 
in 5’ to 3’ direction. 
Morpholino 
Oligonucleotide Sequence 
Prdm14a SpMO GTGTATAACATTTACCTGTAGAACT 
Prdm14b SpMO GTGTAACATTTACCTGTAGAAGTGC 
Standard control MO CCTCTTACCTCAGTTACAATTTATA 
Table 2.3 Summary of morpholino oligonucleotides  
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2.1.5 Overexpression constructs 
The following overexpression constructs used in this study have been 
described previously: NICD-pCS2 (Coffman et al., 1993), MT-Neurog2-pCS2+ 
(Ma et al., 1996), MT-GFP-pCS2+ (Rubenstein et al., 1997), MT-Wnt5a-pCS2+ 
(Damianitsch et al., 2009), Wnt8a-MT-pSP64T (Christian and Moon, 1993), 
ATF2-luc-pGL (van der Sanden et al., 2004), TOPFlash-luc-pGL3 (Korinek et 
al., 1997), Renilla-pRL-TK (Promega) 
 
Prdm14-pCS2+: This construct harbors the full open reading frame of X. laevis 
prdm14. The open reading frame was PCR amplified using following primers: 
Prdm14_for_EcoR1: 5’-CGG AAT TCG ATG GCT CTG TCT GT-3’ and 
Prdm14_rev_Xho1: 5’-GGC TCG AGA TAG GAG GCT TGA AT-3’ with 
Prdm14-pCS2p+ (National Institute for Basis Biology, Japan; clone 
XL280n24ex) as a template. Prdm14 was subcloned into the pCS2+ expression 
vector using the EcoRI and XhoI restriction sites. For the transcription of sense 
mRNA, the construct was linearized with NotI and transcribed with the SP6 
polymerase.  
 
Prdm14-HA-pCS2+: This construct harbors the open reading frame of X. laevis 
prdm14 without the stop codon and an HA tag at the C-terminus. The open 
reading frame was PCR amplified using following primers: P14-HA_EcoRI_ 
START: 5’-GAG AAT TCA TGG CTC TGT CTG TT-3’ and P14-
HA_XhoI_noSTOP2: 5’-TAC TCG AGG AGG CTG GAG TG-3’ with Prdm14-
pCS2p+ (National Institute for Basis Biology, Japan; clone XL280n24ex) as a 
template. Prdm14 was subcloned into the pCS2+ HA vector (Damianitsch, 
2009) using the EcoRI and XhoI restriction sites. This vector contains the 
human influenza hemaglutinin (HA) tag which allows the expression of HA-
tagged proteins. For the transcription of sense mRNA, the construct was 
linearized with NotI and transcribed with the SP6 polymerase.  
 
Prdm14-GR-pCS2+: This construct harbors the open reading frame of X. laevis 
prdm14 without the stop codon. The prdm14 open reading frame was excised 
from prdm14-pCS2+HA and ligated into GRpCS2+ using the EcoRI and XhoI 
restriction sites. This vector contains the human glucocorticoid ligand-binding 
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domain, which allows the induction of the translated protein by dexamethasone 
(Kolm and Sive, 1995). For the transcription of sense mRNA the construct was 
linearized with NotI and transcribed with the SP6 polymerase.  
 
Prdm14-GR-HA-pCS2+: This construct harbors the open reading frame of X. 
laevis prdm14 without the stop codon. This vector contains the human 
glucocorticoid ligand-binding domain, which allows the induction of the 
translated protein by dexamethasone (Kolm and Sive, 1995). The GR-domain 
was PCR amplified using following primers: GR-tag_XhoI_for: ATC TCG AGA 
CCT CTG AAA ATC CT and GR-tag_+2_XbaI_noSTOP_rev: CGT CTA GAC 
ACT TTT GAT GAA ACA G using Prdm14-pCS2+GR as a template. The PCR 
product was cloned between the XhoI and XbaI sites of Prdm14-HA-pCS2+. For 
the transcription of sense mRNA the construct was linearized with NotI and 
transcribed with the SP6 polymerase.  
2.1.6 antisense-RNA-constructs 
Marker Vector RE 
Poly-
merase Reference 
n-tubulin/tubb2b pBst KS BamHI T3 Chitnis et al., 1995 
sox2 pBst SK EcoRI T7 Mizuseki et al., 1998a 
sox10 pCS2+ ClaI T7 Aoki et al., 2003 
hox11L2/tlx3 BstEII StuI T3 Patterson & Krieg, 1999 
neurog1 pCS2p+ EcoRI T7 Nieber et al., 2009 
neurog2 pBst II BamH1 T3 Ma et al., 1996 




SalI T7 Bang et al., 1999 
wnt8 pBst KS BamHI T3 - 
zic1 pCS2p+ HindIII T7 Mizuseki et al., 1998a 
zic2 pCS2p+ EcoRI T7 Brewster et al., 1998 
zic3 pCS2p+ EcoRI T7 Nakata et al., 1997 
vglut pBst KS NotI T3 Gleason et al., 2003 
foxd3 pBst EcoRI T7 Pohl and Knöchel, 2001 
hb9/mnx1 pBst KS XbaI T3 Saha et al., 1997 
Table 2.4 Summary of antisense RNA constructs 
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2.2 Methods 
2.2.1 DNA-standard methods 
2.2.1.1 Polymerase chain reaction (PCR) 
2.2.1.1.1 Reverse transcription-PCR (RT-PCR) 
For semi-quantitative RT-PCR 2.5 µl cDNA was used in a 12.5 µl 
reaction containing 1x Go Taq green reaction buffer (Promega), 0.2 mM of each 
primer and 0.5 units GoTaq DNA-polymerase (Promega). The amplification was 
carried out in a thermocycler (Biometra) with following conditions: 2 min 95°C, 
45 sec 95°C, 30 sec TA of primers -2 °C, 30 sec 72°C, 5 min 72°C. The number 
of cycles between step 2 and step 4 varied between the primer pairs and 
ranged between 25-35 cycles. The RT-PCR reaction were analyzed on a 2% 
agarose gel and documented in a Chemidoc chamber (Biorad) mounted with an 
Intas camera. 
2.2.1.1.2 PCR Cloning 
For molecular cloning the High Fidelity Enzyme Mix (Fermentas) was 
used. A PCR reaction contained 1x High Fidelity Buffer with 15 mM MgCl2, 0.2 
mM dNTP mix (Thermo Scientific), 0.75 µM of each primer, 0.1 ng/µl template 
DNA and 0.1 U/µl High Fidelity PCR enzyme mix. The amplification was carried 
out in a thermocycler (Biometra) with following conditions: 2 min 95°C, 45 sec 
95°C, 45 sec TA of primers -2 °C, 1 min/kb 72°C, 5 min 72°C. The number of 
cycles between step 2 and step 4 varied between the primer pairs and ranged 
between 30-40 cycles. 
2.2.1.2 Agarose gel electrophoresis 
TAE (Tris-acetate-EDTA): 40 mM Tris-acetate, 2 mM EDTA, pH 8.5 
 
Restriction- and PCR-fragments were analyzed by agarose gel 
electrophoresis (Sharp et al., 1973). Depending on the fragment size the 
percentage of the agarose gel was adapted (0.7-2%). Agarose powder was 
heated and dissolved in 1x TAE buffer. To visualize the DNA fragments 
ethidium bromide (0.5 µg/ml) was added to the liquid agarose gel. The 
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electrophoresis was performed in a horizontal electrophoresis chamber filled 
with 1x TAE at 100 V. For determination of the fragment sizes, standard DNA 
ladders (Fast Ruler DNA Ladder, Fermentas) were used. The documentation of 
the gel was carried out in a ChemiDoc (Bio-Rad) documentation chamber using 
an Intas camera and software. 
2.2.1.3 Gel purification of PCR and restriction fragments 
For isolation of DNA fragments from agarose gels, the agarose gel 
containing the desired fragment was excised and the DNA purified using the 
Fragment CleanUp Kit (Invitek) according to the manufacturer’s instructions. 
2.2.1.4 DNA restriction digestion  
For restriction digestions of DNA restriction endonucleases were used 
from Fermentas Life Sciences according to manufacturer’s instructions. 
2.2.1.5 Ligation 
For standard ligation reactions T4 DNA ligase (10 U/µl) (Fermentas Life 
Science) was used according to manufacturer’s protocol. The ligation reaction 
was incubated overnight at 16°C.  
2.2.1.6 Chemical transformation of bacterial cells 
For chemical transformations the chemically competent Escherichia coli-
strain XL1-Blue was used. Ligation or PCR reactions were added to 100-200 µl 
thawed cells and incubated on ice for 30 min. Afterwards the cells were heat 
shocked for 60-90 sec at 42°C and immediately cooled for 3 min on ice. LB 
medium (800 µl) was added to the cells which were then incubated for 30-45 
min under constant shaking (300 rpm) at 37°C. After the incubation, the cells 
were centrifuged (30 sec, 10,000 rpm) and 800 µl of the overlying medium was 
discarded. The cells were resuspended in the remaining medium and seeded 
on LB agar plates containing selective antibiotic. The LB plates were incubated 
overnight at 37°C. 
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2.2.1.7 Plasmid preparation 
The GeneJET Plasmid Miniprep kit (Fermentas) was used according to 
manufacturer’s instructions to isolate DNA. For the isolation of DNA in 
preparative amounts (1 µg/µl) the NucleoBond Xtra Midi kit (Macherey-Nagel) 
was used following the manufacturer’s protocol.  
For DNA quantification the NanoDrop 2000c spectrophotometer (Thermo 
Scientific) was used. 
2.2.1.8 DNA sequencing 
For DNA sequencing, the chain termination method was used (Sanger et 
al., 1977). The sequencing was performed using the Big Dye Terminator Cycle 
Sequencing Kit (Applied Biosystems) according to manufacturer’s instructions. 
The sequencing PCR mixture contained 200-400 ng DNA, 2 µl seq mix, 2 µl seq 
buffer and 1 pmol sequencing primer in a total of 10 µl reaction volume. The 
reaction was performed in a thermocycler using following program: 2 min 95°C, 
30 sec 95°C, 30 sec 55°C, 4 min 72°C, with 26 cycles between step 2 and 4. 
For purification of the sequencing reaction, 1 µl NaAc (3 M), 1 µl EDTA (125 
mM) and 50 µl 100% ethanol were added to the reaction mixture and incubated 
for 5 min at RT. After centrifugation for 15 min at 13,000 rpm, the DNA pellet 
was washed with 70% ethanol, air-dried and dissolved in 15 µl HiDi Buffer 
(Applied Biosystems). The automated sequencing was performed in the 3130 xl 
Genetic Analyzer (Applied Biosystems). 
2.2.2 RNA standard methods 
2.2.2.1 In vitro synthesis of capped sense mRNA 
Capped sense mRNA was synthesized using the SP6 or T7 mMessage 
mMachine Kits (Ambion) according to manufacturer’s protocol. A reaction of 20 
µl contained 1 µg of linearized plasmid and was incubated at 37°C for 2 hours. 
After DNase digestion using 5 U of Turbo DNase I, the synthesized mRNA was 
purified using the Illustra RNAspin Mini kit (GE Healthcare) and eluted in 30 µl 
RNase free water at 80°C. RNA concentration was measured using the 
NanoDrop 2000c spectrophotometer (Thermo Scientific) and the quality was 
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checked on a 1% agarose gel. The RNA was aliquoted (2-4 µl) and stored at –
80°C.  
2.2.2.2 In vitro synthesis of antisense RNA 
For the detection of in vivo transcripts antisense RNA was used in whole 
mount in situ hybridizations (WMISH).  
A standard reaction of 25 µl contained 1 ng linearized plasmid, 1x 
Transcriptionbuffer (Fermentas), 1 mM rATP, rGTP, rCTP (Boehringer), 0.64 
mM rUTP (Boehringer), 0.36 mM Digoxygenin-rUTP (Boehringer), 0.03 µM 
DTT, 1.6 U/µl Ribolock RNase inhibitor (Fermentas), 1.2 U/µl T3, T7 or SP6 
RNA-Polymerase, add RNase-free water. The reaction was incubated for three 
hours at 37°C, followed by template digestion with 0.2 U/µl Turbo DNaseI 
(Ambion) for 30 min at 37°C. The RNeasy Mini kit (Qiagen) was used to purify 
the synthesized antisense RNA according to manufacturer’s instructions. The 
RNA was eluted twice with 50 µl RNase-free water at 80°C. The quality was 
checked on a 1% agarose gel. The antisense RNA was stored at -20°C in 1 ml 
hybridization mix (see whole mount in situ hybridization). 
2.2.2.3 Total RNA isolation from ectodermal explants and whole 
embryos  
For the isolation of total RNA three embryos or 50-100 ectodermal 
explants were fixed in liquid nitrogen and lysated in 400 µl peqGOLD TriFast 
reagent (Peqlab) using a 29-gauge syringe and afterwards vortexed for 30 sec. 
After addition of 80 µl chloroform (Roth) and vortexing for 30 sec, the samples 
were centrifuged for 10 min at 13,000 rpm and 4°C. The supernatant (200 µl) 
was transferred into a new eppendorf tube. 200 µl chloroform were added and 
the sample vortexed for 30 sec and centrifuged for 5 min at 13,000 rpm at 4°C. 
The supernatant (180 µl) was transferred into a new eppendorf tube and 180 µl 
isopropanol were added. After vortexing, the samples were kept overnight at -
20°C for precipitation. After precipitation the samples were centrifuged for 30 
min at 13,000 rpm at 4°C and the pellet was washed with 400 µl 70% ethanol. 
After air drying the pellet was dissolved in 12.5 µl RNase-free water and DNase 
digestion was carried out using DNaseI (1 U/µl) (Thermo Scientific) for 30 min at 
37°C. The DNaseI was denatured by incubation at 70°C for 10 minutes and the 
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RNA concentration measured on the NanoDrop 2000c spectrophotometer 
(Thermo Scientific). The quality of the RNA was analyzed with the 2100 
Bioanalyzer (Agilent). To check for genomic DNA contamination, a control PCR 
with H4 or ODC was performed. 
2.2.2.4 Reverse transcription 
 For the synthesis of 10 µl cDNA, 50-75 ng RNA was used in a standard 
reaction mix containing 1x Go Taq flexi buffer, 5 mM MgCl2 (Fermentas), 2.5 
mM random hexamer (Invitrogen), 1 mM dNTP mix (Thermo Scientific), 0.8 U/µl 
Ribolock RNase inhibitor (Thermo Scientific), 2 U/µl MulV reverse transcriptase 
(Roche). The reaction was carried out in a thermocycler. After an initial 
incubation for 20 min at 20°C the reaction was incubated for 1 hour at 42°C and 
terminated at 95°C for 5 min. 
2.2.2.5 RNA-sequencing 
2.2.2.5.1 Total RNA isolation from ectodermal explants 
For the isolation of total RNA for RNA-sequencing 70-100 ectodermal 
explants were fixed in liquid nitrogen and lysates prepared in 360 µl peqGOLD 
TriFast reagent (Peqlab) using a 29-gauge syringe and afterwards incubated for 
10 min at RT. After addition of 72 µl chloroform the solution was incubated at 
RT for 5 min and centrifuged for 20 min with 13,000 rpm at 4°C. The upper 
phase was transferred into a new Eppendorf tube to which 200 µl chloroform 
was added. The solution was centrifuged for 10 min at 4°C and the upper phase 
transferred into a new Eppendorf tube. After adding 180 µl isopropanol the RNA 
was precipitated overnight at -20°C. The next day, the solution was centrifuged 
for 30 min at 4°C. The pellet was washed with 70% ethanol and centrifuged for 
5 min at 4°C. The pellet was air dried, and resuspended in 43.5 µl RNase-free 
water. For the digestion of genomic DNA, the RNA was incubated for 1 h at 
37°C in a 50 μl reaction containing 1x DNaseI reaction buffer (Thermo 
Scientific), 1 μl DNaseI (Thermo Scientific) and 0.5 μl RNase inhibitor (Thermo 
Scientific). To stop the DNase treatment, 150 µl RNase free water and 200 µl 
phenol/chloroform/isoamylalcohol (25/24/1, Roth) was added to the RNA. After 
centrifugation for 10 min at 4°C the upper phase was transferred to a new 
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Eppendorf tube, 1 vol. of chloroform/isoamylalcohol (24/1) was added. 
Afterwards the RNA was centrifuged for 10 min at 4°C. The supernatant was 
transferred to a new Eppendorf tube to which 1/10 vol. of 5 M ammonium 
acetate and 1 vol. of isopropanol was added. The solution was incubated 
overnight at -20°C. The following day the RNA was centrifuged for 30 min at 
4°C and the pellet washed twice with 70% ethanol and centrifuged for 5 min at 
4°C. The pellet was air dried and resuspended in 20 µl RNase free water. The 
quality of the RNA was analyzed with the 2100 Bioanalyzer (Agilent). To check 
for genomic DNA contamination, a control PCR with H4 or ODC was performed. 
2.2.2.5.2 Sample preparation and sequencing  
LIbrary preparation and sequencing was performed by the DNA 
Microarray and Deep-Sequencing Facility Göttingen (UMG) -
Transkriptomanalyselabor (TAL). Before sequencing, the RNA-libraries were 
prepared with the "TruSeq RNA Sample Prep Kit v2" (Illumina) following the 
manufacturer’s protocol. The single read (50 bp) sequencing was performed 
using the HiSeq 2000 (Illumina). Three independent biological replicates were 
used for each sequencing reaction. The quality of the sequencing was 
controlled using the FastQ software 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).  
2.2.2.5.3 Sequencing alignment (performed by TAL) 
The sequence reads were aligned to the genome reference sequence of 
X. tropicalis (Joint Genome Institute assembly v4.2) using the STAR alignment 
software version 2.3.0e (Dobin et al., 2012). For the alignment, 5 mismatches 
were allowed within 50 bases.  
2.2.2.5.4 Statistical analysis (performed by TAL) 
For normalization and identification of differentially expressed genes the 
R/Bioconductor environment (www.bioconductor.org) with the DESeq2 package 
version 1.2.10 (Anders and Huber, 2010) was used. Genes showing at least a 
2-fold change and a FDR-corrected p-value < 0.05 were considered as 
candidate genes.  
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2.2.3 X. laevis embryo culture and micromanipulations 
For detailed descriptions refer to Sive et al., 2010. 
 
10x MBS: 880 mM NaCl, 10 mM KCl, 10 mM MgSO4, 25 mM NaHCO3, 50 mM 
HEPES, pH 7.8 
1x MBS: 1x MBS, 0.7 mM CaCl2 
5x MBS AC: 880 mM NaCl, 10 mM KCl, 10 mM MgSO4, 25 mM NaHCO3, 50 
mM HEPES, 2.1 mM CaCl2, 1.7 mM Ca(NO3), pH 7.8 
Dejelly solution: 2% (w/v) L-cysteine hydrochloride in 0.1x MBS, pH8 
Injection buffer: 1% ficoll in 1x MBS 
Nile Blue staining solution: 0.01 (w/v) nile blue chloride, 89.6 mM Na2HPO4, 
10.4 mM NaH2PO4, pH 7.8 
Agarose dishes: 60 mm petri-dishes coated with 1% agarose made with 0.8x 
MBS AC 
2.2.3.1 Stimulation of eggs 
To induce the X. laevis female frogs to lay eggs, 1000 U of human 
chorionic gonadotropin (HCG, Sigma Aldrich) was injected subcutaneous into 
the dorsal lymph sac the evening before desired egg laying. The frogs were 
kept at 16°C and started egg-laying 12-24 hours after HCG injection. 
2.2.3.2 Preparation of X. laevis testis 
For in vitro fertilization of the laid eggs, a male X. laevis was sacrificed by 
submersion in 0.05% benzocaine for 30 min at RT. The testis was removed and 
stored at 4°C in 1x MBS for approximately one week. 
2.2.3.3 In vitro fertilization 
Egg-laying was stimulated by massaging the abdomen and sides of the 
frogs. The layed eggs were fertilized by addition of ¼ Vol. macerated testis in 1x 
MBS which was diluted with ¾ Vol. of H2O. To prevent dehydration the fertilized 
eggs were covered in 1x MBS.  
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2.2.3.4 Microinjections 
The jelly coat of the embryos was removed by treatment with dejelly 
solution and washing 3-4 times with 0.1 x MBS. The microinjections were 
performed in injection buffer on a cooling plate set to 12.5°C using a borosilicate 
glass capillary (Harvard Apparatus), which was pulled with a needle puller (PN-
30, Scientific Products GmbH). The needles were back-loaded with the injection 
solution using microloaders (Eppendorf) and placed into a mechanical 
micromanipulator (M1, H. Sauer Laborbedarf) that was attached to a 
microinjector (PV 820, H. Sauer Laborbedarf). Depending on the experimental 
setup, 4 nl of the injection solution was injected animally into either one or two 
blastomeres of two-cell stage embryos, or into one dorsal blastomere of a four-
cell stage embryos. After injection, the embryos were kept for at least one hour 
in injection buffer and were then transferred into 0.1x MBS and cultured at 
different temperatures (12.5-18°C) until the desired developmental stages were 
reached. The developmental stages were determined according to Nieuwkoop 
and Faber (1967). 
2.2.3.5 X. laevis ectodermal explants (“animal caps”) 
Ectodermal explants were excised at blastula stage (stage 8-9) in 0.8x 
MBS on an agarose coated petri-dishes on a cooling plate set at 12.5°C. The 
vitelline membrane was removed with forceps and the ectodermal explant was 
excised from the animal hemisphere using a Gastromaster (Xenotek 
Engineering, Bellville, USA) set to “yellow high” with a yellow tip. The explants 
were cultivated in 0.8x MBS until control sibling embryos reached the desired 
stage. Explants were snap frozen in liquid nitrogen and stored at -80°C until 
RNA isolation. 
2.2.3.6 Dexamethasone treatment 
To control the time point of protein activity, the coding sequence of the 
gene of interest was fused to the ligand binding domain of the human 
glucocorticoid receptor (Kolm and Sive, 1995). To induce protein activity, the 
fusion construct injected embryos or animal caps were cultivated in 0.1x or 0.8x 
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MBS containing 10 µM dexamethasone in the dark until the desired stage was 
reached. 
2.2.3.7 β-Gal staining 
10x MEM: 1 M Mops, 20 mM EGTA, 10 mM MgSO4, pH 7.4 sterile filtered and 
stored in the dark 
10x PBS: 1.8 M NaCl, 1 M KCl, 65 mM Na2HPO4, 18 mM KH2PO4, pH 7.4 
Dent´s solution: 20% (v/v) DMSO in methanol 
K3Fe(CN)6: 0.5 M in H2O, stored in the dark 
K4Fe(CN)6: 0.5 M in H2O, stored in the dark 
MEMFA: 4% (v/v) formaldehyde (37%) in 1x MEM 
X-Gal: 40 mg/ml 5-bromo-4-chloro-3-indolyl-s-D-galactopyranoside in 
formamide, stored at -20°C in the dark. 
X-Gal staining solution: 1 mg/ml X-Gal, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 
mM MgCl2 in 1x PBS 
 
To distinguish the uninjected from the injected side of an embryo lacz 
mRNA (β-Gal) was co-injected as a lineage tracer (Hardcastle et al., 2000). The 
embryos were fixed at the desired stages for 20 min in MEMFA, washed three 
times for (10 min each) in 1X PBS and transferred to X-Gal staining solution. 
Staining took place in the dark until sufficient staining was observed (20-30 
min). The reaction was stopped by washing three times (10 min each) with 1x 
PBS followed by fixation for 25 min in MEMFA. Finally, the embryos were 
dehydrated by washing several times in absolute ethanol and stored at -20°C. 
For pH3 staining and fluorescent immunostaining, the embryos were 
dehydrated in absolute methanol, fixed in Dent’s fix for at least 24 hours at -
20°C and stored in absolute methanol at  
-20°C. 
2.2.4 Whole mount in situ-hybridization (WMISH) 
10X PBS: 1.8 M NaCl, 1 M KCl, 65 mM Na2HPO4, 18 mM KH2PO4, pH 7.4 
20X SSC: 3 M NaCl, 0.3 M NaCitrate, pH 7.2 - 7.4 
5X MAB: 500 mM maleic acid, 750 mM NaCl, pH 7.5 
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Antibody solution: 2% Boehringer Mannheim Blocking reagent (BMB), 20% 
heat treated horse serum (Gibco), 1:2000 dilution of anti-digoxigenin or anti-
fluorescein antibody coupled to alkaline phosphatase (Roche) in 1X MAB 
APB: 100 mM Tris-HCl, pH 9.0, 50 mM MgCl2, 100 mM NaCl,  
0.1% TWEEN-20 
BCIP: 50 mg/mL in 100% dimethylformamide; stored at -20°C 
Bleaching solution: 50% formamide, 1-2% H2O2 in 5x SSC 
Color reaction solution: 80 μg/ml NBT, 175 μg/ml BCIP in APB 
EtOH series: 100%, 75%, 50% ethanol in H2O, 25% ethanol in PTw 
Hybridization Mix (Hyb Mix): 50% formamide, 1 mg/ml, Torula-RNA, 10 μg/ml 
Heparin, 1X Denhardt’s, 0.1% Tween-20, 0.1% CHAPS, 10 mM EDTA in 5X 
SSC 
MeOH series: 100%, 75%, 50%, 25% methanol in H2O 
MAB/BMB: 2% BMB in 1X MAB 
MAB/BMB/HS: 2% BMB, 20% heat-treated horse serum in 1X MAB 
NBT: 100 mg/mL in 70% dimethylformamide; stored at -20°C 
PTw: 0.1% Tween-20 in 1X PBS 
PTw/FA: 4% (v/v) formaldehyde in PTw 
Proteinase K: 5 μg/ml proteinase K (Merck) in 0.1X PBS 
RNAse Solution: 10 μg/ml RNAse A, 0.01 U/ml RNAse T1 in 2X SSC 
Triethanolamine: 0.93 triethanolamine in H2O, pH 7.5 
 
To visualize temporal and spatial gene expression, WMISH was 
performed as previously described (Harland, 1991; Hollemann and Pieler, 1999) 
using digoxigenin-UTP or fluorescin-UTP labelled antisense RNA. All steps 
were performed with mild shaking at room temperature, if not otherwise noted.  
The embryos were rehydrated in an ethanol series (75%, 50%, and 25%) 
and washed four times for 5 min in PTw. To make the surface of the embryo 
penetrable for the antisense RNA probe, they were treated with PTw/proteinase 
K solution (10 µg proteinase K/ml PTw). Stage 14 embryos were treated for 6 
min while Stage 27-28 embryos were treated for 17 minutes. To stop the 
proteinase K treatment the embryos were washed twice for 5 min with 
triethanolamine. To prevent unspecific binding of the antisense RNA probe, free 
amino-acid ends were blocked by addition of 25 µl acetic anhydride to the 
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triethanolamine. After incubation for 5 min, an additional 25 µl acetic anhydrite 
was added to the triethanolamine. Following acetylation, the embryos were 
washed two times for 5 min in PTw, refixed for 20 min in PTw/FA and finally 
washed 5 times for 5 min in PTw. For pre-hybridization, the embryos were 
incubated with Hyb Mix for 5 h at 65°C. After pre-hybridization the embryos 
were incubated overnight at 65°C in Hyb Mix containing the antisense RNA 
probe.  
The following day, the antisense RNA probe containing Hyb Mix was 
exchanged with fresh Hyb Mix for 10 min at 65°C followed by washing three 
times for 15 min each at 65°C with 2x SSC. To remove remaining non-
hybridized antisense RNA probe, the embryos were treated with RNase solution 
at 37°C and afterwards washed once in 2x SSC for 5 min at RT, twice in 0.2x 
SSC at 65°C and two times for 15 min at RT in 1x MAB. To avoid unspecific 
binding of the antibody, the embryos were blocked for 15 min in MAB/BMB and 
afterwards for 40 min in MAB/BMB/HS. The embryos where then incubated 
overnight at 4°C in the antibody solution.  
The next day, the embryos were washed at least 5 times for 10 min in 1x 
MAB. For the color reaction, the embryos were first washed twice for 5 min at 
4°C in fresh APB and then transferred to the color reaction solution. The 
reaction took place at 4°C, in the dark, until staining was sufficient. To stop the 
color reaction and remove background staining, the embryos were dehydrated 
in 100% methanol until no background color leached out of the embryos. For 
rehydration the embryos were incubated in sequentially in 100%, 75%, 50% and 
25% methanol and afterwards fixed in MEMFA for 15 min. The embryos were 
stored indefinitely in MEMFA. To remove the pigmentation, the embryos were 
incubated in bleaching solution until pigmentation was gone and afterwards 
washed two times in 5x SSC followed by fixation and storage in MEMFA. 
2.2.5 Phosphorylated Histone 3 (pH3) staining 
10X PBS: 1.8 M NaCl, 1 M KCl, 65 mM Na2HPO4, 18 mM KH2PO4, pH 7.4 
1° AB solution: 20% horse serum, 5% DMSO, 1/270 dilution rabbit anti-pH3 
antibody (Biomol) 
2° AB solution: 20% horse serum, 5% DMSO, 1/750 dilution goat anti-rabbit 
IgG horseradish peroxidase-coupled secondary antibody (Sigma) 
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APB: 100 mM Tris-HCl, pH 9.0, 50 mM MgCl2, 100 mM NaCl,  
0.1% tween-20 
Color reaction solution: 80 μg/ml NBT, 175 μg/ml BCIP in APB 
MeOH series: 100%, 75%, 50%, in H2O and 25% methanol in 1xPBS 
PBS-TB: 0.05% Tween-20, 0.2% BMB in 1x PBS 
PBS-TBN: 0.3 M NaCl in PBS-TB 
Proteinase K: 5 μg/ml Proteinase K (Merck) in 0.1X PBS 
 
To mark mitotically active cells in whole embryos, phosphohistone H3 
staining was performed as previously described (Dent et al., 1989). Embryos 
were fixed in Dent’s fix after β-gal staining and rehydrated in a MeOH series to 
PBS. After Proteinase K treatment for 10 min, the embryos were washed two 
times in PBS-TB for 10 min at RT. For the first antibody reaction, the embryos 
were pre-incubated in PBS with 20% horse serum. After 2 h at RT the embryos 
were transferred to the 1° AB solution and incubated overnight at 4°C. The next 
day, the embryos were washed twice with PBS-TB for 2 h at RT and afterwards 
with PBS-TB overnight at 4°C. The following day, the embryos were washed for 
2 h with PBS-TBN, 5 min with PBS-TB and overnight at 4°C in 2° AB solution. 
The next day, the embryos were washed twice in PBS-TB for 30 min, once for 
30 min in PBS-TBN, once in PBS-TB for 5 min and then washed overnight in 
PBS-TB at 4°C. For the color reaction the embryos were first washed with PBS-
TB for 10 min, twice in fresh APB for 5 min at 4°C and afterwards transferred to 
the color reaction solution. When the desired staining was reached, the 
embryos were dehydrated and stored in 100% methanol at -20°C. 
2.2.6 Fluorescent immunostaining 
Blocking solution:  
Murray’s clear: benzyl benzoate/benzyl alcohol, 2/1 
TBS: 50mM Tris-HCl, 150 mM NaCl, pH 7.6 
TBST: 0.05 % Tween-20 in TBS 
 
Fluorescent immunostaining was performed to detect acetylated tubulin, 
which marks the axons of neurons (Friedmann et al., 2012). After β-gal staining, 
embryos were fixed overnight in Dent’s fix and dehydrated for at least 24 h in 
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100% methanol. For rehydration the embryos were subjected to a MeOH series 
to TBS. To prevent nonspecific antibody binding, the embryos were blocked for 
30 min in blocking solution at RT. The primary antibody was added directly to 
the blocking solution (anti-acetylated tubulin, 1/200, Sigma-Aldrich) and 
incubated overnight at 4°C. The following day, the embryos were washed at RT 
for 3 h in TBST that was exchanged every 30 min. For the second antibody 
reaction, the embryos were blocked in blocking solution for 15 at RT. The 
secondary antibody (goat anti-mouse Alexa 488, 1/300, Invitrogen) was added 
directly to the blocking solution and incubated overnight at 4°C. The next day, 
the embryos were washed at RT for 3 h in TBST that was exchanged every 30 
min. The embryos were dehydrated in 100% methanol and cleared in Murray’s 
clear for confocal imaging on a LSM780 (Zeiss). 
2.2.7 Luciferase reporter assay 
For luciferase reporter assay two cell stage embryos were injected 
animally into both blastomeres with 100 pg Atf2-Firefly-luciferase reporter (van 
der Sanden et al., 2004) or 200 pg TOPFlash-Firefly-luciferase reporter (Fujimi 
et al., 2011) together with 10 pg Renilla luciferase reporter (Promega) for 
normalization. The reporters were injected alone or co-injected with either 500 
pg MT-wnt5b, 100 pg wnt8a-MT or 500 pg prdm14-GR respectively. At least six 
injected embryos at stage 14 were collected per sample and two samples were 
tested for one condition. For measurement of the Firefly and Renilla luciferase 
activity the Dual Luciferase Reporter Kit (Promega) and a Centro LB960 
luminometer (Berthold Technologies) were used according to manufacturer’s 
protocols. 
2.2.8 Vibratome sectioning 
Gelatin/Albumin: 4.9 mg/ml gelatin albumin was heat dissolved in PBS at 
60°C, followed by the addition of 0.3 g/ml bovine serum albumin and 0.2 mg/ml 
sucrose. The solution was sterile filtered using 0.45 µm filter (Sartorius) and 
stored at -20°C. 
Mowiol: 5 g Mowiol was dissolved in 20 ml PBS and stirred overnight. 
Afterwards 10 ml glycerol was added and the solution again stirred overnight. 
After centrifugation for 30 min at 20,000 g, the undissolved Mowiol was 
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collected and removed and the supernatant was set to pH 7. The solution was 
aliquoted and stored at -20°C. 
 
For sectioning the embryos were mounted in gelatin/albumin, which was 
solidified by addition of glutaraldehyde. Sections of 30 µm were cut using a 
Leica VT1000M vibratome and mounted on a glass slide in Mowiol. 
2.2.9 Protein standard methods 
2.2.9.1 SDS-polyacrylamide gelelectrophoresis (SDS-PAGE) 
10x Laemmli buffer: 250mM Tris, 2.5 M glycine, 0.1% SDS 
2x SDS loading buffer: 100 mM Tris-HCl pH 6.8, 4% (w/v) SDS, 0.2% (w/v) 
bromophenol blue, 20% (v/v) glycerol, 200 mM β-mercaptoethanol 
 
Proteins were separated according to their molecular weight by SDS-
polyacrylamide gel electrophoresis (Laemmli, 1970). For denaturing of the 
proteins, samples were diluted with 2x loading buffer and boiled for 3 min at 
95°C. For separation of the proteins, a 10% SDS gel was prepared according to 
standard protocols (Sambrook and Russel, 2001). The gel electrophoresis was 
performed in 1 x Laemmli buffer and was started with a voltage of 80 V. As 
soon the samples entered the separating gel the voltage was turned up to 200 
V. To determine the molecular weight of the proteins, a standard protein marker 
was used (Page Ruler Plus Prestained Protein Ladder, Fermentas). 
2.2.9.2 Western blotting 
Blocking solution: 5% (w/v) dry, non-fat milk powder in TBST  
TBS: 50 mM Tris, 150 mM NaCl, pH 7.6 
TBST: 0.05 % Tween-20 in TBS 
  
After separation of the proteins by SDS-PAGE, the proteins were 
transferred to a nitrocellulose membrane by semi-dry blotting for 1 h in transfer 
buffer at 13-15 V (Sambrook and Russel, 2001; Towbin et al., 1979). After the 
transfer of the proteins the membrane was blocked in blocking solution for 1 h 
at RT. Incubation with the primary antibody was carried out overnight at 4°C in 
Materials and Methods 37 
blocking solution. The following day, the membrane was washed 3 times for 10 
min in blocking solution. The secondary antibody, which was coupled to a 
fluorescent IRdye (LI-COR), was applied to the blocking solution and the 
membrane was incubated for 1 hour at RT and afterwards washed twice for 10 
min with blocking solution and once for 10 min with TBST at RT. To detect the 
fluorescent signals the LI-COR Odyssey Infrared Imaging system was used. 
 
Name Company Host Type Clonality dilution 
anti-HA Convance mouse primary monoclonal 1:1000 
anti-GR Santa Cruz rabbit primary polyclonal 1:200 




LI-COR goat secondary polyclonal 1:15000 
anti-rabbit 
680 RD IRdye LI-COR goat secondary polyclonal 1:15000 




3. Results  
3.1 Temporal and spatial expression analysis of X. laevis 
prdm14  
To gain insight into the function of prdm14 during early X. laevis 
embryogenesis, a detailed expression analysis was performed. The temporal 
expression of prdm14 was evaluated by semi-quantitative RT-PCR analysis 
using total RNA from staged embryos. As shown in Figure 3.1A, prdm14 
transcripts are maternally provided and are maintained at high levels throughout 
tadpole stages. 
The spatial expression of prdm14 was then determined by whole mount 
in situ hybridization. Prdm14 transcripts are detected in the animal hemisphere 
from early cleavage stages (stage 5, Fig. 3.1B) to blastula stages (stage 8, Fig. 
3.1C). At early mid-gastrula stages (stage 10.5, Fig. 3.1D), prdm14 expression 
is confined to the dorsal ectoderm, which marks the prospective 
neuroectoderm. As shown in the sagittal section, prdm14 transcripts are 
restricted to the deep layer of the ectoderm (Fig. 3.1D’). At the end of 
gastrulation (stage 11.5, Fig. 3.1E), prdm14 is broadly expressed throughout 
the dorsal ectoderm with enrichment in the lateral domains, which most likely 
corresponds to the prospective neural plate border. At stage 12.5, prdm14 
transcripts are present throughout the anterior neural plate (Fig. 3.1F). 
Posteriorly, the expression becomes refined to three longitudinal domains on 
both sides of the midline, which prefigures the territories of primary 
neurogenesis. Strong expression is observed in the intermediate and lateral 
domains, while the expression in the medial domain is weak (Fig. 3.1F). From 
stage 13 to 15, prdm14 expression in the posterior neural plate is maintained 
and becomes stronger in the medial stripe (Fig. 3.1G-I). As seen in transversal 
section of a stage 15 embryo (Fig. 3.1I’), the expression of prdm14 is restricted 
to the deep layer of the neuroectoderm, where the primary neurons arise 
(Hartenstein, 1989). At stage 13, the expression becomes restricted to the 
anterior neural plate border, the trigeminal-profundal placode and to a 
horseshoe shaped domain, which will give rise to the ventral midbrain 




Fig. 3.1 Temporal and spatial expression analysis of prdm14 in X. laevis embryos. (A) 
Prdm14 is maternally expressed. Temporal prdm14 expression analysis by semi-quantitative 
RT-PCR at indicated stages. Expression levels were shown by odc expression. (B-M) Prdm14 
is expressed throughout the developing nervous system. Spatial expression analysis of prdm14 
in X. laevis embryos by whole mount in situ hybridization. (B-D) Lateral view of the embryos, 
animal up. (D’) Sagittal section of embryo shown in D. (E-J) Dorsal view of embryos, anterior 
up. (I’) Transverse section at indicated level of embryo shown in I. (K, M) Anterior view of 
embryo, dorsal up. (L) Lateral view of embryo, anterior right, dorsal up. anpb, anterior neural 
plate border; bp, blastoporus; bpl, blastoporus lip; i, intermediate; l, lateral; m, medial; op, otic 
placode; tg, trigeminal-profundal placode; vmb, ventral midbrain  
 
During neurulation, the expression of prdm14 is maintained in the posterior 
primary neurons, the trigeminal-profundal placode and olfactory placodes (Fig. 
3.1J-M). At stage 26, prdm14 transcripts are detected in the trigeminal 
placodes, otic vesicles, olfactory placodes and throughout the spinal cord (Fig 
3.2A). Transverse sections show that prdm14 transcripts are present in the 
inner segment of the otic vesicle and in the marginal zone of the neural tube 
where postmitotic neurons reside (Fig. 3.2A’-A’’’) (Bellefroid et al., 1996). In the 
anterior neural tube, prdm14 expression is restricted to two distinct domains 
(Fig. 3.2A’’), while more posteriorly the expression spans the entire marginal 
zone of the neural tube (Fig. 3.2A’’’). Double whole mount in situ hybridization 
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for prdm14 and tubb2b shows that the expression domains for both genes 
overlap in the marginal zone throughout the neural tube, confirming that prdm14 
indeed is expressed in postmitotic neurons (Fig. 3.2B-B’’).   
 
 
Fig. 3.2 Prdm14 is expressed in the marginal zone of the neural tube. (A-B’’) Spatial 
expression analysis of prdm14 in X. laevis stage 26 embryos by whole mount in situ 
hybridization. (A, B) Lateral view of embryo (anterior right). (A’-A’’’) Transverse sections at 
indicated levels of embryo shown in A. (B-B’’) Double whole mount in situ hybridization of stage 
26 embryos for tubb2b (red) and prdm14 (purple). (B’-B’’) Transverse sections at indicated 
levels of embryo shown in B. nc, notochord; nt, neural tube; op, olfactory placode; ov, otic 
vesicle; tg, trigeminal profundal placode 
 
Taken together, the expression of prdm14 is strongly indicative for a role 
during the early development of the nervous system. While prdm14 is clearly 
present in the post-mitotic neurons of the neural tube, it is also expressed in the 
neural plate when the proneural genes specify the primary neurons. To further 
clarify the timing of prdm14 expression in relationship to the proneural genes 
neurog1 and neurog2, to which prm14 is most similar, a comparative 
expression analysis was performed. Both prdm14 and neurog2 are expressed 
throughout the prospective neuroectoderm at the onset of gastrulation (stage 
10), with the expression of neurog2 being weaker and located closer to the 
blastopore (Fig. 3.3). At the end of gastrulation (stage 12), transcripts of 
neurog1 and neurog2 are detectable in the posterior neural plate in three 
distinct domains prefiguring the territories of primary neurogenesis. At this stage 
prdm14 transcripts are only present in the medial and lateral stripes of primary 
neurogenesis and the anterior neural plate. At stage 14, prdm14, neurog1 and 
neurog2 are all expressed in the trigeminal-profundal placodes as well as in the 
three bilateral longitudinal domains of primary neurogenesis. However, the 
expression of prdm14 and neurog1 are strikingly similar. They are both 
expressed in the future ventral midbrain, and compared to neurog2, their 
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expression in the longitudinal domains is more refined and extends more 
anteriorly. During neurulation (stage 18) all transcripts are present in the neural 
fold and in the trigeminal-profundal placodes.  
In summary, prdm14 differs from the analyzed proneural genes as it is 
expressed early and strongly in the anterior neural plate. In the territories of 
primary neurogenesis of the posterior neural plate, the expression of neurog2 
prefigures that of prdm14.  
 
 
Fig. 3.3 Prdm14, neurog1 and neurog2 are co expressed in territories of primary 
neurogenesis. Comparative expression analysis of stage matched embryos. Stage 10: lateral 
view, animal up; Stage 12-18: dorsal view, anterior up. anpb, anterior neural plate border; bp, 
blastoporus; hb, hindbrain; i, intermediate; l, lateral; m, medial; tg, trigeminal-profundal placode; 
vmb, ventral midbrain 
 
The temporal expression of prdm14 in the neural plate and in the outer 
mantel layer of the neural tube suggests a function for Prdm14 downstream of 
Neurog2. Therefore, the regulation of prdm14 by the proneural transcription 
factor Neurog2 was analyzed (Ma et al., 1996). Neurog2 mRNA was injected 
together with β-gal mRNA to indicate the cells that have received the injected 
material, into one blastomere of two-cell stage embryos. The embryos were 
analyzed by whole mount in situ hybridization at neural plate stage (Fig. 3.4A). 
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As anticipated, microinjection of neurog2 mRNA strongly induces expression of 
the postmitotic neuronal marker tubb2b (also known as n-tubulin) in the deep 
layer of the ectoderm (n= 13, 100% ectopic expression) (Fig. 3.4 B-B’) (Ma et 
al., 1996, Chalmers et al., 2002). Strong ectopic expression was similarly 
observed for prdm14 (n= 28, 100% ectopic expression) (Fig. 3.4D-D’).  
Prdm14 was identified as a putative target gene of the repressor protein 
Hes5.1, which itself is a target of the Notch pathway (Klisch, 2006, Kiyota et al., 
2001). Therefore, the influence of Notch signaling on prdm14 expression was 
also analyzed. mRNA encoding for the Notch intracellular domain (NICD), which 
is the constitutively active version of the Notch receptor, was injected into one 
blastomere of two-cell stage embryos. Consistent with the known activity as a 
negative regulator of primary neurogenesis (Chitnis and Kintner, 1996), NICD 
mRNA injection resulted in the inhibition of tubb2b on the injected side of the 
embryo (n= 19, 100% downregulated). NICD also strongly inhibited the 
expression of prdm14 (n= 31, 90% downregulated) (Fig. 3.4C-E). Taken 
together, the expression and regulation of prdm14 suggests a role for prdm14 in 
primary neurogenesis in X. laevis. 
 
  
Fig. 3.4 Prdm14 expression is regulated by key regulators of neurogenesis. (A) Neurog2 
(20 pg) or NICD (100 pg) mRNA together with β-Gal (75 pg) mRNA (light blue staining) were 
injected into one blastomere of a two-cell stage embryo. (B-E) Gene expression was analyzed 
by whole mount in situ hybridization using markers indicated on the left side. The injected side 
is on the right, dorsal view, anterior up. (B’, D’) Transverse sections at indicated levels of 
embryo shown in B and D, respectively. Red arrows indicate the midline. 
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3.2 Prdm14 gain of function 
To gain further support for a role of prdm14 during X. laevis primary 
neurogenesis, a gain of function approach was performed. mRNA encoding a 
HA-tagged version of prdm14 (500 pg) was microinjected into one of two 
blastomeres and the influence on neuronal differentiation evaluated by whole 
mount in situ hybridization. At neural plate stage, the expression of tubb2b was 
inhibited on the prdm14 mRNA injected side of the embryo (n= 36, 64% 
downregulated) (Fig. 3.5B). To ensure that the observed phenotype was not 
due to an unspecific effect, gfp mRNA was injected at the same concentration 
as prdm14-HA. Microinjection of gfp mRNA did not affect tubb2b expression, 
which suggested that any observed phenotypes could be attributed to the 
injected prdm14 mRNA (Fig. 3.5A). 
The inhibition of neuronal differentiation by prdm14 was only transient, as 
in the neural tube of tailbud stage embryos the expression of tubb2b was 
recovered (Fig. 3.5C-D’). Since the transient inhibition may be due to low 
protein stability, a GR-tagged version of prdm14 was generated, as GR-fusion 
proteins often exhibit an increased effectiveness due to higher protein stability 
(Kolm and Sive, 1995). The mRNA encoding for prdm14-GR was injected into 
one blastomere of two-cell stage embryos and the activity of the fusion protein 
was induced by addition of dexamethasone (dex) at the four-cell stage (stage 
3). Embryos that were injected with prdm14-GR mRNA and treated with dex 
showed an inhibition of tubb2b at the neural plate stage. Inhibition of tubb2b 
was not observed in injected and untreated embryos, demonstrating that 
Prdm14-GR is indeed hormone inducible (Fig. 3.5E). The phenotype induced by 
prdm14-GR mRNA is similar to that of prdm14-HA mRNA injected embryos (n= 
39, 64% downregulated). However, the inhibition of neuronal differentiation was 
observed at a higher frequency (n= 17, 100% downregulated) (Fig. 3.5F). 
Moreover, Prdm14-GR induced ectopic tubb2b expression in the non-neural 
ectoderm of tailbud stage embryos (n= 23, 83% ectopic expression) (Fig. 3.5G-
H’, red arrows). In the transverse section, tubb2b expression was strongly 
increased and the entire dorsal region of the neural tube was enlarged 
compared to the uninjected side (Fig. 3.5H’). The strongest expansion was 
observed in the dorsal half of the neural tube. Interestingly, a thickening of 
mesenchymal tissue on the injected side of tailbud stage embryos was also 
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observed, which was more prominent in the prdm14-GR injected embryos than 
in the prdm14-HA injected ones (Fig. 3.5D’, H’, black brackets). 
 
 Fig. 3.5 Prdm14-GR overexpression induces stronger phenotypes. (A-H‘) Indicated mRNA 
was injected together with β-Gal (75 pg) mRNA (light blue staining) into one blastomere of a 
two-cell stage embryo. tubb2b expression was analyzed by whole mount in situ hybridization. 
Injected side is always to the right. (A, B, E, F) Neural plate stage, dorsal view, anterior up; (C, 
D, G, H) tailbud stage, lateral view, dorsal up; (A) 500 pg MT-gfp mRNA; (B-D’) 500 pg prdm14-
HA;  (E) 500 pg prdm14-GR; (F-H’) 500 pg prdm14-GR, embryos were treated from four-cell 
stage on with dex; (D’, H’) Transverse sections at indicated levels of embryo shown in D and H 
respectively. Black brackets indicate width of mesenchymal tissue at the level of the notochord. 
Dashed line indicates midline of the neural tube.is, injected side; nt, neural tube; nc, notochord 
 
3.3. Prdm14 promotes proliferation and the expansion of neural 
progenitors 
Prdm14 overexpression at neural plate stage inhibited the expression of 
the postmitotic neuron marker tubb2b (Fig. 3.5B, F) and at tailbud stages 
resulted in an enlarged neural tube and ectopic neuronal differentiation (Fig. 
3.5H’). To analyze if these effects were caused by the expansion of progenitor 
cells, the effect of prdm14-GR overexpression on the neural plate marker sox2 
was evaluated, as it is a definitive marker of neural progenitors (Graham et al., 
2003; Ellis et al., 2004) (Fig. 3.6A). Microinjection of prdm14-GR results in the 
expansion of the sox2 expression domain on the injected side of the embryo 
(n= 20; 75% increased) (Fig. 3.6B).  
To determine if the expansion of sox2 expression by prdm14-GR is the 
result of increased proliferation, the number of mitotically active cells in the 
dorsal ectoderm was quantified by staining for phosphorylated histone 3 (pH3) 
(Dent et al., 1989) (Fig. 3.6C). To quantify the number of mitotically active cells, 
three embryos were sectioned and the pH3 positive cells were counted in the 
dorsal halves of 15 consecutive sections. The number of mitotically active cells 
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in the neuroectoderm was increased almost two-fold on the prdm14-GR injected 
side compared to the uninjected side (Fig. 3.6C’-D). These results suggest that 
prdm14 promotes the proliferation of progenitor cells, resulting in the inhibition 
of neuronal differentiation at neural plate stage and in an enlarged neural tube 
in later stages. 
 
 
Fig. 3.6 Prdm14-GR overexpression promotes proliferation. (A) Prdm14-GR (500 pg) 
mRNA together with β-Gal (75 pg) mRNA (light blue staining) were injected into one blastomere 
of a two-cell stage embryo. Embryos were treated from four-cell stage on with dex. (B-C) Gene 
expression was analyzed at stage 14 by whole mount in situ hybridization using markers 
indicated on the bottom left side. The injected side is on the right, dorsal view, anterior up. (B) 
The white brackets indicate width of expression domain. (C’) Transverse section at indicated 
levels of embryo shown in C. (D) The graph shows the statistical evaluation of 15 consecutive 
sections of three embryos based on the number of pH3 positive cells in the dorsal half on the 
injected and uninjected site as indicated in the cross-section C’. Error bars represent the 
standard error of the mean of two independent experiments (+/-SEM). 
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3.4 Prdm14 promotes ectopic sensory neuron formation 
Prdm14-GR induces ectopic neurons in the non-neural ectoderm of 
tailbud stage embryos (Fig. 3.5G-H’) raising the question as to which neuronal 
subtype they belong to. As the dorsal neural tube, which arises from the neural 
plate border (NPB), was strongly expanded, the expression of tlx3 was 
analyzed, which is expressed in the NPB and the dorsally located glutamatergic 
Rohon-Beard sensory neurons (Patterson and Krieg, 1999; Rossi et al., 2009). 
Whole mount in situ hybridizations of embryos overexpressing prdm14-GR 
showed ectopic expression of tlx3 in the non-neural ectoderm (n= 22; 76% 
ectopic staining) (Fig. 3.7C, red arrows) and an increased expression in the 
dorsal neural tube (Fig. 3.7C’, red arrows). The glutamatergic neurotransmitter 
identity of these neurons was further supported by the ectopic expression of the 
vesicular glutamate transporter 1 slc17a7 (vglut1) (n= 25; 80% ectopic staining) 
(Fig 3.7D-E’). To determine if other ectopic neuronal subtypes are induced by 
Prdm14-GR, the expression of mnx1 (also known as hb9) was analyzed, which 
is expressed in cholinergic motor neurons in the most ventral aspect of the 
neural tube (Saha et al., 1997). Ectopic mnx1 expression was never observed 
in the non-neural ectoderm. Nonetheless, an expansion of the endogenous 
expression domain was observed, which may be the result of an overall 





Fig. 3.7 Prdm14-GR overexpression promotes sensory neurons in tailbud stage embryos. 
(A) Prdm14-GR (500 pg) mRNA together with β-Gal (75 pg) mRNA (light blue staining) were 
injected into one blastomere of a two-cell stage embryo. Embryos were treated from four-cell 
stage on with dex. (B-G’) Gene expression was analyzed at stage 27 by whole mount in situ 
hybridization using markers indicated on the left. The injected side is on the right, lateral view. 
is, injected side (C’, E’, G’) Transverse sections at indicated levels of embryo shown in C, E, G 
respectively. Black brackets indicate width of mesenchymal tissue at the level of the notochord. 
Dashed line indicates midline of the neural tube. nt, neural tube; nc, notochord 
 
To determine if prdm14 overexpression is sufficient to induce 
glutamatergic sensory neurons in pluripotent cells, the animal cap assay was 
used. Control and prdm14-GR mRNA-injected embryos were treated with dex at 
stage 3 and animal caps were isolated from blastula stage embryos (Fig. 3.8A). 
At the equivalent of neural plate stage (stage 14) and tailbud stage (stage 27) 
total RNA was isolated and analyzed by RT-PCR. Similar to the phenotype in 
embryos, at the equivalent of tailbud stages, tubb2b as well as tlx3 were 
induced. These markers were not observed in prdm14-GR mRNA-injected 
animal caps not treated with dex, or control uninjected caps treated with dex. To 
elucidate if prdm14 directly promotes neural differentiation or requires the 
activity of proneural genes, the expression of neurog2 was analyzed. At the 
equivalent of stage 14, neurog2 is induced in caps expressing Prdm14-GR. The 
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absence of tubb2b at the equivalent of neural plate stage is similar to the 
transient inhibition of neurogenesis observed in the embryos. The regulation of 
neurog2 by Prdm14-GR is unexpected as neurog2 strongly promotes prdm14 
(Fig. 3.4B), suggesting a positive feedback loop between these two factors. 
Hence, active Prdm14-GR is able to promote neuronal differentiation in whole 
embryos as well as animal caps. 
 
 
Fig. 3.8 Prdm14-GR overexpression activates sensory neuron marker tlx3 in animal caps. 
(A-B) Prdm14-GR (500 pg) mRNA was injected into both blastomeres of a two-cell stage 
embryo. Control and prdm14-GR mRNA-injected embryos were treated with dex from four-cell 
stage on and animal caps were isolated from blastula stage embryos. At the equivalent of 
neural plate stage (stage 14) and tailbud stage (stage 27) total RNA was isolated and analyzed 




3.5  Knock down of Prdm14 
To further analyze the role of Prdm14 in the regulation of neuronal 
differentiation, loss of function studies were performed. Antisense morpholino 
oligonucleotides were proven as an effective tool in X. laevis for the inhibition of 
gene function (Heasman et al., 2000; Nutt et al., 2001; Heasman, 2002). 
However, their use in X. laevis is complicated by the fact that X. laevis is 
allotetraploid and therefore redundancies might exist. For prdm14 two 
sequence-related paralogs in X. laevis exists, prdm14a and prdm14b. In order 
to efficiently knock down the expression of prdm14, two splicing morpholinos 
(SpMO) were simultaneously used to disrupt the splicing of prdm14a and 
prdm14b. Both SpMOs target the exon1-intron1 boundary to prevent the 
splicing of intron1 (Fig. 3.9A-B). If intron1 is retained, only a truncated protein 
should be translated, as the intron1 contains a stop codon. The resulting 
truncated Prdm14 proteins would have 208 amino acids (Prdm14a) and 210 
amino acids (Prdm14b), and would not contain the PR and Zn finger domains 
(Fig. 3.9C).  
To test the specificity and function of the SpMOs, they were injected 
alone or together at increasing concentrations (5, 10, 25 ng) into both 
blastomeres of a two-cell stage embryo. The embryos were collected at stage 
14 and RT-PCR analysis was performed using primers which bind within exon1 
and exon2 of prdm14a and prdm14b. Knock down of prdm14 by both SpMOs 
led to a concentration-dependent upward shift of the amplicon bands indicating 
a larger size (Fig. 3.9D). As verified by sequencing analysis of these amplicons, 
the increase in size was due to the impaired splicing resulting in intron 1 
retention. While Prdm14a SpMO was specific for prdm14a, the Prdm14b SpMO 
impaired the splicing of both prdm14a, and prdm14b. However, Prdm14b was 
more effective on inhibiting prdm14b splicing. Analysis of tailbud stage embryos 
injected with both SpMOs demonstrated that splicing is efficiently inhibited at 





Fig. 3.9 Injection of Prdm14 splicing morpholinos causes intron1 retention. (A) Nucleotide 
sequence of prdm14a and prdm14b exon1/intron1 boundary. SpMO binding sites are 
highlighted in blue. (B) Schematic representation of prdm14 pre-mRNA. (C) Schematic 
representation of the translated protein after conventional splicing and intron1 retention. (D) 
Morpholino oligonucleotides were injected in indicated combinations into both blastomeres of 
two-cell stage embryos. At the equivalent of neural plate stage (stage 14) and tailbud stage 
(stage 27) total RNA was isolated and analyzed by RT-PCR using markers indicated on the 
right. Expression levels were shown by odc expression. Expected amplicon sizes are indicated 
on the left. 
 
To determine how prdm14 loss of function would affect neuronal 
differentiation at tailbud stage, Prdm14 was knocked down by SpMOs in one 
dorsal blastomere of four-cell stage embryos (Fig. 3.10A). As shown by whole 
mount in situ hybridization, the loss of Prdm14 had no influence on the 
expression of tubb2b and tlx3 (Fig. 3.10B-E’). Next, the influence of Prdm14 
knock down on motor neuron axonal outgrowth in the spinal cord was analyzed, 
since impairments thereof have been reported in zebrafish Prdm14 morphants 
(Liu et al., 2012). Therefore, both morpholinos where injected into both dorsal 
blastomeres of 4-cell stage embryos to specifically target the SpMOs to the 
neural tube (Fig. 3.10F). As shown by immunofluorescence staining against 
acetylated Tubulin, the motor neuron axon outgrowth is not impaired by the 
control morpholino (Fig. 3.10G) or Prdm14 knock down (Fig. 3.10H). In 
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summary, while overexpression of prdm14 leads to the ectopic formation of 
neurons of a specifically glutamatergic character, the knock down of Prdm14 




Fig. 3.10 Knock down of Prdm14 does not influence neuronal differentiation and axon 
outgrowth of motor neurons. (A) Prdm14a SpMO and Prdm14b SpMO (25 pg each) together 
with β-Gal (75 pg) mRNA (light blue staining) were injected into one dorsal blastomere of four-
cell stage embryos. (B-E’) Gene expression was analyzed at stage 27 by whole mount in situ 
hybridization using markers indicated on the left. The injected side is on the right, lateral view. 
is, injected side (C’, E’) Transverse sections at indicated levels of embryos shown in C and E, 
respectively. Dashed line indicates the midline of the neural tube. nt, neural tube; nc, notochord 
(F) Prdm14a SpMO and Prdm14b SpMO (25 pg each) or control morpholino (50 ng) were 
injected into both dorsal blastomeres of four-cell stage embryos. (G-H) Axon outgrowth of motor 
neurons was visualized by fluorescent immunostaining against acetylated tubulin at stage 27. 
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3.6 Identification of Prdm14 downstream targets 
To further investigate the function of Prdm14 during early development, 
gain of function approaches were employed. Overexpression of prdm14-GR 
was sufficient to induce glutamatergic neurons in pluripotent animal cap cells. 
Hence, we decided to use this system to identify the global regulatory gene 
network induced by Prdm14 through RNA-sequencing analysis (Fig. 3.11A). 
Control and prdm14-GR mRNA-injected embryos were treated with dex at four-
cell stage and animal caps were isolated from blastula stage embryos.  At the 
equivalent of neural plate stage (stage 14) and tailbud stage (stage 27) total 
RNA was isolated and reverse transcribed into cDNA, which was subjected to 
single read (50 bp) sequencing. The sequence reads were aligned to the 
genome reference sequence of X. tropicalis (Joint Genome Institute assembly 
v4.2) using the STAR alignment software (Dobin et al., 2012), allowing 5 
mismatches within 50 bases. Using this approach in total 86-89% of the reads 
could be annotated. Genes were considered as candidates if they showed at 
least a 2-fold change (log2FC>1) over control caps and a FDR-corrected p-
value <0.05.  
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Fig. 3.11 RNA-sequencing analysis of prdm14-GR overexpression in animal caps. (A-B) 
Prdm14-GR (500 pg) mRNA was injected into both blastomeres of two-cell stage embryos. 
Control and prdm14-GR mRNA-injected embryos were treated with dex from four-cell stage on 
and animal caps were isolated from blastula stage embryos. At the equivalent of neural plate 
stage (stage 14) and tailbud stage (stage 27) total RNA was isolated and analyzed by RNA-
sequencing. (B) Venn diagrams show the number of unique and shared target genes at stage 
14 and 27, respectively. (C) Summary of identified putative target genes of Prdm14 after 
application of different fold-change categories. Given is the number of target genes with a log2 
fold change higher than 1, 2, 3 or 5 compared to uninjected control caps (CC).  
 
Applying these parameters, Prdm14 induced 338 genes at stage 14 and 
356 genes at stage 27, respectively. From these a total of 65 genes were 
upregulated at both stages (Fig. 3.11B). Conversely, 571 and 41 genes were 
downregulated at stage 14 and 27, with only 11 genes shared between both 
stages. In a more stringent analysis using a minimum log2 fold change of three, 
prdm14-GR induced 68 and 208 genes at stage 14 and 27, respectively. In 
contrast the number of downregulated candidate genes dropped to three and 
zero at stage 14 and stage 27, respectively. For this reason, the further analysis 
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Fig. 3.12 Genes of biological processes involved in neural development are enriched in 
prdm14-GR overexpressing animal caps. Gene Ontology (GO) analysis was performed using 
DAVID (http://david.abcc.ncifcrf.gov) (Dennis et al. 2003). The number of genes in each 
category is shown as well as the -log10 P value at false discovery rate. 
 
Consistent with the previous results in embryos and in animal caps, the RNA-
sequencing analysis revealed a delayed neuronal differentiation induced by 
prdm14-GR, with the expression of tubb2b, tlx3 and slc17a7 all induced at the 
equivalent of stage 27 (Table 3.1). To gain insight into the pathways and 
processes of the Prdm14-induced genes, gene ontology (GO) analysis was 
performed (Appendix 6.2, Fig 3.12). Prdm14-GR upregulated genes at stage 14 
were highly enriched in the category of pattern specification process, of which 
many were hox-transcription factors (hoxc6, hoxc8, hoxc9, hoxa5, hoxa7, 
hoxc5, hoxa10, hoxa9, hoxb4, hoxb7, hoxb8, hoxb6) (Fig. 3.12A). In addition, 
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genes involved in the Wnt receptor signaling pathway, including multiple 
ligands, co-receptors and intracellular components (wnt8a, wnt10a, wnt10b, 
wnt5b, ryk, ror2, fzd7, fzd10) were also upregulated. Several processes, which 
are related to neural development, were upregulated at neural plate as well as 
tailbud stage, such as neuron differentiation, neuron projection development, 
morphogenesis or regulation of neurogenesis (Fig. 3.12B). Interestingly, among 
the strongly upregulated prdm14-GR genes were those involved in the process 
of neural crest formation such as wnt8, cdx1/2/4, pax3 and zic1 (Table 3.1). 
 
Table 3.1 List of selected candidate genes upregulated in prdm14-GR overexpressing 
animal caps. Overview of selected candidate genes with their log2 fold changes at stage 14 
and 27 respectively. 
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3.7 Prdm14 activates canonical Wnt-signaling 
Many components of the Wnt-signaling pathway were identified to be 
upregulated by prdm14-GR in the RNA-sequencing analysis. As the Wnt 
pathway is upstream of many of the genes that were also induced, the 
activation of the Wnt pathway was subject to further verification.  
Ligands associated with both the non-canonical and canonical Wnt-
pathways were induced. Therefore, luciferase reporter assays were performed 
to measure the activation of these two different pathways. Atf2-luc and 
TOPflash served as reporters for non-canonical and canonical signaling, 
respectively (Korinek et al., 1997; Ohkawara and Niehrs, 2011). The reporters 
were injected together with prdm14-GR, wnt5a or wnt8a, which served as 
positive controls for the non-canonical and canonical reporters (Fig. 3.13A). At 
stage 14 embryonic lysates were prepared and luciferase activity quantified. 
Consistent with previous reports (Ohkawara and Niehrs, 2011), the atf2-luc 
reporter was strongly (12-fold) activated upon injection of wnt5a but not of 
wnt8a mRNA. Conversely, the TOPFlash reporter was induced (2-fold) by 
wnt8a but not by wnt5a mRNA injection. Upon overexpression of prdm14-GR 
the non-canonical atf2-luc reporter was only sligthly activated compared to 
wnt5a (Fig. 3.13B). However, prdm14-GR induced the canonical TOPflash 
reporter to similar levels as those observed for wnt8a. The difference in the 
activation level of the non-canonical and canonical Wnt-pathways by Prdm14 is 
also reflected in the data obtained from the RNA-sequencing. There Prdm14-
GR activates wnt8a (log2FC, 7.1) to a much higher extent than wnt5b (log2FC, 
1.5). Consistent with the results from the RNA-sequencing, Prdm14-GR 
activates wnt8 expression in whole embryos at stage 14 (n= 27; 78% increase) 
(Fig. 3.13D, red arrows). The activation of the TOPFlash reporter by Prdm14-
GR further supports the notion that Prdm14 activates canonical Wnt-signaling in 






Fig. 3.13 Prdm14-GR overexpression activates canonical Wnt-signaling. (A) Atf2-luc and 
topflash-luc reporter were injected together with indicated mRNA into both blastomeres of two-
cell stage embryos. Embryos were cultivated until open neural plate stage and luciferase activity 
was measured and normalized to renilla luciferase. (B) Shown is a summary of three 
independent luciferase experiments. Six embryos per injection were collected in duplicates for 
each experiment. Error bars represent the standard error of the mean (+/-SEM). Note the 
different scales in each diagram. (C) Prdm14-GR (500 pg) mRNA together with β-Gal (75 pg) 
mRNA (light blue staining) were injected into one blastomere of a two-cell stage embryo. 
Embryos were treated from four-cell stage on with dex. (D) Wnt8 expression was analyzed at 
stage 14 by whole mount in situ hybridization. The injected side is on the right, dorsal view, 
anterior up. 
 
3.8 Comparative expression analysis of prdm14 with neural 
plate border specifiers 
In addition to Wnt signaling components, the RNA-sequencing analysis 
suggests that prdm14-GR is sufficient to induce the expression of several genes 
involved in the gene regulatory network of neural crest formation. These include 
the upstream neural plate border specifiers pax3 and zic1 (Hong and Saint-
Jeannet, 2007). To determine if prdm14 is present at the correct time and place 
to regulate pax3 and zic1, a comparative expression analysis was performed 
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(Fig. 3.14). At stage 10.5 a broad expression of prdm14 in the dorsal ectoderm 
is observed, while at stage 11.5 the first strong and specific expression of pax3 
and zic1 occurs. Pax3, zic1 and prdm14 are all expressed in the lateral neural 
plate border and the expression of zic1 and prdm14 extends into the anterior 
neural plate border until stage 13. At stage 14 zic1 is still expressed throughout 
the anterior neural plate border while anterior prdm14 expression is maintained 
in the trigeminal-profundal placode. During all developmental stages pax3 
expression is restricted to the lateral neural plate border. Taken together, the 
observation that prdm14 expression precedes and also co-localizes with pax3 
and zic1 expression, at the neural plate border, suggests an early function of 
prdm14 in the regulation of pax3 and zic1. 
 
 
Fig. 3.14 Prdm14 is co-expressed with pax3 and zic1 in regions of the neural plate border. 
Comparative expression analysis of stage matched embryos by whole mount in situ 
hybridization using markers indicated on the bottom left. Stage 10.5-14: dorsal view, anterior up. 
anpb, anterior neural plate border; bp, blastoporus; i, intermediate; l, lateral; m, medial; tg, 
trigeminal-profundal placode; vmb, ventral midbrain  
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3.9 Knock down of Prdm14 has no influence on candidate gene 
expression 
To determine whether Prdm14 is required for the induction of selected 
prdm14-GR candidate genes (Table 3.1), their expression was evaluated under 
knock-down conditions. The specificity and efficiency of the SpMOs has been 
previously confirmed (Fig. 3.9). Therefore, both Prdm14 SpMOs were injected 
into one blastomere of two-cell stage embryos and marker gene expression was 
analyzed by whole mount in situ hybridization at stage 14 (Fig. 3.15A). While 
prdm14-GR overexpression results in an inhibition of tubb2b (Fig. 3.6B, F), 
Prdm14 loss of function showed no effect on tubb2b expression at neural plate 
stage (Fig. 3.15B’). The candidate genes wnt8, the neural plate border genes 
pax3, zic1, zic2 and zic3 as well as the neural crest specifying genes sox10 
showed also no alteration in expression on the injected site (Fig. 3.15C-G, J). 
This was also the case for neurog1 and the Rohon-Beard sensory neuron 
marker tlx3 (Fig. 3.15H-I). The fact that knock down of Prdm14 had no influence 
on the expression of the tested marker genes suggests that Prdm14 might not 
be necessary for their regulation. However, it cannot be excluded that residual 








Fig. 3.15 Prdm14 knock down does not influence the expression of selected candidate 
genes in whole embryos. (A) Prdm14a SpMO and Prdm14b SpMO (25 pg each) together with 
β-Gal (75 pg) mRNA (light blue staining) were injected into one blastomere of a two-cell stage 
embryo. (B-J) Gene expression was analyzed at stage 14 by whole mount in situ hybridization 
using markers indicated on the bottom left. The injected side is on the right, dorsal view, anterior 
up.  
 
3.10 Prdm14 gain of function activates neural crest genes in 
whole embryos 
As the knock down of Prdm14 showed no effect on the expression of 
candidate genes, a gain of function analysis was performed to verify their 
regulation by Prdm14. Prdm14-GR mRNA was injected into one blastomere of 
two-cell stage embryos, which were treated with dexamethasone at the four-cell 
stage (Fig. 3.16A).  
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Fig. 3.16 Prdm14-GR overexpression promotes the expression of selected candidate 
genes in whole embryos. (A) Prdm14-GR (500 pg) mRNA together with β-Gal (75 pg) mRNA 
(light blue staining) were injected into one blastomere of two-cell stage embryos. Embryos were 
treated from four-cell stage on with dex. (B-I) Gene expression was analyzed at stage 14 by 
whole mount in situ hybridization using markers indicated on the bottom left. The injected side is 
on the right, dorsal view, anterior up. White brackets indicate width of expression domain.  
 
As prdm14-GR overexpression activates a number of genes involved in 
the gene regulatory network of neural crest formation, the expression of the 
neural plate border specifiers pax3 and zic1 were analyzed (Fig. 3.16B-C). 
Prdm14-GR overexpression leads to the expansion of pax3 (n= 27; 63% 
increased) as well as zic1 (n= 35; 46% increased) expression, although the 
effect on zic1 is much weaker (Fig. 3.16C). This observation is consistent with 
the RNA-sequencing data, which indicate a stronger activation of pax3 than of 
zic1 (Table 3.1). Interestingly, the neural plate border appeared enlarged on the 
injected side of the embryos. To verify this result, the expression of other neural 
plate border specific genes, which are members of the zic family namely zic2 
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and zic3 was analyzed (Houtmeyers et al., 2013). These  were also shown to 
be upregulated in the prdm14-GR overexpressing animal caps (Table 3.1). In 
agreement with previous observations, the expression of zic2 (n= 55; 50% 
increased) and zic3 (n= 29; 66% increased) was likewise expanded (Fig. 3.16D-
E). Beside genes involved in neural crest formation, the proneural transcription 
factor neurog1 was also highly upregulated in the prdm14-GR overexpressing 
animal caps (Table 3.1). Consistently, an expansion of neurog1 expression 
could be shown (n= 31; 77% increased), whereas the expression in the 
trigeminal placode was alleviated (Fig. 3.16F).  
The RNA-sequencing data revealed not only a strong activation of the 
glutamatergic sensory marker tlx3 at the tailbud stage, but also a weak 
activation at neural plate stage (Table 3.1). This led to the question, wether 
prdm14 promotes the earliest step of Rohon-Beard sensory neuron 
differentiation at the neural plate stage. Indeed, on the injected side tlx3 
expression was expanded in the neural plate border (n= 32; 72% increased), 
but inhibited in the trigeminal placode (Fig. 3.16G).  
In addition, the RNA-sequencing data revealed a strong upregulation of 
the neural crest specifiers sox10 and foxd3 at tailbud stage (Table 3.1). These 
genes are already active at the neural plate stage (Pohl and Knöchel, 2001; 
Aoki et al., 2003), therefore the potential role of Prdm14-GR in the regulation of 
their expression was analyzed. Interestingly, these marker genes were inhibited 
at neural plate stage upon prdm14-GR overexpression (sox10: n= 24; 92% 




Fig. 3.17 Prdm14-GR overexpression promotes the neural crest formation in whole 
embryos. (A) Prdm14-GR (500 pg) mRNA together with β-Gal (75 pg) mRNA (light blue 
staining) were injected into one blastomere of two-cell stage embryos. Embryos were treated 
from four-cell stage on with dex. (B-E’’) Gene expression was analyzed at stage 27 by whole 
mount in situ hybridization using markers indicated on the left. The injected side is on the right, 
lateral view. is, injected side (C’, C’’, E’, E’’) Transverse sections at indicated levels of embryo 
shown in C and E, respectively. Black brackets indicate width of mesenchymal tissue on the 
level of the notochord. Dashed line indicates midline of the neural tube. nt, neural tube; nc, 
notochord 
 
However, consistent with the RNA-sequencing data, prdm14-GR 
microinjection led to an ectopic expression of sox10 and foxd3 in tailbud stage 
embryos (Fig. 3.17B-E’). In cranial neural crest cells, foxd3 and sox10 
expression was increased (Fig. 3.17C’, D’), whereas the trunk neural crest was 
expanded laterally. In all prdm14-GR injected embryos thickening of the 
mesenchymal tissue on the injected side could be observed (Fig. 3.17C’, E’; 
black bracket). Consequently, these findings suggests that prdm14-GR leads to 
the expansion and activation of the expression of neural plate border genes, 
which subsequently might lead to the induction of downstream genes involved 
in neural crest specification such as sox10 and foxd3.  
In summary this study demonstrated that prdm14 is expressed during 
gastrulation in the prospective neuroectoderm and later during development in 
the territories of primary neurogenesis. Consistently, overexpression of the 
proneural transcription factor Neurog2 ectopically activates prdm14 expression. 
At neural plate stage prdm14 promotes and maintains the proliferation of neural 
precursors and therefore delays differentiation at neural plate stage. 
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Overexpression of prdm14 activates canonical Wnt-signaling, expands the 
neural plate border and promotes the expression of neural plate border genes. 
Consequently this might lead to the ectopic differentiation of neural plate border 
derivatives such as Rohon-Beard sensory neurons and neural crest cells.
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4. Discussion 
Regionalized specification and differentiation of the ectoderm is under 
the control of multiple intrinsic and extrinsic factors. The prospective epidermal 
cells are characterized by high BMP signaling, while neural fate differentiation 
within the dorsal ectoderm requires low BMP signaling and the presence of FGF 
signaling (Rogers et al., 2009; Pera et al., 2014). In contrast, Wnt-signaling is 
required for posterior fates but must be inhibited for anterior neural fates 
(McGrew et al., 1997). The neural plate border separates the neural plate from 
the non-neural ectoderm and is established through the interaction of Wnt- and 
FGF-signaling, as well as intermediate levels of BMP signaling, and will give 
rise to the neural crest, the neurogenic placodes and Rohon-beard sensory 
neurons (Simoes-Costa and Bronner, 2015). In this thesis, the role of Prdm14, a 
member of the PR domain family of transcriptional regulators, in the context of 
ectodermal differentiation is described.  
The expression of prdm14 in the prospective neuroectoderm is 
suggestive for a role in the establishment of the neural progenitor cells. In 
agreement, prdm14-GR promoted proliferation and expansion of the progenitor 
pool in the neural plate, while neuronal differentiation was delayed. Prdm14 was 
shown to positively regulate the canonical Wnt pathway and the key neural 
plate border specifying genes, pax3 and zic1. Correspondingly, Prdm14 was 
sufficient to promote derivatives of the neural plate border in pluripotent cells 
and embryos including neural crest cells and Rohon-Beard glutamatergic 
sensory neurons. Prdm14 was also positively regulated by the proneural 
transcription factor Neurog2 and expressed in postmitotic neurons suggesting 
an additional function in the context of the development of the nervous system.  
 
4.1 Prdm14 maintains the proliferation of precursor cells 
 
Previous studies have described a role for Prdm14 in the establishment 
of primordial germ cells (PGC) in mice. In this context, Prdm14 together with 
Prdm1 (Blimp1) promotes stemness characteristics through activation of the 
pluripotency gene sox2 (Yamaji et al., 2008). In hESCs, Prdm14 interacts with 
the core pluripotency genes by co-occupying target genes together with Sox2, 
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Nanog and Oct4. During the development of the nervous system, sox2 serves a 
marker for multipotent proliferating neural progenitor cells and is expressed 
throughout the entire neural plate (Graham et al., 2003; Ellis et al., 2004). 
Similar to a role in ESCs, prdm14 overexpression in X. laevis embryos resulted 
in an expansion of sox2 expression and an increase in the number of pH3 
positive cells, which marks mitotically active cells. This increase in proliferation 
occurred at the expense of differentiation, as shown by the transient inhibition of 
the post-mitotic neuronal marker tubb2b. The ability to promote proliferation and 
maintenance of a progenitor cell fate fits well with the strong and specific 
expression of prdm14 in the prospective neuroectoderm at the onset of 
gastrulation. Prdm14 is also present in the anterior neural plate at the end of 
gastrulation, which maintains its proliferative capacity and undergoes delayed 
neuronal differentiation (Hartenstein, 1989; Eagleson and Harris, 1990; 
Hartenstein, 1993; Papalopulu and Kintner, 1996). 
In the RNA-sequencing analysis, sox2 was only weakly (log2FC, 0.6) 
induced by prdm14 compared to control caps at the equivalent of neural plate 
stage. This suggests that prdm14 may not be sufficient to promote sox2 
expression and requires the cooperation with other factors. Another possible 
explanation might be that the levels of sox2 are already decreasing in prdm14-
GR overexpressing animal cap cells. Therefore, analysis of earlier time points 
might provide more insight in the transcript levels of sox2 in prdm14-GR 
overexpressing animal caps. 
Intriguingly, RNA-sequencing analysis revealed that prdm14 
overexpression in animal caps activated the expression of prdm1 at neural plate 
stage. This is of particular interest, as Prdm14 in combination with Prdm1 is 
known to activate the expression of sox2 during mouse PGC specification 
(Yamaji et al., 2008). However, it must be mentioned, that prdm14 expression in 
mice is specific for PGCs and has not been show in the central nervous system 
(Yabuta et al., 2006; Yamaji et al., 2008). Conversely, in X. laevis prdm14 
expression cannot be detected in PGCs and is restricted to the developing 
nervous system. As the genomic locus with respect to flanking genes of prdm14 
is the same in mice and X. laevis, the regulation of prdm14 expression must 
have changed during evolution. The lack of expression of prdm14 in X. laevis 
PGCs compared to mice may be attributed to the different mechanisms of PGC 
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specification in both species. While mice PGCs are specified by signals from 
the surrounding somatic tissue, the specification of PGCs in X. laevis and 
zebrafish requires the inheritance of maternal germ plasm (Johnson et al., 
2011). Therefore it is possible, that the interaction of Prdm14 and Prdm1 is 
conserved, although in a different developmental context. This is supported by 
the fact that in X. laevis and zebrafish prdm1 is also not expressed in PGCs, but 
in the neural plate border where it is required for Rohon-Beard sensory neurons 
(de Souza et al., 1999; Rossi et al., 2009; Klymkowsky et al., 2010). 
Furthermore, X. laevis prdm1 plays a role in the anterior endomesoderm, where 
it is required for head induction (de Souza et al., 1999). 
As the overexpression of prdm14 influences the expression of the neural 
plate marker sox2 in X. laevis, Prdm14 might be involved in the establishment 
of the neuroectoderm. Furthermore, overexpression of prdm14 in animal caps 
induced the expression of components of the FGF signaling pathway (fgf3, 
fgfr1), whose activity is required for neural induction (Kengaku and Okamoto, 
1995; Lamb and Harland, 1995; Streit et al., 2000; Pera et al., 2003; Linker and 
Stern, 2004, Delaune et al., 2005). In summary, the maintained proliferation 
upon prdm14 overexpression is in agreement with the known function of 
prdm14 to promote and maintain the stemness character in mESC and hESC 
(Tsuneyoshi et al., 2008, Chia et al., 2010; Ma et al., 2011) 
 
4.2 Prdm14 activates canonical Wnt-signaling in X. laevis 
 
The balance between stemness and differentiation in adult stem cell 
niches requires the activity of canonical Wnt-signaling (Fodde and Brabletz, 
2007; Holland et al., 2013). Consequently, the deregulation of canonical Wnt-
signaling is a common occurrence in the formation of cancer. A Wnt-pathway 
modulating activity has been described so far only for Prdm5 (Meani et al., 
2009; Shu et al., 2011). It has been shown that Prdm5 functions as a tumor 
suppressor in part through down regulation of the canonical Wnt-signaling 
pathway (Meani et al., 2009; Shu et al., 2011). Interestingly, overexpression of 
prdm14 activated several components of the Wnt-pathway in X. laevis animal 
caps. Additionally, as demonstrated by the TOPFlash luciferase reporter, 
prdm14 led to an increase in canonical Wnt-signaling. 
Discussion 68 
Prdm14 has also been described to play a role in carcinogenesis, where 
it was first described to promote the proliferation of breast cancer cells 
(Nishikawa et al., 2007). Furthermore, an involvement of Prdm14 in other 
cancer types like lymphoblastic lymphoma, lung cancer, testicular cancer and 
HPV-positive cancers was shown (Dettman and Justice, 2008; Simko et al., 
2012; Zhang et al., 2013; Ruark et al., 2013; Snellenberg et al., 2014; Hubers et 
al., 2015). Interestingly, in X. laevis embryos and animal caps the 
overexpression of prdm14 promotes the expression of the glutamatergic 
sensory marker tlx3, which has also been described to be upregulated in 
pediatric T-cell acute lymphoblastic leukemia (T-ALL) (Sayitoğlu et al., 2012; 
Moussa and Sidhom, 2013). This type of cancer is also characterized by 
elevated levels of prdm14 (Dettman et al., 2011; Simko et al., 2012; Carofino et 
al., 2013). Therefore, it might be of interest to study if and how these genes 
interact in the formation of T-ALL in humans.  
Although prdm14 is deregulated in many types of cancer and its 
overexpression activates canonical Wnt-signaling in X. laevis, no connection 
between the deregulation of Wnt-signaling and Prdm14 in the context of 
carcinogenesis has been shown thus far. However, consistent with the 
observation that Prdm14 activates canonical Wnt-signaling, several 
downstream targets were activated such as the glutamatergic sensory marker 
tlx3, posterior neural plate markers cdx1/2/5 and the neural plate border 
specifiers pax3 and zic1. 
 
4.3 Prdm14 activates the expression of neural plate border genes 
 
The neural plate border (NPB) is the source for multiple derivatives such 
as the neurogenic placodes, Rohon-Beard sensory neurons and neural crest 
cells (Hong and Saint-Jeannet, 2007; Rossi et al., 2009). The establishment of 
the NPB requires FGF-, Notch-, Wnt- signaling and intermediate levels of BMP 
signaling (Pegoraro and Monsoro-Burq, 2012; Simões-Costa and Bronner, 
2015). The activity of these different signaling pathways induces the expression 
of neural plate border specifier genes such as msx1, dlx3, pax3 and zic1. Pax3 
and zic1 in combination are sufficient to induce the expression of neural crest 
specifying genes such as sox8/9/10, snai2 and foxd3 (Milet et al., 2013; 
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Plouhinec et al., 2014). Recently, large scale screening approaches could 
identify several pax3 and zic1 target genes, which might be involved in the 
formation of the developing neural crest (Plouhinec et al., 2014; Bae et al., 
2014).  
Interestingly, prdm14 overexpression led to the expansion of the neural 
plate border and induced the expression of the neural plate border specifying 
genes pax3 and zic1. In X. laevis, the regulation of pax3 and zic1 requires 
canonical Wnt-signaling (Bang et al., 1999, Sato et al., 2005). As previously 
mentioned, prdm14 overexpression in neural plate stage animal caps activated 
canonical Wnt-signaling and downstream targets such as cdx1/2/4 and sp5, 
which are known to be required for Wnt-mediated pax3 expression (Sanchez-
Ferras et al., 2012; Park et al., 2013). Hence, prdm14 might activate canonical 
Wnt-signaling, which in turn, activates pax3 through the action of cdx1/2/4 and 
sp5. The observation that pax3 was much stronger activated than zic1 in 
prdm14 overexpressing animal caps might be the result of a positive 
autoregulation of pax3 (Plouhinec et al., 2014). It is of interest that other neural 
plate border specifying genes such as msx1 and dlx3 were not found to be 
upregulated in prdm14-GR overexpressing animal caps. Recently described 
pax3/zic1 target genes such as lmx1b.1, xarp, elavl3, axin2 and pnhd 
(Plouhinec et al., 2014) have also been identified as prdm14 downstream 
targets in the animal cap assay, supporting the notion that prdm14 activates 
pax3 and zic1 expression. 
Consistent with the early activity of prdm14 to promote proliferation and 
to maintain a progenitor cell fate, the neural crest specifying genes sox10 and 
foxd3 were inhibited at neural plate stage in prdm14-GR mRNA microinjected 
embryos. However, this inhibition was only transient as tailbud stage embryos 
showed ectopic expression of sox10 and foxd3 in the cranial neural crest. It 
remains to be addressed, if the ectopic expression at tailbud stage is due to an 
increased pool of progenitors or due to the increased expression of pax3 and 
zic1. 
It is known that pax3 and zic1 are sufficient to activate the gene 
regulatory network for neural crest formation (Hong and Saint-Jeannet, 2007; 
Plouhinec et al., 2014). Therefore, the induced expression of neural crest 
specifying genes such as snai2, foxd3, sox9/10 and tfap2b/e in prdm14-GR 
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overexpressing animal caps may be the consequence of pax3 and zic1 
activation. These findings support a role for prdm14 in the early establishment 
of the neural plate border. However, it will be of interest to test how other neural 
crest genes, which are not activated in prdm14-GR overexpressing animal 
caps, behave upon prdm14-GR overexpression.  
 
4.4 Prdm14 gain of function phenocopies zic1/2/3 overexpression 
 
Overexpression of the neural plate border genes zic1, 2 and 3 in X. 
laevis promotes neural crest formation and causes an expansion of the neural 
plate (Nakata et al., 1997, Nakata et al., 1998). At tailbud stage an enlargement 
of the neural tube and mesenchymal tissue on the injected side is observed 
when zic1, 2 and 3 are overexpressed. Interestingly, the expansion of the 
neural plate as well as the enlargement of the neural tube and mesenchymal 
tissue can also be detected upon ectopic prdm14 expression in whole embryos. 
Consistently, in prdm14 overexpressing animal caps and embryos the 
expression of zic1, zic2 and zic3 is increased. Therefore, it is possible that the 
prdm14-induced expansion of sox2 expression, as well as the enlargement of 
the neural tube and mesenchymal tissue, are the result of zic activation. Zic2 
might be responsible for the inhibition of tubb2b at neural plate stage as it 
inhibits neuronal differentiation (Brewster et al., 1998) and is also activated by 
prdm14-GR.  
Zic genes are not only described as activators (Merzdorf and Sive, 2006), 
but also as inhibitors of canonical Wnt-signalling (Fujimi et al., 2012; 
Pourebrahim et al., 2011), which would conflict with the finding that Prdm14-GR 
activates canonical Wnt-signaling. Further analyses will clarify, whether the 
activation of wnt8a by Prdm14-GR is required for its downstream activity and if 
the activation of wnt8a is direct or indirect. 
 
4.5 Prdm14 promotes sensory neuron formation 
 
The expression of prdm14 in the prospective neuroectoderm suggests an 
early function in the establishment of the neural plate. In addition to this early 
role, the expression of prdm14 in the territories of primary neurogenesis and in 
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the postmitotic neurons in the neural tube is indicative for a later role in 
neuronal subtype differentiation and maturation. This notion is further supported 
by the positive regulation of prdm14 by Neurog2.  
Recently, it has been shown that Prdm12 is required for the specification 
of X. laevis sensory neurons (Nagy et al., 2015). Overexpression of prdm12 
induces the expression of transcription factors required for sensory neuron 
specification such as brn3d (pou4f1.2), sncg, drgx and tlx3. Interestingly, 
overexpression of prdm14 activates the same set of genes in animal caps, 
suggesting that Prdm14 might also be involved in the specification of sensory 
neurons. This idea is further supported by the finding that prdm14 
overexpression induces ectopic neuronal cells that express markers indicative 
for glutamatergic sensory neurons. 
Glutamatergic Rohon-Beard sensory neurons are the first to be born and 
arise from the neural plate border (Hernandez-Lagunas et al., 2005; Rossi et 
al., 2009; Olesnicky et al., 2010). Well-characterized transcription factors 
involved in the specification of this class of neurons are prdm1, neurog1 and 
neurog2, which upon overexpression induce ectopic sensory neuron formation 
(Olson et al., 1998; Perez et al., 1999; Perron et al., 1999; Cornell and Eisen, 
2002; Hernandez-Lagunas et al., 2005). Interestingly, the expression of these 
transcription factors was activated by Prdm14, indicating an upstream role of 
Prdm14 on sensory neuron formation. The observation that prdm14 precedes 
the expression of neurog1 suggests that Prdm14 may be a direct regulator of 
neurog1. 
The specification of sensory neurons has also been linked to canonical 
Wnt-signaling. Kondo and colleagues showed, that neuralized mesenchymal 
stem cells are able to differentiate into neurons in the presence of canonical 
Wnt-signaling. Interestingly, these differentiating cells express neurog1 and tlx3 
(Kondo et al., 2011). As prdm14 activates canonical Wnt-signaling as well as 
the expression of neurog1 and tlx3, there is the intriguing possibility that 
canonical Wnt-signaling is involved in the process of sensory neuron 
specification in X. laevis.   
Similar to X. laevis, prdm14 is expressed in zebrafish throughout the 
anterior neural plate at bud stage (Liu et al., 2012). At the 3-somite stage, 
prdm14 is co-expressed with neurog1 in dorsal and ventral neuron precursors 
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and at the 26-somite stage in Rohon-Beard sensory and motor neurons. 
Prdm14 knock down in zebrafish does not influence neuronal differentiation (Liu 
et al., 2012). However, shortened axon outgrowth of CaP motor neurons can be 
observed at 26 hpf, which leads to impaired touch response and swimming 
behavior. This is only a transient effect as axon outgrowth is restored in 
embryos at 2.5 dpf, which was attributed to residual Prdm14 activity.  
In this study, functionally verified splicing morpholinos for prdm14a and 
prdm14b were used to knock down both prdm14 paralogs. Similar to zebrafish, 
the knock down of Prdm14 in X. laevis embryos had no effect on neuronal 
differentiation. In addition, the expression of the selected candidate genes, 
identified in the RNA-sequencing analysis of prdm14-GR overexpressing animal 
caps, was not affected. Furthermore, the motor neuron axon outgrowth was not 
affected in tailbud stage X. laevis embryos after Prdm14 knock down 
suggesting that prdm14 is not necessary in these contexts. As Prdm14 is 
maternally supplied, it cannot be ruled out that the use of the splicing 
morpholinos is not effective enough and that the residual Prdm14 proteins might 
be sufficient to exert their function. A further explanation might be the existence 
of functional redundancies, as described in zebrafish for prdm3, 5 and 16 (Ding 
et al., 2013). This is likely, considering that all members of the prdm family are 
expressed in the developing central nervous system of X. laevis (Eguchi et al., 
2015). A potential candidate might be prdm12, which also promotes the 
specification of sensory neurons and therefore might compensate the Prdm14 
knock down. To address the question, if redundancies might exist between 
different Prdms, it would be of interest to knock down more than one Prdm or 







In summary, this study suggests a role for the PR domain protein 
Prdm14 in the establishment of the neuroectoderm and maintenance of a 
proliferative state. As a consequence the pool of progenitor cells is expanded in 
the neural plate and neural plate border at the expense of differentiation. Since 
Prdm14 is able to induce the expression of zic1, 2 and 3, this expansion may 
also occur due to their activity. Through the prdm14-mediated activation of 
canonical Wnt-signaling the neural plate border specifying genes pax3 and zic1 
are induced, which promote the formation of neural crest. The expansion of the 
neural plate border might also play a role in this context. The ectopic 
specification of Rohon-Beard sensory neurons could be caused by the 
expansion of the neural plate border or the activation of neurog1 by Prdm14. 
However, if the promotion of neural plate border derivatives is the direct 
consequence of an expanded progenitor pool or requires the activity of other 
factors remains to be further addressed.   
 
 
Fig. 5.1 Model for the function of Prdm14 in X. laevis. Prdm14 promotes a proliferative, 
undifferentiated state of progenitor cells. Furthermore, the expression of the zic genes is 
activated by Prdm14. Both processes might lead to the expansion of the neural plate border. 
Additionally, Prdm14 activates canonical Wnt-signaling which induces pax3/zic1 and promotes 
neural crest formation. The ectopic differentiation of Rohon-Beard sensory neurons is likely due 
to the expansion of the neural plate border or the induction of neurog1 by Prdm14. 
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6.1 Candidate gene list for the RNA-sequencing analysis of 
prdm14-GR overexpressing animal caps 
Given are the genes which were differentially expressed between prdm14-GR 
overexpressing animal caps and uninjected control caps, equivalent to stage 14 
and 27, in three independent experiments. 
6.1.1 Differentially expressed genes at stage 14 
Given are the ensembl id, official gene name, log2 fold change and the adjusted 
P-value with respect to multiple testing using the FDR method. Genes were 
sorted according to the highest and lowest log2 fold change, respectively. 
 
Table 6.1 Summary of differentially expressed genes at stage 14 
upregulated  downregulated 














015915 prdm14 9.33 1.55E-68 
 
ENSXETG00000
014812 htr1a -3.44 5.72E-06 
ENSXETG00000
010282 cdx1 8.98 3.26E-29 
 
ENSXETG00000
001728 slc6a3 -3.08 5.28E-04 
ENSXETG00000
024458 zic3 8.23 3.45E-23 
 
ENSXETG00000
027551 ces5a -3.02 4.91E-03 
ENSXETG00000
004589 cdx4 8.14 1.08E-46 
 
ENSXETG00000
009166 hmp19 -2.77 1.97E-05 
ENSXETG00000
025525 pnhd 7.71 2.67E-18 
 
ENSXETG00000
017117 vstm5 -2.75 3.44E-03 
ENSXETG00000
025407 sp5 7.21 3.15E-39 
 
ENSXETG00000
012215 hhex -2.67 2.49E-03 
ENSXETG00000
003826 wnt8a 7.13 1.02E-18 
 
ENSXETG00000
022118 gpr37 -2.63 1.30E-14 
ENSXETG00000
001801 hoxd1 6.60 4.96E-17 
 
ENSXETG00000
011262 c20orf85 -2.55 2.42E-03 
ENSXETG00000
007898 neurog1 6.52 1.17E-10 
 
ENSXETG00000
032792 gnrh2 -2.50 4.63E-05 
ENSXETG00000
019220 bmpr1b 5.80 1.02E-09 
 
ENSXETG00000
023176 prox1 -2.50 1.11E-03 
ENSXETG00000
022950 zbtb16 5.79 4.80E-18 
 
ENSXETG00000
014758 dner -2.47 4.76E-06 
ENSXETG00000
022080 emx2 5.66 1.72E-29 
 
ENSXETG00000
017493 tmtops -2.46 1.79E-03 
ENSXETG00000














031623 wnt10a 5.39 2.05E-12 
 
ENSXETG00000
033983 dmrt2 -2.31 3.83E-11 
ENSXETG00000
023986 barhl2 5.29 4.73E-07 
 
ENSXETG00000
013115 kiaa0895 -2.31 5.83E-04 
ENSXETG00000
000742 lmx1b.1 5.18 2.26E-13 
 
ENSXETG00000
033308 efhb -2.31 5.97E-09 
ENSXETG00000
002761 fgf3 5.17 1.30E-06 
 
ENSXETG00000
013407 aatk -2.30 2.02E-04 
ENSXETG00000
020167 tox 4.94 7.99E-29 
 
ENSXETG00000
001353 hmcn2 -2.30 1.80E-02 
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ENSXETG00000
025183 hoxc5 4.77 1.25E-27 
 
ENSXETG00000
032462 smpx -2.27 6.19E-13 
ENSXETG00000
023476 hoxc8 4.74 1.69E-29 
 
ENSXETG00000
017916 galntl1 -2.27 2.27E-04 
ENSXETG00000
000722 hoxa7 4.70 9.15E-11 
 
ENSXETG00000
012021 sema5b -2.25 1.99E-06 
ENSXETG00000
009083 hes7.2 4.69 5.01E-06 
 
ENSXETG00000
031621 c2orf70 -2.23 5.25E-08 
ENSXETG00000
000802 ror2 4.55 3.83E-31 
 
ENSXETG00000
009727 prkag1 -2.22 1.83E-22 
ENSXETG00000
000724 hoxa9 4.54 4.99E-07 
 
ENSXETG00000
013371 plcb2 -2.21 1.79E-02 
ENSXETG00000







000237 zeb2 4.48 4.04E-06 
 
ENSXETG00000
005160 march3 -2.14 6.21E-04 
ENSXETG00000
023479 hoxc6 4.41 3.07E-19 
 
ENSXETG00000
000594 foxc1 -2.12 3.35E-02 
ENSXETG00000
023475 hoxc9 4.38 1.83E-16 
 
ENSXETG00000
024302 atp10a -2.12 6.81E-03 
ENSXETG00000
018660 tpbg 4.31 2.80E-24 
 
ENSXETG00000
001696 syt6 -2.11 2.31E-02 
ENSXETG00000
021703 fmnl2 4.30 1.41E-06 
 
ENSXETG00000
015108 rdh7 -2.11 1.07E-03 
ENSXETG00000
001068 gcm2 4.29 3.43E-05 
 
ENSXETG00000
022840 lphn1 -2.11 5.03E-03 
ENSXETG00000
000728 hoxa10 4.28 3.14E-05 
 
ENSXETG00000
018291 cebpa -2.10 7.44E-05 
ENSXETG00000
010153 ebf2 4.27 1.38E-05 
 
ENSXETG00000
016618 ngf -2.07 4.71E-04 
ENSXETG00000
008000 hnf1b 4.17 3.22E-05 
 
ENSXETG00000
019537 tbc1d24.2 -2.07 4.56E-28 
ENSXETG00000
013607 axin2 4.05 3.35E-06 
 
ENSXETG00000
014344 celf5 -2.07 3.82E-03 
ENSXETG00000
012490 gast 3.95 5.28E-05 
 
ENSXETG00000
008779 fbn1 -2.06 3.11E-03 
ENSXETG00000
033673 fam155b 3.81 1.29E-10 
 
ENSXETG00000
030605 loxhd1 -2.05 7.17E-04 
ENSXETG00000
026355 akap12 3.75 6.41E-06 
 
ENSXETG00000
018430 nkx2-3 -2.05 6.22E-07 
ENSXETG00000







006226 gli1.2 3.65 2.64E-07 
 
ENSXETG00000
015427 adra2c -2.04 6.14E-04 
ENSXETG00000














021987 hoxb6 3.61 7.21E-04 
 
ENSXETG00000
001273 psd4 -2.02 2.70E-02 
ENSXETG00000
018386 pou4f1.2 3.59 1.26E-05 
 
ENSXETG00000
001035 fam132a -2.02 4.56E-03 
ENSXETG00000
027510 itgb6 3.58 4.61E-04 
 
ENSXETG00000
011726 ntrk2 -2.01 3.78E-02 
ENSXETG00000
007794 cldn3 3.54 1.09E-15 
 
ENSXETG00000
007316 slc38a3 -2.01 3.70E-13 
ENSXETG00000
000720 hoxa5 3.53 3.35E-06 
 
ENSXETG00000
021301 akd1 -2.00 5.28E-03 
ENSXETG00000
024347 znf703 3.52 1.96E-22 
 
ENSXETG00000
015542 ccdc78 -1.98 1.24E-07 
ENSXETG00000
010120 mpzl2 3.51 6.06E-12 
 
ENSXETG00000
030611 lrrd1 -1.98 5.30E-10 
ENSXETG00000
020467 cdh11 3.47 5.49E-04 
 
ENSXETG00000
033531 tsc22d4 -1.97 3.94E-02 
ENSXETG00000
021035 pdgfra 3.44 3.73E-04 
 
ENSXETG00000
010505 phox2a -1.96 3.61E-03 
ENSXETG00000
012821 sult1a1 3.31 5.55E-05 
 
ENSXETG00000
021999 ak1 -1.96 1.20E-10 
ENSXETG00000
001223 emilin1 3.30 1.91E-06 
 
ENSXETG00000
017952 efcab5 -1.96 3.56E-09 
ENSXETG00000
010128 nefm 3.29 7.76E-10 
 
ENSXETG00000
005731 sstr5 -1.96 1.53E-09 
ENSXETG00000
018864 zic2 3.23 2.39E-08 
 
ENSXETG00000
017078 s100z -1.96 3.11E-02 
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ENSXETG00000
008971 ywhag 3.23 2.53E-10 
 
ENSXETG00000
015694 kcnrg -1.95 2.45E-05 
ENSXETG00000
001974 st3gal5 3.19 3.14E-07 
 
ENSXETG00000
014625 nell2 -1.95 3.86E-02 
ENSXETG00000
025936 cnrip1 3.18 3.59E-03 
 
ENSXETG00000
014639 palm -1.95 1.59E-02 
ENSXETG00000
031488 pcdh19 3.18 2.69E-04 
 
ENSXETG00000
021296 ppil6 -1.95 2.95E-06 
ENSXETG00000
010435 prss23 3.17 4.14E-07 
 
ENSXETG00000
008426 ehbp1l1 -1.94 7.66E-06 
ENSXETG00000
019101 nova2 3.11 3.60E-06 
 
ENSXETG00000
031406 lnx2 -1.94 1.53E-02 
ENSXETG00000
003251 limd2 3.11 1.26E-11 
 
ENSXETG00000
017940 c11orf41 -1.94 3.93E-04 
ENSXETG00000
033139 zbtb16 3.09 5.77E-05 
 
ENSXETG00000
031483 dnah6 -1.94 2.94E-08 
ENSXETG00000
006965 pxdn 3.06 4.16E-41 
 
ENSXETG00000







010345 stx1a -1.93 7.13E-03 
ENSXETG00000
023080 kif26a 3.04 2.71E-04 
 
ENSXETG00000














007237 zfyve28 -1.91 2.55E-10 
ENSXETG00000
001613 emilin2 2.97 4.94E-03 
 
ENSXETG00000
003267 ttll1 -1.89 1.08E-07 
ENSXETG00000
022798 sostdc1 2.95 7.83E-05 
 
ENSXETG00000
009789 adcy6 -1.89 1.67E-05 
ENSXETG00000
003565 foxf1 2.93 5.36E-04 
 
ENSXETG00000
013478 gas2l2 -1.88 4.00E-04 
ENSXETG00000














019550 pdgfc 2.87 3.38E-03 
 
ENSXETG00000
032659 ces3 -1.86 3.33E-02 
ENSXETG00000







009114 ucma 2.82 2.17E-08 
 
ENSXETG00000
025398 gata3 -1.85 1.01E-07 
ENSXETG00000
021674 tfap2b 2.81 2.45E-05 
 
ENSXETG00000
006186 ahrr -1.85 2.83E-02 
ENSXETG00000
007633 slco3a1 2.81 1.87E-03 
 
ENSXETG00000
017275 dvl3 -1.85 1.09E-06 
ENSXETG00000
018715 olfm4 2.79 1.19E-08 
 
ENSXETG00000
016042 tm4sf1 -1.85 1.30E-02 
ENSXETG00000
034215 sipa1 2.77 3.31E-02 
 
ENSXETG00000
021393 dnhd1 -1.84 4.29E-02 
ENSXETG00000
014867 pltp 2.75 2.41E-06 
 
ENSXETG00000
021314 c6orf186 -1.82 4.26E-02 
ENSXETG00000
021993 hoxb8 2.72 1.36E-02 
 
ENSXETG00000
000586 jak2 -1.81 6.06E-12 
ENSXETG00000
010058 xarp 2.68 5.91E-32 
 
ENSXETG00000
005916 msrb2 -1.80 2.73E-06 
ENSXETG00000
015096 snap25 2.64 2.05E-04 
 
ENSXETG00000







031224 cdhr4 -1.80 1.22E-02 
ENSXETG00000
013886 ngef 2.62 1.23E-11 
 
ENSXETG00000
001935 foxi4.1 -1.79 1.74E-04 
ENSXETG00000
016741 elavl3 2.57 5.94E-03 
 
ENSXETG00000
030156 casc1 -1.79 1.18E-03 
ENSXETG00000
027601 mex3b 2.54 1.06E-07 
 
ENSXETG00000
032214 lrrtm3 -1.79 3.70E-02 
ENSXETG00000
015467 zic1 2.54 7.17E-07 
 
ENSXETG00000
008299 dnah2 -1.78 5.73E-04 
ENSXETG00000














007330 hyal2 2.50 2.99E-12 
 
ENSXETG00000
020893 spag17 -1.77 9.64E-06 
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ENSXETG00000
002878 polr2l.2 2.49 9.62E-03 
 
ENSXETG00000
024528 cfap70 -1.76 1.16E-07 
ENSXETG00000
006798 btc 2.48 3.04E-11 
 
ENSXETG00000









5857146 -1.76 9.44E-12 
ENSXETG00000
012934 bgn 2.47 2.35E-03 
 
ENSXETG00000
004373 tekt2 -1.75 1.40E-09 
ENSXETG00000
007804 smad3 2.47 1.46E-04 
 
ENSXETG00000
015719 odf3 -1.74 2.06E-08 
ENSXETG00000







013266 s1pr1 2.36 3.04E-04 
 
ENSXETG00000
021988 dcdc2 -1.74 4.76E-06 
ENSXETG00000







003071 fbln1 2.32 6.94E-04 
 
ENSXETG00000
032283 dnah3 -1.73 8.46E-07 
ENSXETG00000
010230 grk5 2.31 4.36E-04 
 
ENSXETG00000
021518 kcnn2 -1.73 1.91E-03 
ENSXETG00000
012029 cass4 2.31 3.58E-05 
 
ENSXETG00000
018025 slc22a23 -1.73 2.39E-04 
ENSXETG00000
022662 epn1 2.30 4.54E-14 
 
ENSXETG00000
030029 dnah1 -1.73 4.20E-08 
ENSXETG00000
005738 rasd1 2.29 1.62E-04 
 
ENSXETG00000
000659 efhc1 -1.72 1.11E-09 
ENSXETG00000







011508 manea 2.26 3.45E-03 
 
ENSXETG00000
013506 rnf32 -1.72 2.64E-02 
ENSXETG00000
005370 t 2.26 1.83E-03 
 
ENSXETG00000
004208 rtdr1 -1.71 1.52E-08 
ENSXETG00000
014363 vash2 2.25 7.98E-07 
 
ENSXETG00000




1002559 2.24 3.07E-04 
 
ENSXETG00000
001388 dhrs3 -1.71 5.67E-07 
ENSXETG00000
021973 hoxb4 2.23 2.38E-02 
 
ENSXETG00000
024630 ccdc153 -1.70 8.28E-03 
ENSXETG00000
018322 mcf2 2.23 8.30E-03 
 
ENSXETG00000
016412 rasal1 -1.70 9.02E-09 
ENSXETG00000
018908 c13orf15 2.22 4.05E-06 
 
ENSXETG00000
023103 spata18 -1.70 2.05E-06 
ENSXETG00000







017823 plxnb1 2.21 3.77E-05 
 
ENSXETG00000
021297 ak9 -1.69 1.55E-06 
ENSXETG00000
020971 robo1 2.19 6.08E-10 
 
ENSXETG00000
004297 ppp1r1a -1.69 3.11E-02 
ENSXETG00000
027351 hoxb7 2.17 3.17E-02 
 
ENSXETG00000
002217 kiaa1841 -1.69 4.85E-04 
ENSXETG00000
027392 sncaip 2.17 7.27E-03 
 
ENSXETG00000
009722 ca12 -1.68 5.65E-04 
ENSXETG00000
018304 tlx3 2.17 1.30E-02 
 
ENSXETG00000
015133 phldb3 -1.68 2.17E-03 
ENSXETG00000
009704 tnfrsf19 2.14 9.39E-05 
 
ENSXETG00000
022889 zbbx -1.68 2.32E-02 
ENSXETG00000
030035 abcb9 2.14 7.94E-03 
 
ENSXETG00000
006838 rab37 -1.68 2.58E-04 
ENSXETG00000
019934 srrm4 2.13 1.32E-02 
 
ENSXETG00000
019163 itgb3 -1.68 1.29E-03 
ENSXETG00000
021450 ampd1 2.13 3.28E-03 
 
ENSXETG00000
007116 ttc29 -1.68 5.83E-05 
ENSXETG00000
022554 dhx32 2.11 1.14E-09 
 
ENSXETG00000
014624 gmpr2 -1.68 9.38E-13 
ENSXETG00000
017807 spry2 2.11 3.93E-07 
 
ENSXETG00000
032601 akna -1.68 4.08E-02 
ENSXETG00000
014718 shb 2.10 4.72E-17 
 
ENSXETG00000
003663 pcdh10 -1.67 6.34E-03 
ENSXETG00000
022348 sox9 2.09 2.27E-04 
 
ENSXETG00000
016964 btbd11 -1.67 1.39E-02 
ENSXETG00000







006598 dkk1 2.08 4.04E-02 
 
ENSXETG00000
006261 c9orf9 -1.67 1.60E-05 
Appendix 96 
ENSXETG00000
011173 wnt10b 2.07 4.97E-02 
 
ENSXETG00000
023392 rassf6 -1.67 7.65E-05 
ENSXETG00000
025522 esr10 2.06 2.47E-02 
 
ENSXETG00000
026100 c5orf42 -1.67 5.28E-07 
ENSXETG00000
003296 cxcr7 2.06 1.26E-05 
 
ENSXETG00000
030387 c3orf84 -1.67 1.88E-02 
ENSXETG00000
003938 robo3 2.06 5.52E-23 
 
ENSXETG00000







013869 ccdc108 -1.66 1.06E-09 
ENSXETG00000
013228 egflam 2.04 2.21E-04 
 
ENSXETG00000
013373 fam81b -1.65 1.33E-04 
ENSXETG00000
016415 gas2l1 2.04 1.59E-04 
 
ENSXETG00000
018707 capsl -1.65 2.04E-03 
ENSXETG00000
022245 hes9.1 2.04 4.43E-02 
 
ENSXETG00000
016146 sec14l3 -1.65 1.81E-07 
ENSXETG00000
005880 hip1 2.02 2.18E-03 
 
ENSXETG00000
016844 wdr38 -1.65 2.47E-06 
ENSXETG00000







023193 p2ry4 1.99 2.23E-10 
 
ENSXETG00000




5781886 1.98 8.76E-05 
 
ENSXETG00000
010988 ndrg1 -1.64 3.87E-02 
ENSXETG00000







004222 adora2a 1.94 1.06E-03 
 
ENSXETG00000
009174 c9orf21 -1.64 1.13E-03 
ENSXETG00000
007241 dbn1 1.94 1.62E-03 
 
ENSXETG00000
012367 syne1 -1.63 4.50E-07 
ENSXETG00000
010865 aldh1a2 1.94 2.14E-03 
 
ENSXETG00000
000658 paqr8 -1.63 3.61E-02 
ENSXETG00000
008399 flt4 1.94 2.75E-02 
 
ENSXETG00000
024641 elovl2 -1.63 2.69E-07 
ENSXETG00000
015816 blvra 1.94 2.83E-06 
 
ENSXETG00000
027678 gnaz -1.63 1.16E-07 
ENSXETG00000
021140 cyp1a1 1.92 4.73E-02 
 
ENSXETG00000
011269 cdh15 -1.63 6.04E-04 
ENSXETG00000
012279 lamb1 1.90 2.28E-05 
 
ENSXETG00000
004835 efhc2 -1.63 7.34E-05 
ENSXETG00000
029924 stxbp5 1.90 8.96E-11 
 
ENSXETG00000







019512 pik3r6 -1.62 1.43E-02 
ENSXETG00000
012216 msi1 1.88 2.56E-07 
 
ENSXETG00000
005336 prr29 -1.62 9.81E-05 
ENSXETG00000
010662 ap3b2 1.88 1.06E-02 
 
ENSXETG00000
022781 ets1 -1.62 4.57E-04 
ENSXETG00000
019579 pmp22 1.88 1.57E-02 
 
ENSXETG00000
015189 c2orf73 -1.62 5.92E-06 
ENSXETG00000
001066 gpr63 1.88 4.97E-02 
 
ENSXETG00000
003686 als2cl -1.62 1.60E-09 
ENSXETG00000
032528 sspo 1.87 4.28E-02 
 
ENSXETG00000
018553 dnah14 -1.62 1.61E-04 
ENSXETG00000
000758 pcsk5 1.87 1.18E-06 
 
ENSXETG00000
013834 c17orf105 -1.61 7.94E-04 
ENSXETG00000
005259 stk40 1.86 1.36E-04 
 
ENSXETG00000
014590 ccdc170 -1.61 3.51E-09 
ENSXETG00000
019568 spry4 1.86 3.22E-03 
 
ENSXETG00000
010527 rsph1 -1.61 1.43E-09 
ENSXETG00000







015431 mylip 1.85 1.00E-04 
 
ENSXETG00000
032089 spef1 -1.61 3.57E-05 
ENSXETG00000
029928 gas1 1.85 3.30E-06 
 
ENSXETG00000
007897 h2afy -1.61 2.08E-03 
ENSXETG00000
018847 plk2 1.83 7.47E-16 
 
ENSXETG00000
008812 fzd8 -1.61 4.77E-04 
ENSXETG00000
008674 prdm1 1.83 1.55E-05 
 
ENSXETG00000
006725 c11orf66 -1.60 2.42E-06 
ENSXETG00000
030115 sp8 1.81 2.17E-08 
 
ENSXETG00000
005595 tns1 -1.60 1.30E-02 
ENSXETG00000
016853 slc23a2 1.80 8.61E-05 
 
ENSXETG00000
007384 spag6 -1.60 2.40E-11 
Appendix 97 
ENSXETG00000
021344 fyn 1.79 4.12E-02 
 
ENSXETG00000
026587 ccdc180 -1.60 7.03E-05 
ENSXETG00000







016286 trps1 1.77 1.89E-03 
 
ENSXETG00000
023295 lmo4.1 -1.60 2.98E-08 
ENSXETG00000
002103 ndnf 1.76 2.45E-02 
 
ENSXETG00000
005917 armc3 -1.60 1.04E-06 
ENSXETG00000
015557 vsnl1 1.76 1.43E-09 
 
ENSXETG00000
010437 ccdc81 -1.59 1.59E-04 
ENSXETG00000
007560 elf5 1.76 4.11E-02 
 
ENSXETG00000
008630 wdr63 -1.59 1.38E-08 
ENSXETG00000
022354 nos1 1.76 3.36E-02 
 
ENSXETG00000
022691 dzip1l -1.59 2.18E-06 
ENSXETG00000
011941 tmem132a 1.75 7.19E-04 
 
ENSXETG00000
016326 morn5 -1.59 8.25E-05 
ENSXETG00000







003934 slc37a2 1.74 2.81E-09 
 
ENSXETG00000
000514 mgat5 -1.58 6.29E-03 
ENSXETG00000
010956 mycl1 1.73 1.62E-04 
 
ENSXETG00000
014934 c2orf62 -1.58 2.27E-05 
ENSXETG00000







023872 ngfr 1.72 2.74E-07 
 
ENSXETG00000
016481 gjb3 -1.58 8.65E-03 
ENSXETG00000
023832 tmcc3 1.71 8.11E-04 
 
ENSXETG00000
008519 add2 -1.58 5.20E-03 
ENSXETG00000
000251 hmox1 1.71 1.23E-07 
 
ENSXETG00000
022961 kcnj16 -1.58 4.91E-03 
ENSXETG00000
005911 hes6.1 1.69 5.58E-05 
 
ENSXETG00000
032300 stmnd1 -1.58 1.79E-09 
ENSXETG00000
001837 trim2 1.69 2.04E-03 
 
ENSXETG00000
022016 ribc1 -1.57 2.39E-08 
ENSXETG00000
016100 tcf7 1.67 2.16E-06 
 
ENSXETG00000
024952 tnnt3 -1.57 4.02E-02 
ENSXETG00000
010491 pcbp2 1.67 4.05E-02 
 
ENSXETG00000
019324 bcam -1.57 1.85E-02 
ENSXETG00000
001802 mtx2 1.66 1.27E-03 
 
ENSXETG00000
024951 stard9 -1.57 4.38E-04 
ENSXETG00000
010410 phf15 1.65 3.72E-02 
 
ENSXETG00000
018735 tcf7l2 -1.57 2.47E-02 
ENSXETG00000
021972 col27a1 1.65 2.04E-04 
 
ENSXETG00000
008892 irx4 -1.57 1.66E-04 
ENSXETG00000
007198 nudt22 1.65 9.82E-03 
 
ENSXETG00000
015159 eml6 -1.57 4.61E-04 
ENSXETG00000







025626 tmem69 1.63 1.52E-08 
 
ENSXETG00000
015289 anxa2 -1.56 7.39E-06 
ENSXETG00000
019257 rab34 1.62 1.15E-02 
 
ENSXETG00000
021497 epb41l4a -1.56 3.55E-04 
ENSXETG00000





5949053 -1.56 1.33E-02 
ENSXETG00000
023439 sox11 1.61 2.18E-05 
 
ENSXETG00000
005341 cxorf22 -1.56 9.91E-03 
ENSXETG00000
011665 ncam1 1.61 2.58E-02 
 
ENSXETG00000
004292 rapgef3 -1.55 1.31E-03 
ENSXETG00000
002340 jag1 1.60 2.30E-03 
 
ENSXETG00000
016804 inpp5a.2 -1.55 5.98E-03 
ENSXETG00000
021454 dennd2c 1.60 2.25E-02 
 
ENSXETG00000
032500 fam179a -1.55 7.63E-04 
ENSXETG00000
013354 slitrk1 1.60 1.93E-02 
 
ENSXETG00000
007146 lrrc18 -1.55 5.24E-06 
ENSXETG00000
005062 etv1 1.60 1.67E-04 
 
ENSXETG00000
001021 acap3 -1.55 4.86E-04 
ENSXETG00000
022669 mmp14 1.58 1.86E-05 
 
ENSXETG00000
030526 tsga10 -1.55 5.57E-05 
ENSXETG00000





5992704 -1.55 5.46E-07 
ENSXETG00000
017378 ptgs2 1.57 2.37E-05 
 
ENSXETG00000
015878 hydin -1.54 6.21E-07 
ENSXETG00000
018892 ptch2 1.55 4.19E-03 
 
ENSXETG00000








024614 tbcel -1.54 1.43E-13 
ENSXETG00000
013631 adamts1 1.53 6.68E-03 
 
ENSXETG00000
019733 ccdc146 -1.54 7.95E-08 
ENSXETG00000
016416 rasl10a 1.53 1.65E-03 
 
ENSXETG00000
021596 gpr146 -1.54 4.01E-04 
ENSXETG00000
011490 col6a2 1.52 1.72E-02 
 
ENSXETG00000
024914 rab36 -1.54 1.10E-05 
ENSXETG00000





5950142 -1.53 2.12E-04 
ENSXETG00000
032223 cltcl1 1.52 1.62E-03 
 
ENSXETG00000
016135 hhla2 -1.53 1.18E-02 
ENSXETG00000
012718 dpysl3 1.52 2.90E-02 
 
ENSXETG00000
008117 fam63a -1.53 4.31E-07 
ENSXETG00000
021813 cttnbp2 1.51 4.42E-05 
 
ENSXETG00000
019168 c13orf26 -1.53 2.42E-11 
ENSXETG00000
014353 tle2 1.51 2.04E-06 
 
ENSXETG00000
014319 eno4 -1.53 4.50E-10 
ENSXETG00000
010707 sparc 1.51 9.66E-03 
 
ENSXETG00000
012713 stk33 -1.53 8.82E-04 
ENSXETG00000
004642 cdc42ep4 1.50 9.92E-05 
 
ENSXETG00000
002847 c14orf45 -1.52 4.61E-04 
ENSXETG00000
027807 cited2 1.50 3.36E-02 
 
ENSXETG00000
012703 klhdc9 -1.52 6.90E-03 
ENSXETG00000
000904 il17rd 1.48 6.79E-03 
 
ENSXETG00000
027390 znf474 -1.52 4.49E-13 
ENSXETG00000
026881 nr2c2ap 1.48 3.37E-02 
 
ENSXETG00000
033778 tbata -1.51 3.06E-07 
ENSXETG00000







009405 wnt5b 1.48 3.23E-03 
 
ENSXETG00000
025251 dnah9 -1.51 2.32E-02 
ENSXETG00000
011877 cd74 1.47 2.22E-03 
 
ENSXETG00000
033908 ube2u -1.51 3.92E-02 
ENSXETG00000
000581 fmnl3 1.46 7.96E-04 
 
ENSXETG00000
005487 arhgap42 -1.51 6.21E-07 
ENSXETG00000
000696 rai14 1.46 2.06E-04 
 
ENSXETG00000
015093 ankrd5 -1.50 1.54E-11 
ENSXETG00000
016573 dlx6 1.46 7.31E-04 
 
ENSXETG00000
022383 mapk4 -1.50 3.43E-02 
ENSXETG00000
023744 ptp4a3 1.45 7.14E-04 
 
ENSXETG00000
030188 dnah10 -1.50 2.63E-06 
ENSXETG00000
031265 raph1 1.45 9.02E-05 
 
ENSXETG00000
019423 plcg1 -1.49 7.63E-04 
ENSXETG00000
006108 col9a3 1.45 9.54E-04 
 
ENSXETG00000
000693 sox7 -1.49 7.80E-17 
ENSXETG00000
018919 cnn3 1.44 5.10E-06 
 
ENSXETG00000
010195 c9orf96 -1.49 1.85E-03 
ENSXETG00000
026104 st3gal6 1.44 1.62E-02 
 
ENSXETG00000
001452 mdm1 -1.49 7.51E-04 
ENSXETG00000
014751 atp1b3 1.43 1.25E-03 
 
ENSXETG00000
032973 iqca1 -1.49 4.11E-06 
ENSXETG00000
012324 lin28a 1.42 4.50E-02 
 
ENSXETG00000
019904 lrrc3b -1.48 1.06E-02 
ENSXETG00000
025992 cdh3 1.41 5.13E-12 
 
ENSXETG00000
033755 speg -1.48 2.90E-02 
ENSXETG00000







011231 cmtm3 1.39 1.31E-02 
 
ENSXETG00000











003952 nrarp 1.39 5.89E-04 
 
ENSXETG00000
000335 cdkl2 -1.47 9.22E-06 
ENSXETG00000
017085 pkp1 1.39 3.86E-02 
 
ENSXETG00000
013463 zmynd12 -1.47 3.37E-07 
ENSXETG00000
031404 draxin 1.38 1.57E-02 
 
ENSXETG00000
010186 coro2a -1.47 4.42E-02 
ENSXETG00000
015391 cadm1 1.37 6.52E-04 
 
ENSXETG00000
003349 poc5 -1.47 3.57E-06 
ENSXETG00000
025060 shprh 1.37 3.85E-03 
 
ENSXETG00000

















5817486 -1.46 3.65E-03 
ENSXETG00000
020160 pros1 1.35 3.74E-02 
 
ENSXETG00000
017409 kiaa0513 -1.46 9.09E-04 
ENSXETG00000
027751 marcks 1.35 1.54E-02 
 
ENSXETG00000
006299 xepsin -1.46 1.50E-02 
ENSXETG00000
004371 tspan1 1.34 1.06E-03 
 
ENSXETG00000
021376 mpped2 -1.46 3.99E-02 
ENSXETG00000
008603 akt1 1.33 8.43E-04 
 
ENSXETG00000
019539 wdr16 -1.46 3.67E-14 
ENSXETG00000
020280 fam171a1 1.33 7.09E-03 
 
ENSXETG00000
006312 casz1 -1.46 1.69E-11 
ENSXETG00000
002238 akap2 1.32 1.99E-04 
 
ENSXETG00000
000118 slc2a12 -1.46 4.79E-02 
ENSXETG00000
025083 c6orf35 1.32 3.59E-02 
 
ENSXETG00000
013421 crocc -1.46 5.04E-04 
ENSXETG00000
005091 lrp4 1.31 2.47E-05 
 
ENSXETG00000
030034 lrrc73 -1.45 1.81E-02 
ENSXETG00000





5922677 -1.45 3.09E-08 
ENSXETG00000







025368 best2 1.30 7.43E-03 
 
ENSXETG00000
013950 ak7 -1.45 5.91E-09 
ENSXETG00000
018074 rasgrp1 1.29 1.14E-02 
 
ENSXETG00000
016747 rgl3 -1.45 3.15E-03 
ENSXETG00000
016775 fgfr1 1.29 2.64E-07 
 
ENSXETG00000
018928 c2orf77 -1.45 9.09E-04 
ENSXETG00000
016111 slc27a2 1.29 3.30E-06 
 
ENSXETG00000
023781 c2orf50 -1.45 1.33E-04 
ENSXETG00000
022029 pfkfb1 1.29 1.10E-12 
 
ENSXETG00000
005240 dcdc2b -1.45 6.88E-05 
ENSXETG00000
018375 anxa11 1.29 4.86E-04 
 
ENSXETG00000











011781 rab11fip5 1.28 3.22E-02 
 
ENSXETG00000
013234 cdc14a -1.44 8.29E-07 
ENSXETG00000
018359 zmiz1 1.27 4.54E-04 
 
ENSXETG00000
022874 wdr49 -1.44 1.53E-04 
ENSXETG00000
010302 chga 1.27 1.25E-02 
 
ENSXETG00000
017416 fam92b -1.44 2.54E-05 
ENSXETG00000
027667 c9orf6 1.27 6.90E-08 
 
ENSXETG00000
001591 cetn4 -1.43 1.89E-05 
ENSXETG00000
009866 znf503 1.27 2.61E-05 
 
ENSXETG00000
032161 morn3 -1.43 9.27E-07 
ENSXETG00000
033367 tmem2 1.27 5.59E-07 
 
ENSXETG00000
025413 mest -1.43 2.34E-02 
ENSXETG00000
015500 mllt3 1.26 3.26E-02 
 
ENSXETG00000
011276 slc22a31 -1.43 5.65E-04 
ENSXETG00000
010460 nos1ap 1.26 1.23E-05 
 
ENSXETG00000
014603 slc7a8 -1.43 3.49E-05 
ENSXETG00000







019763 mospd1 1.25 1.30E-04 
 
ENSXETG00000
000061 dnal1 -1.43 1.42E-08 
ENSXETG00000
011217 thbs1 1.24 2.50E-02 
 
ENSXETG00000
010363 tekt1 -1.43 1.15E-09 
ENSXETG00000
011962 dact1 1.24 1.10E-03 
 
ENSXETG00000
020932 esrrg -1.42 7.37E-03 
ENSXETG00000












5902318 -1.42 2.88E-03 
ENSXETG00000
020924 ippk 1.23 3.24E-02 
 
ENSXETG00000
013823 elmo3 -1.41 2.18E-03 
ENSXETG00000
025190 lrrc8b 1.23 5.40E-03 
 
ENSXETG00000
012922 pde4c -1.41 2.28E-02 
ENSXETG00000
016563 tcf12 1.23 6.41E-06 
 
ENSXETG00000
004839 maob -1.41 1.58E-02 
ENSXETG00000
010357 nme3 1.22 2.58E-02 
 
ENSXETG00000
018269 cep89 -1.41 1.06E-05 
ENSXETG00000
017315 adcy9 1.21 4.81E-07 
 
ENSXETG00000
012560 c2cd3 -1.41 4.28E-06 
Appendix 100 
ENSXETG00000
007197 dnajc4 1.21 4.27E-03 
 
ENSXETG00000
002998 c1orf173 -1.41 7.13E-03 
ENSXETG00000
017793 zc4h2 1.21 4.92E-03 
 
ENSXETG00000







034073 mdh1b -1.41 4.57E-06 
ENSXETG00000
026157 cdk5rap2 1.21 3.04E-02 
 
ENSXETG00000







011397 neurl -1.40 9.95E-05 
ENSXETG00000
027014 traf4 1.20 4.72E-02 
 
ENSXETG00000
003974 clic3 -1.40 9.96E-05 
ENSXETG00000
034081 cul5 1.19 1.18E-02 
 
ENSXETG00000
022138 iqub -1.40 1.40E-08 
ENSXETG00000
017566 smarca5 1.19 4.24E-08 
 
ENSXETG00000
006354 kiaa1370 -1.39 8.74E-08 
ENSXETG00000
011565 mdfic 1.18 3.45E-02 
 
ENSXETG00000
013608 cep112 -1.39 1.33E-02 
ENSXETG00000
018620 prrg1 1.18 1.50E-10 
 
ENSXETG00000
008631 lpar3 -1.39 4.69E-03 
ENSXETG00000
009218 mynn 1.18 6.04E-04 
 
ENSXETG00000
017777 wdr52 -1.39 7.33E-03 
ENSXETG00000







014857 ostm1 1.17 1.99E-06 
 
ENSXETG00000
019906 nek10 -1.39 3.52E-03 
ENSXETG00000
011833 ptprd 1.17 1.36E-03 
 
ENSXETG00000
030298 pifo -1.39 4.22E-02 
ENSXETG00000
012186 ccnj 1.16 1.41E-03 
 
ENSXETG00000
014097 rarres1 -1.38 1.00E-03 
ENSXETG00000
011897 eno1 1.15 6.82E-03 
 
ENSXETG00000
022093 dnah7 -1.38 7.46E-05 
ENSXETG00000
012289 rps6ka1 1.15 1.65E-04 
 
ENSXETG00000
023071 fam102a -1.38 3.07E-02 
ENSXETG00000
023793 greb1 1.15 4.28E-03 
 
ENSXETG00000
005871 fam149a -1.37 1.57E-02 
ENSXETG00000
013793 setd6 1.15 5.09E-06 
 
ENSXETG00000
032269 lrrfip1 -1.37 6.92E-04 
ENSXETG00000
010313 otub2 1.14 2.75E-02 
 
ENSXETG00000
026283 gjb1 -1.37 1.16E-02 
ENSXETG00000
030447 dusp8 1.14 3.97E-03 
 
ENSXETG00000
022580 nhsl2 -1.37 2.94E-03 
ENSXETG00000
012743 rcor1 1.13 5.45E-03 
 
ENSXETG00000
007409 rapgef5 -1.36 8.92E-07 
ENSXETG00000
021414 egln1 1.12 1.22E-02 
 
ENSXETG00000
009576 oat.2 -1.36 5.05E-09 
ENSXETG00000
010841 dock7 1.12 6.22E-06 
 
ENSXETG00000
004679 lox -1.36 3.17E-02 
ENSXETG00000
005431 sema3d 1.12 4.72E-02 
 
ENSXETG00000
032814 clhc1 -1.36 3.35E-06 
ENSXETG00000
024679 spats2 1.12 6.57E-06 
 
ENSXETG00000
023923 lrrc23 -1.36 8.85E-09 
ENSXETG00000
004155 abi2 1.11 7.67E-07 
 
ENSXETG00000
025131 sgpp1 -1.35 1.25E-04 
ENSXETG00000
024397 nr1d1 1.10 1.28E-02 
 
ENSXETG00000
033099 jag2 -1.35 2.94E-03 
ENSXETG00000
003253 pik3r3 1.10 8.28E-03 
 
ENSXETG00000
031301 cdc20b -1.35 9.59E-05 
ENSXETG00000
005342 arhgap6 1.10 1.28E-03 
 
ENSXETG00000
013238 fos -1.35 4.00E-03 
ENSXETG00000
011818 ryk 1.08 7.21E-04 
 
ENSXETG00000
015673 arl11 -1.35 1.33E-02 
ENSXETG00000
017437 cdk2ap2 1.08 2.16E-02 
 
ENSXETG00000
026793 tmem30b -1.35 1.44E-03 
ENSXETG00000
012160 srebf1 1.08 2.11E-04 
 
ENSXETG00000
002371 kif27 -1.35 2.63E-03 
ENSXETG00000
030743 mb 1.08 2.10E-04 
 
ENSXETG00000
021433 snta1 -1.35 1.15E-04 
ENSXETG00000







011111 hes3.1 1.08 5.91E-03 
 
ENSXETG00000
002233 fam161a -1.34 2.10E-04 
ENSXETG00000
001573 spry1 1.07 3.26E-02 
 
ENSXETG00000
010212 hopx -1.34 3.49E-03 
Appendix 101 
ENSXETG00000
014939 smo 1.06 4.08E-02 
 
ENSXETG00000
021129 bmper -1.34 8.22E-03 
ENSXETG00000
012949 ctps 1.06 3.88E-06 
 
ENSXETG00000
018451 dlec1 -1.34 4.35E-03 
ENSXETG00000
015984 nol12 1.06 2.84E-02 
 
ENSXETG00000
031212 lrrc61 -1.34 1.09E-03 
ENSXETG00000
011847 med20 1.05 4.16E-04 
 
ENSXETG00000
007364 slc4a1 -1.33 4.86E-04 
ENSXETG00000
007756 shf 1.05 2.88E-02 
 
ENSXETG00000
000511 tubal3 -1.33 1.37E-06 
ENSXETG00000
012714 arhgef37 1.05 3.32E-05 
 
ENSXETG00000
025129 fam154b -1.32 4.36E-07 
ENSXETG00000







009119 lrr1 1.04 3.06E-02 
 
ENSXETG00000
011664 ttc12 -1.32 1.31E-03 
ENSXETG00000
013749 polr1b 1.04 1.37E-06 
 
ENSXETG00000
013794 c20orf12 -1.32 3.25E-07 
ENSXETG00000
021731 epha2 1.03 3.73E-04 
 
ENSXETG00000
006039 lrrc56 -1.32 1.06E-02 
ENSXETG00000
014976 slc39a6 1.03 2.94E-02 
 
ENSXETG00000
005411 meig1 -1.32 9.85E-05 
ENSXETG00000







003247 znf451 1.03 2.14E-03 
 
ENSXETG00000
021807 cdkl5 -1.31 3.26E-02 
ENSXETG00000
022626 prmt5 1.02 9.08E-04 
 
ENSXETG00000
020259 fam195a -1.31 1.98E-04 
ENSXETG00000
021932 c18orf21 1.02 3.88E-04 
 
ENSXETG00000
024054 rsph10b -1.31 8.25E-05 
ENSXETG00000
015231 sulf1 1.01 3.12E-02 
 
ENSXETG00000
004553 armc4 -1.30 3.19E-06 
ENSXETG00000
021691 mapk8 1.01 2.22E-03 
 
ENSXETG00000
008083 sptlc3 -1.29 3.39E-06 
ENSXETG00000
012163 ppp1r7 1.01 1.87E-03 
 
ENSXETG00000
019807 cntrl -1.29 1.05E-06 
ENSXETG00000
021431 cbfa2t2 1.01 1.85E-05 
 
ENSXETG00000
000221 sertad4 -1.29 2.78E-02 
ENSXETG00000
020027 cbfb 1.01 1.74E-02 
 
ENSXETG00000
001621 fam83b -1.29 3.56E-03 
ENSXETG00000







018603 mvk 1.00 8.54E-05 
 
ENSXETG00000
021922 pfkp -1.29 4.43E-02 
ENSXETG00000
015037 taf1a 1.00 1.76E-02 
 
ENSXETG00000
010513 rhobtb2 -1.29 2.63E-02 
     
ENSXETG00000
030628 cep41 -1.29 9.00E-10 
     
ENSXETG00000
003474 eya2 -1.29 3.26E-02 
     
ENSXETG00000
008832 syt7 -1.29 1.15E-02 
     
ENSXETG00000
000853 nfatc1 -1.28 1.68E-04 
     
ENSXETG00000
020342 lrrc49 -1.28 6.07E-05 
     
ENSXETG00000
018749 b9d2 -1.28 2.85E-05 
     
ENSXETG00000
025359 spef2 -1.28 5.05E-09 
     
ENSXETG00000
007441 c7orf63 -1.28 5.83E-06 
     
ENSXETG00000
023547 cidec -1.28 1.50E-06 
     
ENSXETG00000
018054 c3orf15 -1.28 1.46E-06 
     
ENSXETG00000
021532 atp6v1b1 -1.28 2.40E-02 
     
ENSXETG00000
010337 ern2 -1.28 8.25E-05 
     
ENSXETG00000
025736 id4 -1.27 4.86E-04 
     
ENSXETG00000
017121 ccdc67 -1.27 2.00E-07 
Appendix 102 





     
ENSXETG00000
005339 ankrd9 -1.27 2.69E-05 
     
ENSXETG00000
017407 fbxo31 -1.27 3.35E-06 
     
ENSXETG00000
021693 c12orf63 -1.27 1.12E-02 
     
ENSXETG00000
017719 pde7b -1.27 1.47E-03 





     
ENSXETG00000
015230 c8orf34 -1.26 4.70E-02 
     
ENSXETG00000
008245 ctgf -1.26 1.35E-02 
     
ENSXETG00000
025254 ccdc60 -1.26 3.53E-02 
     
ENSXETG00000
000681 mtus1 -1.26 5.58E-08 
     
ENSXETG00000
016064 tekt4 -1.26 2.37E-07 
     
ENSXETG00000
019283 ptprn -1.26 3.54E-02 
     
ENSXETG00000
017281 ttc16 -1.26 7.21E-03 
     
ENSXETG00000
030994 kiaa0226 -1.26 7.60E-03 





     
ENSXETG00000
003003 lrrc45 -1.25 2.07E-02 
     
ENSXETG00000
014869 efna5 -1.25 1.06E-02 
     
ENSXETG00000
004470 c9orf117 -1.25 5.77E-05 
     
ENSXETG00000
024488 c1orf177 -1.25 1.97E-05 
     
ENSXETG00000
027042 eif2c3 -1.25 3.15E-03 
     
ENSXETG00000
015826 egfr -1.25 5.39E-03 





     
ENSXETG00000
007211 esrra -1.25 2.98E-05 





     
ENSXETG00000
005016 wrap73 -1.25 3.28E-03 
     
ENSXETG00000
031073 katnal1 -1.24 7.19E-03 
     
ENSXETG00000
030978 cfap57 -1.24 3.23E-06 
     
ENSXETG00000
023111 slc26a5 -1.24 4.75E-02 
     
ENSXETG00000
001379 pdgfa -1.24 2.53E-02 
     
ENSXETG00000
026042 rgs12 -1.24 3.14E-02 





     
ENSXETG00000
021994 pip5kl1 -1.24 3.01E-04 
     
ENSXETG00000
009776 ezr -1.24 2.16E-02 
     
ENSXETG00000
000346 rbl2 -1.23 3.82E-03 
     
ENSXETG00000
000961 ubr1 -1.23 9.39E-03 
     
ENSXETG00000
033951 ccdc96 -1.23 1.64E-03 
     
ENSXETG00000
007177 iqsec2 -1.23 1.13E-02 
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ENSXETG00000
010016 pde9a -1.23 5.57E-03 
     
ENSXETG00000
006790 tctex1d1 -1.23 2.60E-09 
     
ENSXETG00000
009243 pvrl1 -1.23 2.09E-13 
     
ENSXETG00000
001752 tuba8 -1.23 1.48E-03 





     
ENSXETG00000
004522 lypd6 -1.23 1.71E-02 
     
ENSXETG00000
018935 bbs5 -1.22 4.73E-07 
     
ENSXETG00000
007584 baz2b -1.22 5.37E-03 
     
ENSXETG00000
013287 atp2c2 -1.22 2.24E-03 
     
ENSXETG00000
010879 rsph9 -1.22 2.28E-03 
     
ENSXETG00000
021049 kit -1.22 4.85E-04 
     
ENSXETG00000
004424 scube2 -1.22 1.93E-02 
     
ENSXETG00000
016981 lrrc9 -1.22 1.60E-03 
     
ENSXETG00000
004770 fbxw9 -1.22 2.01E-04 
     
ENSXETG00000
030456 mgst2 -1.21 3.00E-03 
     
ENSXETG00000
030879 efcab11 -1.21 1.13E-02 
     
ENSXETG00000
019577 tekt3 -1.21 1.27E-05 
     
ENSXETG00000
025737 c4orf47 -1.21 2.18E-06 
     
ENSXETG00000
012662 ccdc14 -1.21 2.97E-02 
     
ENSXETG00000
006697 egr1 -1.20 3.32E-02 
     
ENSXETG00000
034354 nek11 -1.20 1.39E-03 
     
ENSXETG00000
006172 c6orf165 -1.20 4.60E-07 
     
ENSXETG00000
007394 c10orf140 -1.20 1.63E-02 
     
ENSXETG00000
030283 fgd1 -1.20 6.07E-05 
     
ENSXETG00000
017882 fbxo43 -1.20 2.39E-06 





     
ENSXETG00000
013759 ccdc135 -1.20 1.41E-05 
     
ENSXETG00000
030281 sntb2 -1.20 2.07E-08 
     
ENSXETG00000
023804 gfra1 -1.19 3.01E-02 
     
ENSXETG00000
016145 ccdc157 -1.19 4.21E-05 
     
ENSXETG00000
033712 fry -1.19 3.31E-03 
     
ENSXETG00000
009697 c20orf26 -1.19 9.83E-03 
     
ENSXETG00000
008640 ctbs -1.19 1.58E-02 
     
ENSXETG00000
023191 fam83a -1.19 2.91E-02 




5818700 -1.19 1.66E-02 
     
ENSXETG00000
003627 wdr90 -1.19 4.85E-10 






     
ENSXETG00000
009994 mycbpap -1.18 1.86E-04 
     
ENSXETG00000
016761 cep19 -1.18 1.16E-02 





     
ENSXETG00000
019549 foxj1 -1.18 2.77E-06 
     
ENSXETG00000
030692 sh3tc2 -1.18 3.87E-02 
     
ENSXETG00000
023988 zfpm1 -1.18 4.71E-04 
     
ENSXETG00000
020484 zfyve28 -1.18 4.37E-02 
     
ENSXETG00000
001893 c12orf55 -1.18 3.86E-02 
     
ENSXETG00000
008804 atf5.2 -1.18 2.02E-02 
     
ENSXETG00000
002166 dnali1 -1.18 2.26E-04 
     
ENSXETG00000
016124 alcam -1.18 5.01E-03 
     
ENSXETG00000
009215 lrrc31 -1.18 1.13E-02 
     
ENSXETG00000
006170 ccdc13 -1.17 1.84E-02 
     
ENSXETG00000
013405 mapk15 -1.17 5.67E-07 
     
ENSXETG00000
004564 fut1 -1.17 9.55E-03 
     
ENSXETG00000
017730 wdr93 -1.17 2.46E-02 
     
ENSXETG00000
013740 ca2 -1.17 1.42E-02 
     
ENSXETG00000
023881 kif9 -1.17 1.09E-06 
     
ENSXETG00000
022522 plk4 -1.16 1.43E-09 
     
ENSXETG00000
001302 noxred1 -1.16 1.09E-02 
     
ENSXETG00000
019671 cep76 -1.16 7.08E-05 
     
ENSXETG00000
000715 hoxa1 -1.16 1.27E-02 
     
ENSXETG00000
001588 bbs12 -1.16 5.58E-04 
     
ENSXETG00000
005936 fam126a -1.16 3.35E-03 
     
ENSXETG00000
006579 tbx3 -1.16 3.00E-02 
     
ENSXETG00000
009392 fam160a1 -1.15 2.64E-02 
     
ENSXETG00000
018333 kiaa0556 -1.15 2.84E-04 





     
ENSXETG00000
013734 atp6v0d2 -1.15 6.65E-04 
     
ENSXETG00000
005517 fermt1 -1.15 4.18E-02 
     
ENSXETG00000
022616 fam184a -1.15 6.17E-03 





     
ENSXETG00000
021413 tpp1 -1.15 3.34E-02 
     
ENSXETG00000
018202 fam228b -1.15 3.83E-02 
     
ENSXETG00000
022999 ccdc18 -1.14 2.89E-02 
     
ENSXETG00000
012882 meis2 -1.14 1.19E-02 






     
ENSXETG00000
031455 ift88 -1.14 3.60E-06 
     
ENSXETG00000
003366 rab27b -1.14 1.74E-02 
     
ENSXETG00000
032327 ccdc92 -1.14 1.57E-04 
     
ENSXETG00000
031527 ccdc87 -1.13 3.85E-03 
     
ENSXETG00000
001384 aadacl4 -1.13 8.16E-03 
     
ENSXETG00000
010779 spata4 -1.13 7.30E-07 
     
ENSXETG00000
030332 kiaa1407 -1.13 6.22E-03 
     
ENSXETG00000
012541 dnajb13 -1.13 7.30E-07 
     
ENSXETG00000
008955 acaca -1.13 3.07E-02 
     
ENSXETG00000
015924 lrrk1 -1.13 2.03E-02 
     
ENSXETG00000
013007 ugp2 -1.13 1.30E-05 
     
ENSXETG00000
009728 usp3 -1.13 3.28E-05 
     
ENSXETG00000
004420 ccdc89 -1.13 1.50E-02 
     
ENSXETG00000
006535 prickle2 -1.12 6.21E-04 
     
ENSXETG00000
025336 cxorf58 -1.12 1.33E-02 
     
ENSXETG00000
003329 ccdc164 -1.12 3.28E-03 
     
ENSXETG00000
031946 dennd1b -1.12 2.90E-02 
     
ENSXETG00000
024543 tex9 -1.12 2.65E-05 
     
ENSXETG00000
001355 ncs1 -1.12 9.94E-04 
     
ENSXETG00000
004106 fzd6 -1.12 1.06E-03 
     
ENSXETG00000
023039 lrrc6 -1.11 1.67E-02 
     
ENSXETG00000
016749 eppk1 -1.11 5.30E-03 
     
ENSXETG00000
024456 fbxo46 -1.11 8.98E-04 
     
ENSXETG00000
009961 kcnk5 -1.11 8.64E-03 
     
ENSXETG00000
004670 mvp -1.11 2.28E-05 
     
ENSXETG00000
031364 nsf -1.11 1.40E-02 
     
ENSXETG00000
019251 tuba1a -1.11 5.42E-07 
     
ENSXETG00000
010700 ccdc83 -1.11 4.29E-02 
     
ENSXETG00000
009216 lrriq4 -1.11 2.62E-03 
     
ENSXETG00000
024111 casp6 -1.11 1.41E-03 
     
ENSXETG00000
012423 scnn1g -1.11 4.68E-02 
     
ENSXETG00000
020096 siah2 -1.11 1.83E-02 
     
ENSXETG00000
019437 ccdc39 -1.11 4.28E-06 
     
ENSXETG00000
009902 c21orf59 -1.10 1.91E-07 
     
ENSXETG00000
016769 hs6st1 -1.10 2.91E-04 
     
ENSXETG00000
018842 enkur -1.10 4.25E-05 
     
ENSXETG00000
010315 ppp4r4 -1.10 1.56E-04 
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ENSXETG00000
021254 ift172 -1.10 1.59E-04 
     
ENSXETG00000
032001 bicd1 -1.10 3.80E-02 
     
ENSXETG00000
016745 ccdc151 -1.10 1.76E-03 
     
ENSXETG00000
020238 agbl3 -1.10 1.20E-02 
     
ENSXETG00000
033274 mcidas -1.10 1.91E-03 
     
ENSXETG00000
009178 c9orf93 -1.10 2.63E-06 
     
ENSXETG00000
020322 ccdc11 -1.10 1.72E-05 
     
ENSXETG00000
002073 c19orf44 -1.09 6.09E-05 





     
ENSXETG00000
002225 rod1 -1.09 6.26E-03 
     
ENSXETG00000
005963 tmprss2 -1.09 3.04E-03 
     
ENSXETG00000
020468 ppargc1a -1.09 8.43E-04 
     
ENSXETG00000
021069 cep135 -1.09 2.69E-04 
     
ENSXETG00000
028091 ccno -1.08 6.74E-03 
     
ENSXETG00000
031645 efnb3 -1.08 5.98E-03 
     
ENSXETG00000
010891 tcte1 -1.08 2.69E-03 
     
ENSXETG00000
030937 fsip1 -1.08 1.86E-05 





     
ENSXETG00000
008997 plekha8 -1.08 2.03E-02 
     
ENSXETG00000
012970 rap1gap2 -1.08 1.89E-02 
     
ENSXETG00000
011732 agtpbp1 -1.08 6.01E-03 
     
ENSXETG00000
009217 lrrc34 -1.07 7.79E-05 
     
ENSXETG00000
025773 c1orf222 -1.07 1.15E-03 
     
ENSXETG00000
033996 pcnt -1.07 5.57E-03 
     
ENSXETG00000
012328 ubxn11 -1.07 5.45E-03 
     
ENSXETG00000
017447 c1orf21 -1.07 2.59E-04 
     
ENSXETG00000
016556 mns1 -1.07 1.91E-03 
     
ENSXETG00000
019096 rsph6a -1.07 9.66E-05 
     
ENSXETG00000
001463 ift122 -1.06 3.26E-02 
     
ENSXETG00000
025625 agr2 -1.06 1.55E-06 
     
ENSXETG00000
018105 micall2 -1.06 9.61E-06 
     
ENSXETG00000
008978 styxl1 -1.06 8.97E-09 
     
ENSXETG00000
013739 ccdc113 -1.06 4.01E-04 
     
ENSXETG00000
014260 fam129b -1.05 2.20E-06 
     
ENSXETG00000
006071 ccdc104 -1.05 1.58E-08 
     
ENSXETG00000
009815 ccdc65 -1.05 3.14E-05 
     
ENSXETG00000
012155 lrrc48 -1.05 7.42E-03 
Appendix 107 
     
ENSXETG00000
001229 mgc79783 -1.05 1.85E-02 
     
ENSXETG00000
018573 foxn4 -1.05 7.60E-03 
     
ENSXETG00000
018017 gpr156 -1.04 2.45E-02 
     
ENSXETG00000
023264 cspp1 -1.03 3.00E-02 
     
ENSXETG00000
013130 magi1 -1.03 5.27E-03 




5815363 -1.03 1.68E-02 
     
ENSXETG00000
000979 ttbk2 -1.03 2.61E-02 
     
ENSXETG00000
007807 iqch -1.03 1.02E-03 
     
ENSXETG00000
020472 pacrgl -1.03 2.07E-02 
     
ENSXETG00000
000702 ttc23l -1.02 7.11E-05 
     
ENSXETG00000
017228 rnasek -1.02 8.47E-05 
     
ENSXETG00000
004733 kifap3 -1.02 3.20E-02 
     
ENSXETG00000
003223 esyt3 -1.02 4.47E-03 





     
ENSXETG00000
033349 mgc147546 -1.02 2.66E-04 
     
ENSXETG00000
019937 agbl2 -1.02 2.16E-02 
     
ENSXETG00000
016014 stoml3 -1.02 8.64E-03 
     
ENSXETG00000
002292 acly -1.02 1.92E-04 
     
ENSXETG00000
012554 capn7 -1.02 2.15E-04 
     
ENSXETG00000
007726 plp2 -1.01 1.50E-02 
     
ENSXETG00000
030278 adam7 -1.01 1.15E-03 
     
ENSXETG00000
008635 ssx2ip -1.01 6.12E-03 
     
ENSXETG00000
016097 pgp -1.01 1.95E-03 
     
ENSXETG00000
014740 arhgap23 -1.01 1.01E-02 
     
ENSXETG00000
015225 arl3.1 -1.01 7.82E-08 
     
ENSXETG00000
021305 nbeal2 -1.01 2.38E-02 
     
ENSXETG00000
014645 slc4a11 -1.00 5.41E-03 
     
ENSXETG00000
031231 fbf1 -1.00 3.12E-03 
     
ENSXETG00000
018458 plcd1 -1.00 1.45E-02 
     
ENSXETG00000
000967 nadsyn1 -1.00 2.05E-03 
     
ENSXETG00000
002421 c1orf114 -1.00 1.68E-04 
     
ENSXETG00000
020945 ift81 -1.00 6.89E-04 
     
ENSXETG00000
031398 ccp110 -1.00 3.74E-04 
     
ENSXETG00000





6.1.2 Differentially expressed genes at stage 27 
Given are the ensembl id, official gene name, log2 fold change and the adjusted 
P-value with respect to multiple testing using the FDR method. Genes were 
sorted according to the highest and lowest log2 fold change, respectively. 
 
Table 6.2 Summary of differentially expressed genes at stage 27 
upregulated  downregulated 














006348 sox10 7.92 7.84E-21 
 
ENSXETG00000
032850 lrrn3 -2.69 8.13E-03 
ENSXETG00000
023476 hoxc8 7.56 1.34E-37 
 
ENSXETG00000
001728 slc6a3 -2.50 2.79E-02 
ENSXETG00000
015915 prdm14 7.44 1.19E-33 
 
ENSXETG00000
032366 lgr5 -2.49 7.86E-04 
ENSXETG00000
007863 stmn2 7.25 5.73E-11 
 
ENSXETG00000
008859 hkdc1 -2.16 1.27E-03 
ENSXETG00000





990053 -1.99 2.94E-04 
ENSXETG00000
023475 hoxc9 6.65 7.84E-21 
 
ENSXETG00000
001035 fam132a -1.93 1.45E-02 
ENSXETG00000
003618 atp2b4 6.61 4.11E-10 
 
ENSXETG00000
017075 pde8b -1.89 4.70E-02 
ENSXETG00000
016479 trpm1 6.58 1.29E-10 
 
ENSXETG00000
027798 pnmt -1.88 2.89E-02 
ENSXETG00000
023479 hoxc6 6.40 2.40E-15 
 
ENSXETG00000022857 -1.83 9.72E-03 
ENSXETG00000
010836 foxd3 6.34 3.01E-10 
 
ENSXETG00000
007353 tgm5 -1.78 6.28E-03 
ENSXETG00000
032598 map1b 6.34 1.85E-10 
 
ENSXETG00000
031045 sepp1 -1.64 1.91E-02 
ENSXETG00000
027815 vcan 6.28 1.89E-09 
 
ENSXETG00000







014607 calb1 -1.60 1.15E-02 
ENSXETG00000
018387 ednrb2 6.20 1.29E-08 
 
ENSXETG00000
004839 maob -1.56 4.89E-02 
ENSXETG00000
022336 olfm1 6.15 1.51E-09 
 
ENSXETG00000
020701 tpte2 -1.56 2.91E-04 
ENSXETG00000
015096 snap25 6.14 1.07E-17 
 
ENSXETG00000032779 -1.55 1.80E-04 
ENSXETG00000
008965 scn3a 6.12 2.24E-10 
 
ENSXETG00000
032204 plcl1 -1.52 1.98E-02 
ENSXETG00000
003388 adam11 5.97 3.77E-09 
 
ENSXETG00000
020033 serpinc1 -1.51 8.88E-06 
ENSXETG00000
011738 tyr 5.91 2.04E-08 
 
ENSXETG00000
018739 cdo1 -1.49 4.41E-03 
ENSXETG00000
018304 tlx3 5.91 5.73E-11 
 
ENSXETG00000031991 -1.47 4.52E-05 
ENSXETG00000
030140 stx1b 5.84 2.36E-07 
 
ENSXETG00000
033983 dmrt2 -1.47 3.72E-04 
ENSXETG00000
003399 slc17a7 5.78 4.18E-09 
 
ENSXETG00000






ENSXETG00000018800 -1.42 3.28E-02 
ENSXETG00000
000237 zeb2 5.73 5.32E-09 
 
ENSXETG00000
017719 pde7b -1.42 5.79E-04 
ENSXETG00000
019179 adcyap1 5.68 4.49E-08 
 
ENSXETG00000
007364 slc4a1 -1.38 6.87E-04 
ENSXETG00000
013347 gpm6b 5.62 1.03E-09 
 
ENSXETG00000
002371 kif27 -1.36 2.12E-02 
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ENSXETG00000
000724 hoxa9 5.56 1.29E-08 
 
ENSXETG00000
008892 irx4 -1.34 4.41E-03 
ENSXETG00000
020467 cdh11 5.56 1.79E-08 
 
ENSXETG00000
010125 tmprss13 -1.29 4.31E-02 
ENSXETG00000
003657 sncg 5.56 1.20E-14 
 
ENSXETG00000
020335 fgfbp2 -1.28 2.71E-02 
ENSXETG00000
019353 cadm3 5.45 6.81E-06 
 
ENSXETG00000
032404 axdnd1 -1.28 2.43E-02 
ENSXETG00000
018040 ntrk1 5.35 2.73E-06 
 
ENSXETG00000
013722 ephb1 -1.27 1.16E-05 
ENSXETG00000





5822257 -1.25 1.59E-02 
ENSXETG00000
020978 robo2 5.34 3.74E-08 
 
ENSXETG00000030875 -1.21 1.66E-03 
ENSXETG00000
000719 l1cam 5.32 2.27E-10 
 
ENSXETG00000000901 -1.13 2.45E-03 
ENSXETG00000
011751 rab38 5.31 4.37E-06 
 
ENSXETG00000
000157 ppp1r14a -1.10 3.27E-03 
ENSXETG00000
006932 cdh2 5.29 2.71E-09 
 
ENSXETG00000032488 -1.09 8.57E-03 
ENSXETG00000





5815363 -1.06 4.15E-02 
ENSXETG00000
009943 ntng1 5.14 1.82E-05 
 
ENSXETG00000
009697 c20orf26 -1.06 4.10E-02 
ENSXETG00000
013534 rtn4rl1 5.11 9.82E-08 
 
ENSXETG00000
014867 pltp -1.05 5.90E-03 
ENSXETG00000
023938 tnc 5.10 1.24E-09 
 
ENSXETG00000
020710 nek5 -1.01 3.59E-03 
ENSXETG00000
021492 lrfn5 5.08 2.01E-05 
 
ENSXETG00000
024858 cyp2c18 -1.00 1.07E-02 
ENSXETG00000
010942 dct 5.07 6.40E-06 
     ENSXETG00000
015442 syt4 5.05 1.71E-05 
     ENSXETG00000
026846 sncb 5.04 1.75E-07 
     ENSXETG00000
032855 tmem196 5.02 4.07E-05 
     ENSXETG00000
031363 rab6b 5.00 7.86E-08 
     ENSXETG00000
006562 shc2 4.99 1.10E-05 
     ENSXETG00000
005838 mllt11 4.99 8.53E-06 
     ENSXETG00000
010153 ebf2 4.96 4.12E-06 
     ENSXETG00000
009667 c1orf216 4.91 1.24E-05 
     ENSXETG00000
032232 mlph 4.86 1.49E-05 
     ENSXETG00000
023585 dpysl4 4.85 2.94E-08 
     ENSXETG00000
034215 sipa1 4.84 6.25E-05 
     ENSXETG00000
001025 mapk8ip1 4.82 3.30E-06 
     ENSXETG00000
007640 pax3 4.82 1.65E-05 
     ENSXETG00000
003477 fgf13 4.81 1.13E-05 
     ENSXETG00000
016741 elavl3 4.81 6.64E-07 
     ENSXETG00000
009037 fam176b 4.77 6.01E-05 
     ENSXETG00000
019618 nptx1 4.74 6.05E-10 
     ENSXETG00000
004068 syt1 4.73 2.36E-04 
     ENSXETG00000
022924 brsk1 4.73 2.57E-04 
     ENSXETG00000
014261 stxbp1 4.69 2.36E-09 
     ENSXETG00000
030030 kctd16 4.68 2.25E-04 
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ENSXETG00000
022315 cplx2 4.66 1.29E-08 
     ENSXETG00000
000728 hoxa10 4.65 3.94E-05 
     ENSXETG00000
030920 atp2b3 4.63 1.27E-11 
     ENSXETG00000
015058 klhl35 4.63 1.56E-04 
     ENSXETG00000
021181 pcdh9 4.61 4.83E-05 
     ENSXETG00000
000722 hoxa7 4.58 1.65E-09 
     ENSXETG00000
025525 pnhd 4.51 1.13E-05 
     ENSXETG00000
015810 cntn1 4.50 6.57E-05 
     ENSXETG00000
015061 map6 4.48 3.33E-04 
     ENSXETG00000
018386 pou4f1.2 4.47 4.39E-08 
     ENSXETG00000
011339 sez6l2 4.47 9.87E-06 
     ENSXETG00000
000225 kcnh1 4.44 6.92E-04 
     ENSXETG00000
007718 syp 4.42 1.33E-06 
     ENSXETG00000
020282 itga8 4.39 5.23E-04 
     ENSXETG00000
005746 sox8 4.37 2.10E-05 
     ENSXETG00000
000910 arl8a 4.37 8.02E-09 
     ENSXETG00000
002939 scg2 4.35 1.95E-05 
     ENSXETG00000
022304 svop 4.34 2.91E-04 
     ENSXETG00000
007649 c11orf87 4.34 3.00E-04 
     ENSXETG00000
025183 hoxc5 4.29 5.89E-15 
     ENSXETG00000
007626 sv2b 4.28 1.66E-03 
     ENSXETG00000
006906 nptxr 4.25 7.19E-07 
     ENSXETG00000
016503 apba2 4.24 2.79E-07 
     ENSXETG00000
022780 fli1 4.24 8.94E-04 
     ENSXETG00000
010118 adam23 4.23 6.01E-05 
     ENSXETG00000
033967 slc18a3 4.18 4.68E-04 
     ENSXETG00000
015711 grm7 4.18 1.12E-03 
     ENSXETG00000
020846 scn1a 4.16 4.76E-04 
     ENSXETG00000
008680 elavl4 4.15 5.01E-07 
     ENSXETG00000
002245 frmpd1 4.14 2.06E-04 
     ENSXETG00000
023482 bhlhe41 4.13 6.73E-04 
     ENSXETG00000
001353 hmcn2 4.13 4.38E-07 
     ENSXETG00000
012179 rtn4r 4.10 2.27E-03 
     ENSXETG00000
006793 pdzrn4 4.09 1.56E-03 
     ENSXETG00000
022950 zbtb16 4.09 6.37E-16 
     ENSXETG00000
025936 cnrip1 4.05 4.52E-04 
     ENSXETG00000
027666 tmeff1 4.05 3.34E-10 
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ENSXETG00000
010674 atp8a2 4.04 1.52E-03 
     ENSXETG00000
034346 dpysl2 4.04 6.29E-07 
     ENSXETG00000
000742 lmx1b.1 4.00 4.22E-07 
     ENSXETG00000
004296 
xb-gene-
987190 4.00 1.18E-03 
     ENSXETG00000
001812 postn 3.99 4.62E-03 
     ENSXETG00000
032363 pou4f3 3.98 4.03E-03 
     ENSXETG00000
000108 c6orf192 3.96 3.59E-03 




     ENSXETG00000
006083 slc1a3 3.92 1.12E-06 
     ENSXETG00000
007492 kcnj12 3.92 4.64E-03 
     ENSXETG00000
009344 kank2 3.90 4.39E-03 
     ENSXETG00000
025170 gpr173 3.89 5.75E-03 
     ENSXETG00000
026334 cacnb1 3.88 1.23E-04 
     ENSXETG00000
021973 hoxb4 3.87 6.89E-04 
     ENSXETG00000
005205 parp6 3.87 1.50E-03 
     ENSXETG00000
020236 rbfox3 3.86 3.11E-04 
     ENSXETG00000
030565 drgx 3.86 1.56E-04 
     ENSXETG00000
021993 hoxb8 3.85 1.81E-03 




     ENSXETG00000
006675 smpd3 3.80 3.27E-05 
     ENSXETG00000
012718 dpysl3 3.80 8.12E-11 
     ENSXETG00000
022629 snap91 3.78 4.07E-05 
     ENSXETG00000
012629 nrp1 3.76 1.52E-04 
     ENSXETG00000
017979 avp 3.75 9.78E-03 
     ENSXETG00000
017099 kif21b 3.75 7.73E-03 
     ENSXETG00000
003405 slit1 3.74 4.74E-05 
     ENSXETG00000
020230 hs3st5 3.73 6.22E-03 
     ENSXETG00000
015595 npr3 3.73 8.99E-03 
     ENSXETG00000
032535 fbn2 3.71 1.12E-03 
     ENSXETG00000
011744 mgat4c 3.71 1.11E-02 
     ENSXETG00000
014639 palm 3.69 8.48E-08 
     ENSXETG00000
019847 dbndd1 3.69 1.09E-02 
     ENSXETG00000
003565 foxf1 3.67 3.68E-04 
     ENSXETG00000
014625 nell2 3.66 7.69E-05 
     ENSXETG00000
010136 homer3 3.66 3.26E-03 
     ENSXETG00000
013321 phlda1 3.65 1.20E-03 
     ENSXETG00000
025361 
xb-gene-
5911701 3.65 3.59E-03 
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ENSXETG00000
022236 tspan18 3.62 1.43E-02 
     ENSXETG00000
032009 kcnq2 3.61 3.91E-03 
     ENSXETG00000
009439 pmel 3.60 1.19E-04 
     ENSXETG00000
003071 fbln1 3.59 1.10E-05 
     ENSXETG00000
031277 spry3 3.58 9.78E-03 
     ENSXETG00000
009191 trim63 3.57 1.04E-02 
     ENSXETG00000
022008 sh2d3c 3.56 2.32E-03 
     ENSXETG00000
033300 gareml 3.55 1.74E-02 
     ENSXETG00000
011309 ebf3 3.55 2.57E-05 
     ENSXETG00000
009683 tpbgl 3.54 1.79E-02 
     ENSXETG00000
026804 ptprr 3.52 5.27E-03 
     ENSXETG00000
007501 fscn1 3.51 2.46E-09 
     ENSXETG00000
021591 mcam 3.51 3.00E-03 
     ENSXETG00000
011743 htr1b 3.50 2.03E-02 
     ENSXETG00000
007838 adamts7 3.49 1.50E-02 




     ENSXETG00000
025181 hoxc3 3.48 2.46E-03 
     ENSXETG00000
011600 crmp1 3.47 1.26E-03 
     ENSXETG00000
019220 bmpr1b 3.47 1.81E-03 
     ENSXETG00000
010128 nefm 3.46 3.30E-09 
     ENSXETG00000
023484 hoxc4 3.44 9.95E-07 
     ENSXETG00000
018406 slc24a5 3.44 7.17E-05 
     ENSXETG00000
019915 nes 3.41 2.22E-02 
     ENSXETG00000
015623 cdh19 3.41 2.66E-02 
     ENSXETG00000
013268 olfm3 3.41 2.45E-03 
     ENSXETG00000
004054 piezo2 3.40 4.02E-05 
     ENSXETG00000
008490 kcna1 3.39 1.90E-02 
     ENSXETG00000
012905 tyrp1 3.39 1.26E-03 
     ENSXETG00000
030791 mmrn2 3.38 1.44E-02 
     ENSXETG00000
004192 kcnk18 3.36 6.66E-03 
     ENSXETG00000
023916 clstn3 3.36 8.71E-05 
     ENSXETG00000
019927 crabp2 3.35 1.18E-02 
     ENSXETG00000
013830 plcd4 3.33 4.88E-03 
     ENSXETG00000
008612 slc6a8 3.33 6.09E-03 
     ENSXETG00000
003449 kcnt1 3.31 1.25E-02 
     ENSXETG00000
018094 scg5 3.30 3.28E-04 
     ENSXETG00000
001801 hoxd1 3.30 5.01E-03 
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ENSXETG00000
003372 ppp1r9b 3.30 3.84E-03 
     ENSXETG00000
017530 stmn4 3.29 1.98E-02 
     ENSXETG00000
017708 foxb1 3.29 3.35E-02 
     ENSXETG00000
021987 hoxb6 3.28 1.70E-02 
     ENSXETG00000
011726 ntrk2 3.27 7.97E-04 
     ENSXETG00000
007556 cd44 3.25 2.30E-02 
     ENSXETG00000
006011 slc45a1 3.21 6.83E-03 
     ENSXETG00000
022371 
xb-gene-
5730963 3.20 5.42E-03 
     ENSXETG00000
034183 mapk8ip3 3.20 8.96E-04 
     ENSXETG00000
021035 pdgfra 3.19 1.17E-02 
     ENSXETG00000
014391 kcnc1 3.19 4.71E-02 
     ENSXETG00000
009066 kcnab3 3.18 1.67E-02 
     ENSXETG00000
027289 slmo1 3.18 4.39E-02 
     ENSXETG00000
018862 dclk1 3.16 2.42E-02 
     ENSXETG00000
027719 tfap2e 3.16 7.86E-08 
     ENSXETG00000
010491 pcbp2 3.16 6.55E-05 
     ENSXETG00000
016492 gng2 3.16 5.44E-03 
     ENSXETG00000
005309 lrfn1 3.14 2.92E-02 
     ENSXETG00000
033812 tmem116 3.13 2.43E-02 
     ENSXETG00000
022020 fam198a 3.12 1.26E-02 
     ENSXETG00000
023385 fst 3.12 4.15E-02 
     ENSXETG00000
005841 nhlh1 3.12 4.20E-02 
     ENSXETG00000
031503 grik5 3.12 4.71E-02 
     ENSXETG00000
000442 optc 3.11 3.68E-04 
     ENSXETG00000
012138 kif1a 3.10 4.41E-03 
     ENSXETG00000
006647 igdcc4 3.09 4.66E-02 
     ENSXETG00000
005585 cacna1a 3.08 5.32E-03 
     ENSXETG00000
000314 nr5a2 3.07 4.41E-03 
     ENSXETG00000
023470 hoxc12 3.06 4.71E-02 
     ENSXETG00000
013424 mfap2 3.06 7.38E-03 
     ENSXETG00000
023751 kiaa1274 3.05 5.83E-04 
     ENSXETG00000
022299 kal1 3.03 9.26E-03 
     ENSXETG00000
004290 ccdc165 3.02 3.68E-04 
     ENSXETG00000
010095 nrp2 3.01 4.41E-03 
     ENSXETG00000
009083 hes7.2 2.99 4.29E-02 
     ENSXETG00000
015532 fbxl16 2.97 3.47E-03 
     ENSXETG00000
023880 rgmb 2.95 9.80E-04 
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ENSXETG00000
020755 scg3 2.95 4.91E-02 
     ENSXETG00000
030958 kcnh5 2.95 1.26E-02 
     ENSXETG00000
003986 lmo2 2.95 3.12E-02 
     ENSXETG00000
021660 scarf2 2.93 2.77E-02 
     ENSXETG00000
021341 krt16 2.93 1.75E-07 
     ENSXETG00000
006199 mapk10 2.93 9.02E-04 
     ENSXETG00000
012355 dach1 2.92 4.71E-02 
     ENSXETG00000
001772 gdap1l1 2.92 3.42E-04 
     ENSXETG00000
015485 mycn 2.92 3.31E-04 
     ENSXETG00000
020864 ppp2r2b 2.91 3.87E-04 
     ENSXETG00000
022243 cadps 2.89 2.12E-03 








     ENSXETG00000
031488 pcdh19 2.87 1.79E-02 
     ENSXETG00000
003707 apc2 2.85 2.77E-03 
     ENSXETG00000
030305 amph 2.85 3.50E-02 
     ENSXETG00000
014034 lix1l 2.81 5.84E-03 
     ENSXETG00000
003954 ptgds 2.79 1.25E-02 
     ENSXETG00000
007462 vim 2.77 1.92E-06 
     ENSXETG00000
008109 xkr4 2.77 5.57E-03 
     ENSXETG00000
018024 c6orf145 2.74 7.93E-03 
     ENSXETG00000
032893 plekhg4b 2.74 2.56E-02 
     ENSXETG00000
027686 serpinf1 2.72 3.81E-04 
     ENSXETG00000
020206 timp2 2.72 3.28E-02 
     ENSXETG00000
010662 ap3b2 2.71 4.76E-04 
     ENSXETG00000
002780 clip3 2.70 2.06E-03 
     ENSXETG00000
007241 dbn1 2.69 1.20E-05 
     ENSXETG00000
000735 srpk2 2.69 1.04E-02 
     ENSXETG00000
022354 nos1 2.69 1.12E-03 
     ENSXETG00000
013597 unc13a 2.63 2.92E-02 
     ENSXETG00000
003735 pcdh8l 2.63 3.64E-02 
     ENSXETG00000
020455 krt18 2.63 5.35E-10 
     ENSXETG00000
002894 kcnab2 2.62 2.43E-02 
     ENSXETG00000
011446 plxna4 2.60 3.41E-02 
     ENSXETG00000
032158 wasf3 2.60 2.92E-02 
     ENSXETG00000
009658 mrz 09 2.60 6.66E-03 
     ENSXETG00000
021674 tfap2b 2.57 1.17E-04 
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ENSXETG00000
022636 prss35 2.57 7.37E-05 
     ENSXETG00000
003570 cxcl12 2.55 7.71E-03 
     ENSXETG00000
015769 nrcam 2.53 1.70E-02 
     ENSXETG00000
002702 mmp24 2.52 1.78E-02 
     ENSXETG00000
023036 kcnq3 2.51 4.33E-02 
     ENSXETG00000
018853 rab3c 2.49 2.56E-02 
     ENSXETG00000
012785 bsn 2.46 2.90E-03 
     ENSXETG00000
001650 ppp2r5b 2.44 1.80E-02 
     ENSXETG00000
017780 fez1 2.43 1.79E-02 
     ENSXETG00000
003374 col1a1 2.42 1.29E-08 
     ENSXETG00000
011604 ppp2r2c 2.42 4.59E-02 
     ENSXETG00000
012934 bgn 2.41 8.09E-05 
     ENSXETG00000
031380 gng3 2.40 4.49E-03 
     ENSXETG00000
002263 ttc28 2.39 2.03E-02 
     ENSXETG00000
016983 rtn1 2.38 4.83E-03 
     ENSXETG00000
020369 sgip1 2.37 2.42E-02 
     ENSXETG00000
011375 mmp25 2.36 8.46E-04 
     ENSXETG00000
030341 rab3il1 2.35 2.86E-02 
     ENSXETG00000
029995 sptbn1 2.35 4.04E-06 
     ENSXETG00000
011332 vwde 2.32 4.71E-02 
     ENSXETG00000
000720 hoxa5 2.32 4.22E-03 
     ENSXETG00000
015555 ank2 2.31 6.66E-03 
     ENSXETG00000
009096 vamp2 2.31 4.71E-02 
     ENSXETG00000
006707 b4galnt4 2.31 1.27E-02 
     ENSXETG00000
011788 cdx2 2.30 2.20E-03 
     ENSXETG00000
017443 glt25d2 2.26 2.13E-02 
     ENSXETG00000
011665 ncam1 2.24 6.66E-03 
     ENSXETG00000
031133 sema3e 2.24 1.79E-02 








     ENSXETG00000
004486 kif5c 2.21 3.76E-02 




     ENSXETG00000
011188 prph 2.19 4.41E-03 
     ENSXETG00000
007431 adam22 2.19 2.49E-03 
     ENSXETG00000
004589 cdx4 2.18 4.38E-03 
     ENSXETG00000
022798 sostdc1 2.16 3.47E-02 
     ENSXETG00000
026058 cnfn.1 2.13 1.07E-02 
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ENSXETG00000
020346 gabbr1 2.09 3.51E-03 
     ENSXETG00000
032203 map1a 2.08 3.10E-02 
     ENSXETG00000
002308 rims1 2.08 4.63E-02 
     ENSXETG00000
007363 rundc3a 2.06 9.90E-04 
     ENSXETG00000
018184 cyp26a1 2.06 9.26E-03 
     ENSXETG00000
025407 sp5 2.06 2.08E-02 
     ENSXETG00000
030115 sp8 2.05 1.46E-08 
     ENSXETG00000
012198 nid2 2.03 1.72E-06 
     ENSXETG00000
015806 hecw1 2.03 3.37E-02 
     ENSXETG00000
027090 
xb-gene-
5768884 2.01 6.07E-04 
     ENSXETG00000
013742 ndrg3 2.00 6.66E-03 
     ENSXETG00000
005949 mst1 1.99 3.48E-02 
     ENSXETG00000
018032 tubb2b 1.98 4.85E-04 
     ENSXETG00000
008971 ywhag 1.96 8.73E-04 
     ENSXETG00000
021967 hoxb3 1.95 4.18E-02 
     ENSXETG00000
016758 
xb-gene-
1002559 1.95 2.24E-06 
     ENSXETG00000
020280 fam171a1 1.94 1.97E-04 
     ENSXETG00000
024006 snai2 1.92 2.69E-03 
     ENSXETG00000
031472 tenm2 1.91 1.85E-05 
     ENSXETG00000
031338 cntn4 1.91 2.89E-02 
     ENSXETG00000
014880 
xb-gene-
5936529 1.89 2.38E-02 
     ENSXETG00000
017270 c3 1.88 1.04E-02 
     ENSXETG00000
010655 col2a1 1.88 4.18E-06 
     ENSXETG00000
017823 plxnb1 1.88 4.83E-03 
     ENSXETG00000
016109 gatm 1.86 6.29E-07 
     ENSXETG00000
007614 epha4 1.86 5.55E-03 
     ENSXETG00000
013228 egflam 1.86 2.99E-03 
     ENSXETG00000
019579 pmp22 1.80 1.04E-02 
     ENSXETG00000
009499 slc39a5 1.80 8.81E-04 
     ENSXETG00000
027751 marcks 1.79 1.71E-03 
     ENSXETG00000
005960 c3orf54 1.79 9.28E-04 
     ENSXETG00000
023647 rufy3 1.78 1.53E-03 
     ENSXETG00000
008706 flrt3 1.71 1.18E-02 
     ENSXETG00000
010898 fn1 1.66 8.57E-03 
     ENSXETG00000
010192 pde4dip 1.66 2.43E-02 
     ENSXETG00000
002710 rcor2 1.65 4.71E-02 
     ENSXETG00000
005775 gng13 1.65 4.73E-03 
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ENSXETG00000
004959 epb41l3 1.63 2.13E-02 
     ENSXETG00000
000172 maf 1.61 3.27E-02 
     ENSXETG00000
021398 dgki 1.61 4.26E-03 




     ENSXETG00000
002597 lpar1 1.57 4.71E-02 
     ENSXETG00000
007569 hapln3 1.57 9.12E-03 
     ENSXETG00000
011877 cd74 1.53 1.60E-02 
     ENSXETG00000
020022 gnao1 1.53 1.06E-02 
     ENSXETG00000
031404 draxin 1.49 1.77E-03 
     ENSXETG00000
018597 aldh3b1 1.47 6.85E-04 
     ENSXETG00000
007165 myo10.2 1.47 4.55E-02 
     ENSXETG00000
024138 rgma 1.46 2.76E-03 
     ENSXETG00000
011757 col5a3 1.46 1.70E-02 
     ENSXETG00000
011615 fam171a2 1.44 2.39E-02 
     ENSXETG00000
013891 kcnj13 1.39 3.95E-02 
     ENSXETG00000
012216 msi1 1.39 1.36E-02 
     ENSXETG00000
025032 mmp15 1.36 2.21E-02 
     ENSXETG00000
013633 rab30 1.36 1.92E-02 
     ENSXETG00000
020090 pfn2 1.34 1.74E-02 
     ENSXETG00000
003486 st3gal3 1.31 4.10E-02 
     ENSXETG00000
010561 dmd 1.30 1.40E-02 
     ENSXETG00000
018626 xk 1.30 4.71E-02 
     ENSXETG00000
011231 cmtm3 1.30 2.96E-02 
     ENSXETG00000
004468 kiaa0182 1.28 2.33E-03 
     ENSXETG00000
034199 prkg1 1.26 8.08E-04 
     ENSXETG00000
001502 cyfip2 1.21 1.65E-02 
     ENSXETG00000
018465 rell1 1.21 3.90E-02 
     ENSXETG00000
017308 dlgap4 1.18 5.73E-03 
     ENSXETG00000
027945 slc30a8 1.09 2.24E-02 
     ENSXETG00000
011833 ptprd 1.05 2.03E-02 
     ENSXETG00000
023814 angpt4 1.05 3.06E-03 
     ENSXETG00000
024861 loxl1 1.05 3.48E-02 
     ENSXETG00000
018462 nkd1 1.03 7.00E-03 
     ENSXETG00000
014931 pnkd 1.00 2.92E-02 




6.2 GO analysis of candidate genes 
Gene Ontology (GO) analysis was performed using DAVID 
(http://david.abcc.ncifcrf.gov) as previously described (Dennis et al., 2003). 
Analyzed were genes which were up and downregulated at stage 14 and 27, 
respectively. 
 
6.2.1 GO analysis of candidate genes upregulated at stage 14 
Given is the biological process, the number of genes and the P-value. Biological 
processes were sorted according to the P-value from lowest to highest. 
 
Table 6.3 Summary of GO analysis of genes upregulated at stage 14 
Biological Processes Count P-value 
GO:0007389~pattern specification process 33 5.20E-17 
GO:0003002~regionalization 28 6.70E-16 
GO:0001501~skeletal system development 34 1.55E-15 
GO:0009952~anterior/posterior pattern formation 24 1.71E-15 
GO:0009792~embryonic development ending in birth or egg hatching 30 7.64E-12 
GO:0043009~chordate embryonic development 29 3.36E-11 
GO:0048568~embryonic organ development 20 6.65E-10 
GO:0048598~embryonic morphogenesis 26 8.97E-10 
GO:0048706~embryonic skeletal system development 13 2.10E-08 
GO:0048705~skeletal system morphogenesis 14 1.98E-07 
GO:0016055~Wnt receptor signaling pathway 15 2.29E-07 
GO:0030182~neuron differentiation 27 2.72E-07 
GO:0006355~regulation of transcription, DNA-dependent 61 4.31E-06 
GO:0048562~embryonic organ morphogenesis 13 8.57E-06 
GO:0051252~regulation of RNA metabolic process 61 8.75E-06 
GO:0045165~cell fate commitment 13 1.35E-05 
GO:0035107~appendage morphogenesis 11 1.82E-05 
GO:0035108~limb morphogenesis 11 1.82E-05 
GO:0035295~tube development 16 2.02E-05 
GO:0002009~morphogenesis of an epithelium 11 2.17E-05 
GO:0048736~appendage development 11 2.57E-05 
GO:0060173~limb development 11 2.57E-05 
GO:0042127~regulation of cell proliferation 33 3.83E-05 
GO:0006357~regulation of transcription from RNA polymerase II promoter 31 5.19E-05 
GO:0045449~regulation of transcription 76 6.73E-05 
GO:0001568~blood vessel development 16 6.99E-05 
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GO:0001944~vasculature development 16 9.18E-05 
GO:0048704~embryonic skeletal system morphogenesis 8 9.68E-05 
GO:0006350~transcription 64 1.05E-04 
GO:0060429~epithelium development 15 1.13E-04 
GO:0031175~neuron projection development 16 1.15E-04 
GO:0060348~bone development 11 1.17E-04 
GO:0048729~tissue morphogenesis 13 1.69E-04 
GO:0030326~embryonic limb morphogenesis 9 2.44E-04 
GO:0035113~embryonic appendage morphogenesis 9 2.44E-04 
GO:0051960~regulation of nervous system development 13 3.07E-04 
GO:0051893~regulation of focal adhesion formation 4 3.54E-04 
GO:0070482~response to oxygen levels 11 3.59E-04 
GO:0022610~biological adhesion 28 3.78E-04 
GO:0007155~cell adhesion 28 3.78E-04 
GO:0007223~Wnt receptor signaling pathway, calcium modulating pathway 5 5.90E-04 
GO:0031328~positive regulation of cellular biosynthetic process 27 6.12E-04 
GO:0030030~cell projection organization 18 6.79E-04 
GO:0010557~positive regulation of macromolecule biosynthetic process 26 7.03E-04 
GO:0030323~respiratory tube development 9 7.16E-04 
GO:0048514~blood vessel morphogenesis 13 7.19E-04 
GO:0009891~positive regulation of biosynthetic process 27 7.53E-04 
GO:0051094~positive regulation of developmental process 15 8.82E-04 
GO:0022604~regulation of cell morphogenesis 10 8.83E-04 
GO:0001890~placenta development 7 9.41E-04 
GO:0008284~positive regulation of cell proliferation 19 9.51E-04 
GO:0045664~regulation of neuron differentiation 10 9.84E-04 
GO:0001666~response to hypoxia 10 0.001037845 
GO:0050767~regulation of neurogenesis 11 0.001277265 
GO:0048146~positive regulation of fibroblast proliferation 5 0.001368572 
GO:0045597~positive regulation of cell differentiation 13 0.001454326 
GO:0031344~regulation of cell projection organization 8 0.001507788 
GO:0001503~ossification 9 0.001564536 
GO:0010810~regulation of cell-substrate adhesion 6 0.001727396 
GO:0021915~neural tube development 7 0.001813197 
GO:0006928~cell motion 20 0.001833765 
GO:0060284~regulation of cell development 12 0.00188405 
GO:0035270~endocrine system development 7 0.00195489 
GO:0035282~segmentation 6 0.002092464 
GO:0010975~regulation of neuron projection development 7 0.002104804 
GO:0048666~neuron development 16 0.002122653 
GO:0001822~kidney development 8 0.002332143 
GO:0048812~neuron projection morphogenesis 12 0.002542962 
GO:0001708~cell fate specification 6 0.002741333 
GO:0051173~positive regulation of nitrogen compound metabolic process 24 0.002765258 
GO:0045596~negative regulation of cell differentiation 12 0.002834022 
GO:0035239~tube morphogenesis 9 0.002920086 
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GO:0060485~mesenchyme development 6 0.002986784 
GO:0014033~neural crest cell differentiation 5 0.00337608 
GO:0014032~neural crest cell development 5 0.00337608 
GO:0010769~regulation of cell morphogenesis involved in differentiation 7 0.003409922 
GO:0051895~negative regulation of focal adhesion formation 3 0.003461661 
GO:0010604~positive regulation of macromolecule metabolic process 29 0.003550878 
GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and 
nucleic acid metabolic process 23 0.003923674 
GO:0048145~regulation of fibroblast proliferation 5 0.004193864 
GO:0050770~regulation of axonogenesis 6 0.00445706 
GO:0045893~positive regulation of transcription, DNA-dependent 19 0.004459939 
GO:0030155~regulation of cell adhesion 9 0.004634042 
GO:0045944~positive regulation of transcription from RNA polymerase II 
promoter 16 0.00488243 
GO:0051254~positive regulation of RNA metabolic process 19 0.00490873 
GO:0001655~urogenital system development 8 0.00498123 
GO:0006469~negative regulation of protein kinase activity 7 0.006210497 
GO:0016477~cell migration 13 0.006593595 
GO:0000904~cell morphogenesis involved in differentiation 12 0.007032767 
GO:0002011~morphogenesis of an epithelial sheet 3 0.007088879 
GO:0060216~definitive hemopoiesis 3 0.007088879 
GO:0048858~cell projection morphogenesis 12 0.007244738 
GO:0033673~negative regulation of kinase activity 7 0.007306829 
GO:0001570~vasculogenesis 5 0.007423532 
GO:0010628~positive regulation of gene expression 21 0.007600185 
GO:0010629~negative regulation of gene expression 19 0.007718019 
GO:0051130~positive regulation of cellular component organization 10 0.007749873 
GO:0035136~forelimb morphogenesis 4 0.007990003 
GO:0007507~heart development 11 0.008095522 
GO:0000902~cell morphogenesis 15 0.00825573 
GO:0045892~negative regulation of transcription, DNA-dependent 15 0.00825573 
GO:0043549~regulation of kinase activity 15 0.008437681 
GO:0009855~determination of bilateral symmetry 5 0.008783876 
GO:0009799~determination of symmetry 5 0.008783876 
GO:0060562~epithelial tube morphogenesis 6 0.008824926 
GO:0032989~cellular component morphogenesis 16 0.009012378 
GO:0009954~proximal/distal pattern formation 4 0.009061354 
GO:0051253~negative regulation of RNA metabolic process 15 0.009381825 
GO:0043583~ear development 7 0.009434829 
GO:0051348~negative regulation of transferase activity 7 0.009908341 
GO:0032990~cell part morphogenesis 12 0.009912217 
GO:0010720~positive regulation of cell development 6 0.00996161 
GO:0042981~regulation of apoptosis 26 0.010494514 
GO:0040012~regulation of locomotion 10 0.011167629 
GO:0030324~lung development 7 0.01143017 
GO:0050772~positive regulation of axonogenesis 4 0.011445024 
GO:0045941~positive regulation of transcription 20 0.011537427 
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GO:0007409~axonogenesis 10 0.011545858 
GO:0043067~regulation of programmed cell death 26 0.0118267 
GO:0051338~regulation of transferase activity 15 0.011865452 
GO:0031346~positive regulation of cell projection organization 5 0.011970439 
GO:0010941~regulation of cell death 26 0.01219235 
GO:0007423~sensory organ development 11 0.012269742 
GO:0001952~regulation of cell-matrix adhesion 4 0.014156404 
GO:0016481~negative regulation of transcription 17 0.014505195 
GO:0048870~cell motility 13 0.014567628 
GO:0051674~localization of cell 13 0.014567628 
GO:0001953~negative regulation of cell-matrix adhesion 3 0.01463005 
GO:0045859~regulation of protein kinase activity 14 0.01481493 
GO:0030334~regulation of cell migration 9 0.015480762 
GO:0010811~positive regulation of cell-substrate adhesion 4 0.015636844 
GO:0014031~mesenchymal cell development 5 0.015816193 
GO:0048762~mesenchymal cell differentiation 5 0.015816193 
GO:0030278~regulation of ossification 6 0.016323553 
GO:0016337~cell-cell adhesion 12 0.016588266 
GO:0060541~respiratory system development 7 0.01697508 
GO:0048839~inner ear development 6 0.017164717 
GO:0043065~positive regulation of apoptosis 16 0.017541166 
GO:0010812~negative regulation of cell-substrate adhesion 3 0.017659224 
GO:0043405~regulation of MAP kinase activity 8 0.018111471 
GO:0048667~cell morphogenesis involved in neuron differentiation 10 0.01852925 
GO:0043068~positive regulation of programmed cell death 16 0.018540644 
GO:0044087~regulation of cellular component biogenesis 8 0.018753038 
GO:0060606~tube closure 4 0.01884975 
GO:0001843~neural tube closure 4 0.01884975 
GO:0010942~positive regulation of cell death 16 0.019262565 
GO:0010033~response to organic substance 23 0.019360157 
GO:0008285~negative regulation of cell proliferation 14 0.020732215 
GO:0048566~embryonic gut development 3 0.020928455 
GO:0042573~retinoic acid metabolic process 3 0.020928455 
GO:0009719~response to endogenous stimulus 15 0.022644706 
GO:0051174~regulation of phosphorus metabolic process 17 0.02297031 
GO:0019220~regulation of phosphate metabolic process 17 0.02297031 
GO:0009725~response to hormone stimulus 14 0.02326085 
GO:0006351~transcription, DNA-dependent 12 0.023974942 
GO:0016331~morphogenesis of embryonic epithelium 5 0.024243091 
GO:0014020~primary neural tube formation 4 0.024303066 
GO:0006775~fat-soluble vitamin metabolic process 4 0.024303066 
GO:0070633~transepithelial transport 3 0.024427602 
GO:0051726~regulation of cell cycle 13 0.024755656 
GO:0048589~developmental growth 6 0.024939263 
GO:0050769~positive regulation of neurogenesis 5 0.025630326 
GO:0032774~RNA biosynthetic process 12 0.02613828 
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GO:0001756~somitogenesis 4 0.02629014 
GO:0045785~positive regulation of cell adhesion 5 0.027064424 
GO:0030902~hindbrain development 5 0.027064424 
GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway 10 0.027491236 
GO:0045668~negative regulation of osteoblast differentiation 3 0.028146821 
GO:0003006~reproductive developmental process 11 0.028314277 
GO:0006468~protein amino acid phosphorylation 21 0.028893477 
GO:0048545~response to steroid hormone stimulus 9 0.030354731 
GO:0007167~enzyme linked receptor protein signaling pathway 13 0.030451206 
GO:0048565~gut development 4 0.03051738 
GO:0043407~negative regulation of MAP kinase activity 4 0.03051738 
GO:0016310~phosphorylation 24 0.030890604 
GO:0051270~regulation of cell motion 9 0.031228716 
GO:0001893~maternal placenta development 3 0.032076557 
GO:0042325~regulation of phosphorylation 16 0.03277587 
GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and 
nucleic acid metabolic process 17 0.035341015 
GO:0007090~regulation of S phase of mitotic cell cycle 3 0.036207534 
GO:0007398~ectoderm development 9 0.036435924 
GO:0042471~ear morphogenesis 5 0.036665433 
GO:0043066~negative regulation of apoptosis 13 0.038284051 
GO:0008283~cell proliferation 15 0.039144981 
GO:0051172~negative regulation of nitrogen compound metabolic process 17 0.039248832 
GO:0001841~neural tube formation 4 0.039973844 
GO:0043069~negative regulation of programmed cell death 13 0.041564695 
GO:0006917~induction of apoptosis 12 0.042136077 
GO:0010035~response to inorganic substance 9 0.042158107 
GO:0060548~negative regulation of cell death 13 0.042766221 
GO:0012502~induction of programmed cell death 12 0.043017406 
GO:0012501~programmed cell death 19 0.043551309 
GO:0048732~gland development 7 0.043969141 
GO:0022405~hair cycle process 4 0.045194271 
GO:0001942~hair follicle development 4 0.045194271 
GO:0007368~determination of left/right symmetry 4 0.045194271 
GO:0022404~molting cycle process 4 0.045194271 
GO:0042303~molting cycle 4 0.047925051 
GO:0007162~negative regulation of cell adhesion 4 0.047925051 
GO:0045667~regulation of osteoblast differentiation 4 0.047925051 
GO:0001838~embryonic epithelial tube formation 4 0.047925051 
GO:0042633~hair cycle 4 0.047925051 
GO:0030198~extracellular matrix organization 6 0.048104005 
GO:0007166~cell surface receptor linked signal transduction 46 0.048768893 
GO:0006796~phosphate metabolic process 27 0.048780288 
GO:0006793~phosphorus metabolic process 27 0.048780288 
GO:0021587~cerebellum morphogenesis 3 0.049719237 
GO:0031128~developmental induction 3 0.049719237 
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GO:0035115~embryonic forelimb morphogenesis 3 0.049719237 
GO:0001502~cartilage condensation 3 0.049719237 
GO:0051492~regulation of stress fiber formation 3 0.049719237 
GO:0045168~cell-cell signaling involved in cell fate specification 3 0.049719237 
GO:0043627~response to estrogen stimulus 6 0.049761407 
GO:0003007~heart morphogenesis 5 0.050048384 
GO:0007243~protein kinase cascade 13 0.050540179 
GO:0006720~isoprenoid metabolic process 4 0.050735094 
GO:0035148~tube lumen formation 4 0.050735094 
GO:0001701~in utero embryonic development 8 0.051147881 
GO:0006766~vitamin metabolic process 5 0.054303387 
GO:0044092~negative regulation of molecular function 12 0.054485982 
GO:0001825~blastocyst formation 3 0.05456781 
GO:0008299~isoprenoid biosynthetic process 3 0.05456781 
GO:0033261~regulation of S phase 3 0.05456781 
GO:0046149~pigment catabolic process 2 0.055921085 
GO:0040037~negative regulation of fibroblast growth factor receptor signaling 
pathway 2 0.055921085 
GO:0032536~regulation of cell projection size 2 0.055921085 
GO:0031133~regulation of axon diameter 2 0.055921085 
GO:0042167~heme catabolic process 2 0.055921085 
GO:0008219~cell death 21 0.056076417 
GO:0030111~regulation of Wnt receptor signaling pathway 4 0.056589295 
GO:0010558~negative regulation of macromolecule biosynthetic process 17 0.05772314 
GO:0016265~death 21 0.058148938 
GO:0032231~regulation of actin filament bundle formation 3 0.059575223 
GO:0009746~response to hexose stimulus 4 0.05963149 
GO:0034284~response to monosaccharide stimulus 4 0.05963149 
GO:0040007~growth 8 0.060379206 
GO:0048534~hemopoietic or lymphoid organ development 10 0.060923059 
GO:0000165~MAPKKK cascade 8 0.061876376 
GO:0008544~epidermis development 8 0.061876376 
GO:0001525~angiogenesis 7 0.063230158 
GO:0043547~positive regulation of GTPase activity 3 0.064733745 
GO:0008633~activation of pro-apoptotic gene products 3 0.064733745 
GO:0010564~regulation of cell cycle process 6 0.06617626 
GO:0006915~apoptosis 18 0.067397024 
GO:0000122~negative regulation of transcription from RNA polymerase II 
promoter 10 0.067789829 
GO:0007548~sex differentiation 7 0.068282648 
GO:0010817~regulation of hormone levels 7 0.068282648 
GO:0031327~negative regulation of cellular biosynthetic process 17 0.068700964 
GO:0007346~regulation of mitotic cell cycle 7 0.070017571 
GO:0048806~genitalia development 3 0.070035878 
GO:0021575~hindbrain morphogenesis 3 0.070035878 
GO:0001523~retinoid metabolic process 3 0.070035878 
GO:0006776~vitamin A metabolic process 3 0.070035878 
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GO:0016101~diterpenoid metabolic process 3 0.070035878 
GO:0001755~neural crest cell migration 3 0.070035878 
GO:0044057~regulation of system process 11 0.070928679 
GO:0002683~negative regulation of immune system process 5 0.073205344 
GO:0010746~regulation of plasma membrane long-chain fatty acid transport 2 0.073860329 
GO:0051497~negative regulation of stress fiber formation 2 0.073860329 
GO:0060441~branching involved in lung morphogenesis 2 0.073860329 
GO:0045110~intermediate filament bundle assembly 2 0.073860329 
GO:0042904~9-cis-retinoic acid biosynthetic process 2 0.073860329 
GO:0010748~negative regulation of plasma membrane long-chain fatty acid 
transport 2 0.073860329 
GO:0042905~9-cis-retinoic acid metabolic process 2 0.073860329 
GO:0031558~induction of apoptosis in response to chemical stimulus 2 0.073860329 
GO:0060438~trachea development 2 0.073860329 
GO:0035238~vitamin A biosynthetic process 2 0.073860329 
GO:0033674~positive regulation of kinase activity 9 0.074038316 
GO:0045778~positive regulation of ossification 3 0.075474351 
GO:0001892~embryonic placenta development 3 0.075474351 
GO:0046777~protein amino acid autophosphorylation 5 0.078390786 
GO:0007242~intracellular signaling cascade 32 0.078534519 
GO:0001889~liver development 4 0.079427237 
GO:0009890~negative regulation of biosynthetic process 17 0.080132165 
GO:0006721~terpenoid metabolic process 3 0.081042119 
GO:0006606~protein import into nucleus 5 0.081050684 
GO:0002520~immune system development 10 0.081103167 
GO:0048609~reproductive process in a multicellular organism 15 0.081411812 
GO:0032504~multicellular organism reproduction 15 0.081411812 
GO:0030097~hemopoiesis 9 0.081471717 
GO:0042476~odontogenesis 4 0.082972575 
GO:0051170~nuclear import 5 0.086502872 
GO:0018149~peptide cross-linking 3 0.08673235 
GO:0051347~positive regulation of transferase activity 9 0.087711566 
GO:0043623~cellular protein complex assembly 7 0.088754002 
GO:0030335~positive regulation of cell migration 5 0.089294329 
GO:0042472~inner ear morphogenesis 4 0.090262802 
GO:0043062~extracellular structure organization 7 0.090765091 
GO:0031557~induction of programmed cell death in response to chemical 
stimulus 2 0.091459996 
GO:0045683~negative regulation of epidermis development 2 0.091459996 
GO:0006787~porphyrin catabolic process 2 0.091459996 
GO:0042362~fat-soluble vitamin biosynthetic process 2 0.091459996 
GO:0033015~tetrapyrrole catabolic process 2 0.091459996 
GO:0032232~negative regulation of actin filament bundle formation 2 0.091459996 
GO:0002695~negative regulation of leukocyte activation 4 0.094005045 
GO:0045787~positive regulation of cell cycle 4 0.094005045 
GO:0051240~positive regulation of multicellular organismal process 9 0.094221975 
GO:0010647~positive regulation of cell communication 11 0.097158063 
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6.2.2 GO analysis of candidate genes downregulated at stage 14 
Given is the biological process, the number of genes and the P-value. Biological 
processes were sorted according to the P-value from lowest to highest. 
 
Table 6.4 Summary of GO analysis of genes downregulated at stage 14 
Biological Process Count P-Value 
GO:0007017~microtubule-based process 25 2.09E-10 
GO:0007018~microtubule-based movement 16 6.13E-09 
GO:0030030~cell projection organization 25 3.15E-07 
GO:0006928~cell motion 25 2.56E-05 
GO:0035295~tube development 16 3.30E-05 
GO:0030031~cell projection assembly 10 3.76E-05 
GO:0001539~ciliary or flagellar motility 5 1.29E-04 
GO:0060271~cilium morphogenesis 6 4.43E-04 
GO:0030324~lung development 9 7.72E-04 
GO:0030323~respiratory tube development 9 9.40E-04 
GO:0007507~heart development 13 1.22E-03 
GO:0051674~localization of cell 16 1.23E-03 
GO:0048870~cell motility 16 1.23E-03 
GO:0060541~respiratory system development 9 1.36E-03 
GO:0000902~cell morphogenesis 17 1.99E-03 
GO:0042384~cilium assembly 5 2.12E-03 
GO:0032989~cellular component morphogenesis 18 2.43E-03 
GO:0048729~tissue morphogenesis 11 3.17E-03 
GO:0048858~cell projection morphogenesis 13 3.64E-03 
GO:0002009~morphogenesis of an epithelium 8 3.91E-03 
GO:0032990~cell part morphogenesis 13 5.13E-03 
GO:0007423~sensory organ development 12 6.04E-03 
GO:0046777~protein amino acid autophosphorylation 7 6.77E-03 
GO:0048232~male gamete generation 14 8.57E-03 
GO:0007283~spermatogenesis 14 8.57E-03 
GO:0048286~lung alveolus development 4 8.96E-03 
GO:0007242~intracellular signaling cascade 38 9.30E-03 
GO:0019953~sexual reproduction 18 9.96E-03 
GO:0007276~gamete generation 16 1.23E-02 
GO:0003007~heart morphogenesis 6 1.48E-02 
GO:0048609~reproductive process in a multicellular organism 18 1.72E-02 
GO:0032504~multicellular organism reproduction 18 1.72E-02 
GO:0008360~regulation of cell shape 5 2.20E-02 
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GO:0051350~negative regulation of lyase activity 5 2.33E-02 
GO:0031280~negative regulation of cyclase activity 5 2.33E-02 
GO:0007194~negative regulation of adenylate cyclase activity 5 2.33E-02 
GO:0001701~in utero embryonic development 9 2.42E-02 
GO:0001568~blood vessel development 11 2.47E-02 
GO:0000226~microtubule cytoskeleton organization 8 2.71E-02 
GO:0007588~excretion 5 2.77E-02 
GO:0016331~morphogenesis of embryonic epithelium 5 2.77E-02 
GO:0045893~positive regulation of transcription, DNA-dependent 17 2.83E-02 
GO:0001944~vasculature development 11 2.84E-02 
GO:0051056~regulation of small GTPase mediated signal transduction 11 2.91E-02 
GO:0043193~positive regulation of gene-specific transcription 6 2.92E-02 
GO:0017157~regulation of exocytosis 4 2.93E-02 
GO:0051254~positive regulation of RNA metabolic process 17 3.06E-02 
GO:0001890~placenta development 5 3.09E-02 
GO:0022037~metencephalon development 4 3.16E-02 
GO:0051173~positive regulation of nitrogen compound metabolic process 21 3.16E-02 
GO:0031328~positive regulation of cellular biosynthetic process 22 3.16E-02 
GO:0043009~chordate embryonic development 13 3.27E-02 
GO:0009792~embryonic development ending in birth or egg hatching 13 3.44E-02 
GO:0035088~establishment or maintenance of apical/basal cell polarity 3 3.46E-02 
GO:0007169~transmembrane receptor protein tyrosine kinase signaling 
pathway 10 3.49E-02 
GO:0009891~positive regulation of biosynthetic process 22 3.60E-02 
GO:0046903~secretion 12 3.70E-02 
GO:0048545~response to steroid hormone stimulus 9 3.78E-02 
GO:0048639~positive regulation of developmental growth 3 3.91E-02 
GO:0010628~positive regulation of gene expression 19 4.08E-02 
GO:0007264~small GTPase mediated signal transduction 12 4.09E-02 
GO:0042475~odontogenesis of dentine-containing tooth 4 4.16E-02 
GO:0045761~regulation of adenylate cyclase activity 6 4.19E-02 
GO:0006468~protein amino acid phosphorylation 21 4.25E-02 
GO:0048598~embryonic morphogenesis 12 4.31E-02 
GO:0050796~regulation of insulin secretion 4 4.44E-02 
GO:0007193~inhibition of adenylate cyclase activity by G-protein signaling 4 4.44E-02 
GO:0021915~neural tube development 5 4.58E-02 
GO:0016310~phosphorylation 24 4.61E-02 
GO:0031279~regulation of cyclase activity 6 4.68E-02 
GO:0006796~phosphate metabolic process 28 4.75E-02 
GO:0006793~phosphorus metabolic process 28 4.75E-02 
GO:0001654~eye development 7 4.75E-02 
GO:0051046~regulation of secretion 9 4.85E-02 
GO:0016055~Wnt receptor signaling pathway 7 4.90E-02 
GO:0030817~regulation of cAMP biosynthetic process 6 5.03E-02 
Appendix 127 
GO:0051339~regulation of lyase activity 6 5.03E-02 
GO:0032583~regulation of gene-specific transcription 7 5.05E-02 
GO:0048732~gland development 7 5.20E-02 
GO:0007010~cytoskeleton organization 15 5.23E-02 
GO:0030814~regulation of cAMP metabolic process 6 5.38E-02 
GO:0045941~positive regulation of transcription 18 5.67E-02 
GO:0046034~ATP metabolic process 6 5.76E-02 
GO:0043627~response to estrogen stimulus 6 5.76E-02 
GO:0046599~regulation of centriole replication 2 5.83E-02 
GO:0007498~mesoderm development 5 5.91E-02 
GO:0010557~positive regulation of macromolecule biosynthetic process 20 6.20E-02 
GO:0002791~regulation of peptide secretion 4 6.26E-02 
GO:0046928~regulation of neurotransmitter secretion 3 6.41E-02 
GO:0051017~actin filament bundle formation 3 6.41E-02 
GO:0045944~positive regulation of transcription from RNA polymerase II 
promoter 13 6.50E-02 
GO:0030808~regulation of nucleotide biosynthetic process 6 6.75E-02 
GO:0030802~regulation of cyclic nucleotide biosynthetic process 6 6.75E-02 
GO:0001947~heart looping 3 6.97E-02 
GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and 
nucleic acid metabolic process 19 7.11E-02 
GO:0048839~inner ear development 5 7.16E-02 
GO:0019216~regulation of lipid metabolic process 6 7.18E-02 
GO:0030799~regulation of cyclic nucleotide metabolic process 6 7.39E-02 
GO:0007044~cell-substrate junction assembly 3 7.53E-02 
GO:0002088~lens development in camera-type eye 3 7.53E-02 
GO:0006140~regulation of nucleotide metabolic process 6 8.07E-02 
GO:0009205~purine ribonucleoside triphosphate metabolic process 6 8.30E-02 
GO:0060429~epithelium development 9 8.33E-02 
GO:0009199~ribonucleoside triphosphate metabolic process 6 8.53E-02 
GO:0006357~regulation of transcription from RNA polymerase II promoter 21 8.55E-02 
GO:0010604~positive regulation of macromolecule metabolic process 24 8.55E-02 
GO:0042733~embryonic digit morphogenesis 3 8.71E-02 
GO:0042476~odontogenesis 4 9.14E-02 
GO:0042692~muscle cell differentiation 6 9.26E-02 
GO:0051588~regulation of neurotransmitter transport 3 9.31E-02 
GO:0009144~purine nucleoside triphosphate metabolic process 6 9.51E-02 
GO:0060411~heart septum morphogenesis 2 9.52E-02 
GO:0030182~neuron differentiation 14 9.64E-02 





6.2.3 GO analysis of candidate genes upregulated at stage 27 
Given is the biological process, the number of genes and the P-value. Biological 
processes were sorted according to the P-value from lowest to highest. 
 
Table 6.5 Summary of GO analysis of genes upregulated at stage 27 
Biological Process Count P-value 
GO:0030182~neuron differentiation 41 1.16E-16 
GO:0031175~neuron projection development 29 8.25E-14 
GO:0048666~neuron development 32 4.71E-13 
GO:0048667~cell morphogenesis involved in neuron differentiation 25 1.88E-12 
GO:0048812~neuron projection morphogenesis 25 2.84E-12 
GO:0000904~cell morphogenesis involved in differentiation 26 8.19E-12 
GO:0007409~axonogenesis 23 1.90E-11 
GO:0030030~cell projection organization 31 2.15E-11 
GO:0048858~cell projection morphogenesis 25 5.67E-11 
GO:0032990~cell part morphogenesis 25 1.42E-10 
GO:0000902~cell morphogenesis 29 2.41E-10 
GO:0032989~cellular component morphogenesis 30 6.46E-10 
GO:0007389~pattern specification process 24 1.85E-09 
GO:0007155~cell adhesion 39 6.09E-09 
GO:0022610~biological adhesion 39 6.21E-09 
GO:0048706~embryonic skeletal system development 13 2.39E-08 
GO:0043009~chordate embryonic development 25 2.43E-08 
GO:0009792~embryonic development ending in birth or egg hatching 25 2.89E-08 
GO:0045664~regulation of neuron differentiation 16 3.87E-08 
GO:0009952~anterior/posterior pattern formation 16 7.73E-08 
GO:0010975~regulation of neuron projection development 12 8.50E-08 
GO:0050767~regulation of neurogenesis 17 1.26E-07 
GO:0007411~axon guidance 14 1.31E-07 
GO:0051960~regulation of nervous system development 18 1.74E-07 
GO:0001501~skeletal system development 23 2.27E-07 
GO:0003002~regionalization 18 2.52E-07 
GO:0007268~synaptic transmission 22 3.05E-07 
GO:0006928~cell motion 28 4.70E-07 
GO:0006836~neurotransmitter transport 12 5.09E-07 
GO:0031344~regulation of cell projection organization 12 1.04E-06 
GO:0019226~transmission of nerve impulse 23 1.11E-06 
GO:0050770~regulation of axonogenesis 10 1.25E-06 
GO:0007267~cell-cell signaling 31 1.57E-06 
GO:0048598~embryonic morphogenesis 21 2.02E-06 
GO:0060284~regulation of cell development 17 2.18E-06 
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GO:0016337~cell-cell adhesion 19 6.52E-06 
GO:0048066~pigmentation during development 7 7.93E-06 
GO:0048705~skeletal system morphogenesis 12 1.01E-05 
GO:0006813~potassium ion transport 14 1.29E-05 
GO:0010769~regulation of cell morphogenesis involved in differentiation 10 1.61E-05 
GO:0051969~regulation of transmission of nerve impulse 13 2.65E-05 
GO:0048568~embryonic organ development 14 2.79E-05 
GO:0030001~metal ion transport 24 3.29E-05 
GO:0031644~regulation of neurological system process 13 3.95E-05 
GO:0022604~regulation of cell morphogenesis 12 4.44E-05 
GO:0043062~extracellular structure organization 13 7.32E-05 
GO:0044057~regulation of system process 18 1.01E-04 
GO:0048704~embryonic skeletal system morphogenesis 8 1.04E-04 
GO:0007610~behavior 23 1.07E-04 
GO:0015672~monovalent inorganic cation transport 18 1.43E-04 
GO:0030814~regulation of cAMP metabolic process 10 1.62E-04 
GO:0048562~embryonic organ morphogenesis 11 2.46E-04 
GO:0001505~regulation of neurotransmitter levels 8 2.91E-04 
GO:0050804~regulation of synaptic transmission 11 2.94E-04 
GO:0030799~regulation of cyclic nucleotide metabolic process 10 3.26E-04 
GO:0042438~melanin biosynthetic process 4 3.66E-04 
GO:0006140~regulation of nucleotide metabolic process 10 3.97E-04 
GO:0006812~cation transport 24 4.26E-04 
GO:0016358~dendrite development 6 5.11E-04 
GO:0051046~regulation of secretion 13 5.39E-04 
GO:0006582~melanin metabolic process 4 5.41E-04 
GO:0032940~secretion by cell 13 6.70E-04 
GO:0030817~regulation of cAMP biosynthetic process 9 7.24E-04 
GO:0007626~locomotory behavior 15 8.59E-04 
GO:0043473~pigmentation 7 9.14E-04 
GO:0016477~cell migration 15 9.23E-04 
GO:0003001~generation of a signal involved in cell-cell signaling 8 0.001231481 
GO:0030802~regulation of cyclic nucleotide biosynthetic process 9 0.001265542 
GO:0030808~regulation of nucleotide biosynthetic process 9 0.001265542 
GO:0006811~ion transport 28 0.001768227 
GO:0048870~cell motility 15 0.0025172 
GO:0051674~localization of cell 15 0.0025172 
GO:0001568~blood vessel development 13 0.002811991 
GO:0035108~limb morphogenesis 8 0.002961616 
GO:0035107~appendage morphogenesis 8 0.002961616 
GO:0060341~regulation of cellular localization 13 0.003114642 
GO:0035239~tube morphogenesis 9 0.003134576 
GO:0021700~developmental maturation 8 0.00331301 
GO:0001944~vasculature development 13 0.003419115 
GO:0048489~synaptic vesicle transport 5 0.003519358 
GO:0035295~tube development 12 0.003569016 
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GO:0048736~appendage development 8 0.003695362 
GO:0060173~limb development 8 0.003695362 
GO:0007156~homophilic cell adhesion 9 0.003789648 
GO:0030198~extracellular matrix organization 8 0.00389868 
GO:0017157~regulation of exocytosis 5 0.003929277 
GO:0007269~neurotransmitter secretion 5 0.003929277 
GO:0046903~secretion 14 0.005404261 
GO:0032535~regulation of cellular component size 13 0.006246604 
GO:0055085~transmembrane transport 21 0.006911794 
GO:0046928~regulation of neurotransmitter secretion 4 0.007224663 
GO:0030815~negative regulation of cAMP metabolic process 3 0.007250275 
GO:0034109~homotypic cell-cell adhesion 3 0.007250275 
GO:0060425~lung morphogenesis 3 0.007250275 
GO:0060216~definitive hemopoiesis 3 0.007250275 
GO:0030818~negative regulation of cAMP biosynthetic process 3 0.007250275 
GO:0048754~branching morphogenesis of a tube 6 0.008159968 
GO:0007157~heterophilic cell adhesion 4 0.008248185 
GO:0045596~negative regulation of cell differentiation 11 0.009099984 
GO:0060562~epithelial tube morphogenesis 6 0.009251241 
GO:0030800~negative regulation of cyclic nucleotide metabolic process 3 0.009545066 
GO:0030803~negative regulation of cyclic nucleotide biosynthetic process 3 0.009545066 
GO:0030809~negative regulation of nucleotide biosynthetic process 3 0.009545066 
GO:0045761~regulation of adenylate cyclase activity 7 0.010452748 
GO:0007605~sensory perception of sound 7 0.010967908 
GO:0031279~regulation of cyclase activity 7 0.012051707 
GO:0051588~regulation of neurotransmitter transport 4 0.013163109 
GO:0002009~morphogenesis of an epithelium 7 0.013208821 
GO:0051339~regulation of lyase activity 7 0.013208821 
GO:0001763~morphogenesis of a branching structure 6 0.013856403 
GO:0051216~cartilage development 6 0.013856403 
GO:0050954~sensory perception of mechanical stimulus 7 0.014441604 
GO:0031103~axon regeneration 3 0.014956548 
GO:0007413~axonal fasciculation 3 0.014956548 
GO:0045980~negative regulation of nucleotide metabolic process 3 0.014956548 
GO:0050877~neurological system process 35 0.015730745 
GO:0060485~mesenchyme development 5 0.017544866 
GO:0019748~secondary metabolic process 6 0.017956203 
GO:0008344~adult locomotory behavior 5 0.019898081 
GO:0001701~in utero embryonic development 9 0.020509356 
GO:0031102~neuron projection regeneration 3 0.021389283 
GO:0000768~syncytium formation by plasma membrane fusion 3 0.021389283 
GO:0007416~synaptogenesis 4 0.023087282 
GO:0048729~tissue morphogenesis 9 0.023132422 
GO:0006887~exocytosis 7 0.02355024 
GO:0030534~adult behavior 6 0.024933099 
GO:0014032~neural crest cell development 4 0.025044074 
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GO:0014033~neural crest cell differentiation 4 0.025044074 
GO:0000165~MAPKKK cascade 9 0.02591496 
GO:0030326~embryonic limb morphogenesis 6 0.026053265 
GO:0035113~embryonic appendage morphogenesis 6 0.026053265 
GO:0006949~syncytium formation 3 0.028758271 
GO:0030318~melanocyte differentiation 3 0.028758271 
GO:0048488~synaptic vesicle endocytosis 3 0.028758271 
GO:0050808~synapse organization 5 0.029616122 
GO:0031290~retinal ganglion cell axon guidance 3 0.032768659 
GO:0050931~pigment cell differentiation 3 0.032768659 
GO:0001667~ameboidal cell migration 4 0.03373438 
GO:0001764~neuron migration 5 0.034504837 
GO:0048167~regulation of synaptic plasticity 5 0.034504837 
GO:0060627~regulation of vesicle-mediated transport 6 0.037588508 
GO:0048791~calcium ion-dependent exocytosis of neurotransmitter 2 0.038070802 
GO:0006583~melanin biosynthetic process from tyrosine 2 0.038070802 
GO:0046148~pigment biosynthetic process 4 0.038592163 
GO:0033555~multicellular organismal response to stress 4 0.038592163 
GO:0007229~integrin-mediated signaling pathway 5 0.045608009 
GO:0008361~regulation of cell size 9 0.045875901 
GO:0006029~proteoglycan metabolic process 4 0.049308912 
GO:0021545~cranial nerve development 3 0.050763034 
GO:0016192~vesicle-mediated transport 18 0.052921235 
GO:0042440~pigment metabolic process 4 0.05515485 
GO:0048678~response to axon injury 3 0.05570552 
GO:0030516~regulation of axon extension 3 0.05570552 
GO:0008038~neuron recognition 3 0.060808768 
GO:0040007~growth 8 0.063432166 
GO:0007628~adult walking behavior 3 0.066064826 
GO:0045103~intermediate filament-based process 3 0.066064826 
GO:0035136~forelimb morphogenesis 3 0.066064826 
GO:0007167~enzyme linked receptor protein signaling pathway 12 0.06630625 
GO:0007018~microtubule-based movement 6 0.066795171 
GO:0010817~regulation of hormone levels 7 0.071348392 
GO:0009954~proximal/distal pattern formation 3 0.071465987 
GO:0001755~neural crest cell migration 3 0.071465987 
GO:0014031~mesenchymal cell development 4 0.074545726 
GO:0048762~mesenchymal cell differentiation 4 0.074545726 
GO:0060441~branching involved in lung morphogenesis 2 0.07469758 
GO:0060438~trachea development 2 0.07469758 
GO:0006904~vesicle docking during exocytosis 3 0.077004782 
GO:0016050~vesicle organization 4 0.078035575 
GO:0001558~regulation of cell growth 8 0.080849044 
GO:0050771~negative regulation of axonogenesis 3 0.082673971 
GO:0050772~positive regulation of axonogenesis 3 0.082673971 
GO:0051970~negative regulation of transmission of nerve impulse 3 0.082673971 
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GO:0021675~nerve development 3 0.082673971 
GO:0009611~response to wounding 16 0.083449246 
GO:0042476~odontogenesis 4 0.085225078 
GO:0048589~developmental growth 5 0.086531155 
GO:0006355~regulation of transcription, DNA-dependent 43 0.086826183 
GO:0007242~intracellular signaling cascade 32 0.088261636 
GO:0018149~peptide cross-linking 3 0.088466543 
GO:0048278~vesicle docking 3 0.088466543 
GO:0008037~cell recognition 4 0.088922057 
GO:0031280~negative regulation of cyclase activity 4 0.088922057 
GO:0051350~negative regulation of lyase activity 4 0.088922057 
GO:0007194~negative regulation of adenylate cyclase activity 4 0.088922057 
GO:0007160~cell-matrix adhesion 5 0.09222525 
GO:0032229~negative regulation of synaptic transmission, GABAergic 2 0.092486595 
GO:0016188~synaptic vesicle maturation 2 0.092486595 
 
6.2.4 GO analysis of candidate genes downregulated at stage 27 
Given is the biological process, the number of genes and the P-value. Biological 
processes were sorted according to the P-value from lowest to highest. 
 
Table 6.6 Summary of GO analysis of genes downregulated at stage 27 
Biological Process Count P-value 
GO:0042398~cellular amino acid derivative biosynthetic process 3 0.004423821 
GO:0009309~amine biosynthetic process 3 0.009715815 
GO:0042423~catecholamine biosynthetic process 2 0.020148791 
GO:0006575~cellular amino acid derivative metabolic process 3 0.037332173 
GO:0007595~lactation 2 0.050523221 
GO:0042401~biogenic amine biosynthetic process 2 0.054036675 
GO:0007610~behavior 4 0.054132144 
GO:0006584~catecholamine metabolic process 2 0.061026178 
GO:0009712~catechol metabolic process 2 0.061026178 
GO:0034311~diol metabolic process 2 0.061026178 
GO:0018958~phenol metabolic process 2 0.062765791 
GO:0051591~response to cAMP 2 0.074856742 
GO:0032102~negative regulation of response to external stimulus 2 0.088491623 
GO:0007626~locomotory behavior 3 0.090424381 
  
 
